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Abstract 
    Glaucoma is the second most common cause of blindness worldwide and is often associated with 
an increased intraocular pressure (IOP). IOP is determined by the dynamics of aqueous humour, 
the liquid filling the anterior segment of the eye. In primary-open angle glaucoma, the elevated IOP 
is caused by a decreased outflow facility of aqueous humour through the conventional pathway 
(decreased conventional facility, C). Existing glaucoma therapies aim to lower IOP, but remain 
inefficient because they fail to target C. As a result, there is growing interest in using the mouse to 
unravel the mechanisms controlling C. The mouse is a particularly powerful model because it can 
be routinely manipulated genetically, thereby giving insight into molecules and genes involved in 
determining C. However, it is still not clear whether mice are suitable surrogates for studying human 
C. 
    To fill this gap, we aim to demonstrate that the mouse is a suitable model for human IOP 
regulation, and to then use this model to investigate key processes in IOP regulation.  
    To achieve this aim we used an existing perfusion system to measure C in enucleated mouse 
eyes. First, we improved the perfusion system by including hydration and temperature control to 
better mimic in vivo perfusions. Secondly, selected receptor-mediated drugs were found to have 
similar effects on C in mice as they did in past human studies. Finally, we show, amongst other 
studies, anti-metabolic agents decreased C, suggesting aqueous humour outflow is metabolic 
dependent.  
    We conclude that the mouse is a valid model for studying human conventional facility, yielding 
novel insight into the mechanisms controlling conventional facility. Importantly, this will help the 
design of novel efficient anti-glaucoma treatments. Notably, this project will have brought 
fundamental insight into mouse eye perfusions, thereby consolidating the technique for future 
studies. 
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Chapter 1: Introduction 
1.   Problem 
    Glaucoma is a major ocular neuropathy that impairs vision and which can lead to blindness. In 
2010, it affected approximately 60 million people, of which 8.4 were bilaterally blind1. Importantly, 
loss of vision caused by glaucoma is irreversible. Thus, the sole strategy to tackle the disease is to 
slow its progression in its early stages. This, however, is made difficult by the poor understanding of 
the disease which hampers the design of efficient diagnostic tools and therapies. Thus, there is a 
pressing need for deeper knowledge of the condition so as to develop targeted drugs and treatment 
approaches.  
    Notably, the diagnosis of glaucoma is challenging because it is mostly asymptomatic until its later 
stages. Still, an increased intraocular pressure (IOP) is known to be a primary risk factor for the 
disease1. In most cases of glaucoma, elevated intraocular pressure is a causal risk factor that 
progressively leads to blindness by damaging the retinal ganglion cell axons that form the optic 
nerve and which are responsible for transmitting visual information from the retina to the brain. 
Lowering IOP has been shown to be beneficial to glaucomatous patients, as well as persons 
suspected of being at risk of developing the condition1. Strikingly, in spite of being the only strategy 
to slow down glaucoma, treatments that lower IOP remain inefficient because the precise 
mechanisms underlying IOP regulation are not known.  
    In the majority of cases, the increased IOP associated with glaucoma is  caused by an increased 
resistance to outflow of aqueous humour from the eye 2. Aqueous humour (AH) is a liquid produced 
in the eye which exits either via the conventional or unconventional pathways. In glaucoma, AH 
outflow through the conventional pathway is impaired, although the exact underlying reasons 
remain unclear. Yet, current glaucoma therapies decrease IOP by increasing outflow through the 
unconventional pathway or by suppressing AH inflow, thus not directly addressing the root problem 
lying in the conventional pathway. Thus, drugs would be more efficient if they corrected the fault in 
the conventional pathway responsible for impairing outflow, so as to eventually reinstate the normal 
homeostatic functions of outflow tissues3. In order to help the design of such drugs, this project aims 
16 
 
to better understand the mechanisms of AH outflow in the conventional pathway by using the 
mouse as a model for aqueous humour outflow in humans. 
    Mice are incredibly powerful models because they are routinely manipulated genetically, thus 
providing insight into the genetic and molecular factors involved in a disease or phenotype4. In 
addition, they are inexpensive and possess a thoroughly characterized genome. As a result they 
have been used in a wide range of medical research fields, although they have not been used 
extensively for studying IOP regulation and aqueous humour outflow. This “under-use” was a 
consequence of the experimental challenges posed by the small size of mouse eyes, making 
measurement of aqueous humour outflow difficult. Also, it has not been well understood whether the 
mouse is a suitable surrogate for studying aqueous humour outflow in humans. In the last decade, 
many technical challenges have been overcome, resulting in a growing community studying murine 
aqueous humour outflow dynamics 5–17.  
    Despite this increasing interest, it is still not clear whether aqueous humour outflow dynamics in 
mice are similar to those in humans. This issue needs to be addressed to be able to confidently 
extrapolate findings observed in mice to humans. For instance, mice need to respond to drugs 
affecting aqueous humour outflow (and thus IOP) in a manner that is similar to humans to be 
suitable pharmacological models.  
    This study therefore aims to determine whether the mouse is a good model for human aqueous 
humour outflow dynamics. Further, we wish to use the mouse model to investigate fundamental 
mechanisms underlying outflow resistance regulation. The potential advantages of this approach 
are two-fold. First, it can validate the mouse as a suitable model for testing anti-glaucoma drugs. 
Second, it can provide invaluable insight into fundamental mechanisms underlying outflow 
resistance generation. In the long term, we expect that this work will motivate further research to 
screen novel drugs capable of specifically targeting mechanisms to lower IOP, and eventually 
benefit glaucoma patients. 
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2. Specific aims 
    This project has two goals. First, we wish to determine whether the mouse is a good model for 
studying human IOP regulation and aqueous humour outflow. Second, we wish to use the mouse as 
a model to investigate fundamental mechanisms of aqueous humour outflow regulation in humans. 
In order to investigate aqueous humour outflow, our laboratory has developed a perfusion system 
for measuring outflow facility in enucleated mouse eyes12. This technique is described in further 
details in Ch. 2, and will be core to most of our studies.  
    This thesis comprises several studies, described in separate chapters (Ch. 2-7), each with a 
specific aim and hypothesis as outlined below. 
    In Chapter 2, we hypothesise physical factors such as hydration, temperature and post mortem 
times have significant effects on outflow facility measurements in enucleated mouse eyes. We 
tested our hypothesis by including both temperature and hydration control in our previously 
developed perfusion system. More specifically, outflow facility was measured in eyes submerged (or 
not) in isotonic saline, and in eyes maintained at room or physiological temperature. Finally, eyes 
were perfused at different post mortem times. This study allowed us to characterise our improved 
system for measuring outflow facility of enucleated mouse eyes in a more physiologically relevant 
manner. 
    In Chapter 3, we hypothesise that the mouse responds to the receptor mediated drugs 
sphingosine-1-phosphate (S1P) and the prostanoid EP4 agonist 3,7-dithia PGE1 similarly to 
humans. This was tested by measuring outflow facility in mouse eyes treated with the drugs, or left 
untreated. Furthermore, drugs were tested 24 hrs following death, to assess whether post mortem 
times changed their effects on outflow facility. This study aimed to demonstrate that the mouse is a 
good model for studying the pharmacology of human IOP regulation as occurs in the conventional 
drainage pathway. 
    In Chapter 4, we hypothesise that strain-specific differences in IOP are attributable to strain-
specific differences in outflow facility. To test this hypothesis, IOP was measured in vivo in BALB/cJ, 
C57BL/6J and CBA/J mice and outflow facility was measured in the same eyes ex vivo, using our 
improved perfusion system for enucleated mouse eyes. The goal of this study was to show outflow 
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facility is the primary determinant of IOP in mice, and to motivate further research into the molecular 
or genetic differences underlying differences in outflow facility between mouse strains. 
    In Chapter 5, we postulate outflow facility is dependent on metabolic activity in the mouse eye. 
This was tested by perfusing mouse eyes with or without anti-metabolic agents (2-Dideoxy-D-
glucose and Sodium azide). The morphology of treated and untreated eyes was also investigated to 
analyse the effects of anti-metabolic agents the conventional outflow pathway.  
    In Chapter 6, we study the effects of pressure on conventional facility, Schlemm’s Canal 
morphology and outflow patterns. Our governing hypotheses were the following: we postulated 
changes in outflow resistance occurred at higher pressures, and could be related to changes in the 
SC morphology. Furthermore, we hypothesised that outflow patterns would change with changes in 
outflow facility at high pressures. We present preliminary data on two techniques to image outflow 
patterns and Schlemm‟s Canal morphology in 3D in whole mouse eyes; these data validate the 
novel protocols, and form the basis of on-going studies. The long term goal of this study is to 
develop a technique to image both outflow patterns and morphology of the outflow pathways in 3D 
in whole mouse eyes, thereby relating outflow patterns to outflow facility. 
    In Chapter 7, we introduced modifications to the original Goldmann’s equation to account for 
volume and pressure effects on outflow facility. We hypothesised this modified equation might better 
explain our flow rate vs. pressure data acquired in cohorts of mice used in this thesis. The fit of our 
modified equation against our data was then tested. The goal of this study was to investigate 
whether outflow facility is dependent on pressure or volume in mice, which would require the use of 
a novel equation to extrapolate outflow facility from our data. Importantly, this novel equation could 
also be used for perfusion studies in other species. 
    Altogether, these studies aim at consolidating the mouse as a model for investigating IOP 
regulation as occurs in the human conventional pathway. Before describing specific studies, the 
reader will be provided with the background required to appreciate their relevance and impact. 
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3. Background 
3.1. Intraocular Pressure generation in humans 
3.1.1. Intraocular Pressure 
    The unique purpose of the eye is to enable vision.  This vital task requires the ability to focus light 
and convey the resulting visual information to the brain. Consequently, the mammalian eye has 
developed into a complex organ composed of different structures which transmit, refract or convert 
light.  
 
    In particular, vision requires transparent tissues that let light pass; as a result, tissues such as the 
cornea or lens cannot be vascularised.  Instead, aqueous humour (AH), a clear liquid that fills the 
anterior part of the eye and contacts both the cornea and the lens, is responsible for nourishing 
these anterior tissues. Importantly, it needs to be constantly turned over in order to provide fresh 
nutrients, and is also involved in clearing the anterior chamber of inflammation products. AH 
facilitates light transmission by being transparent and having a low protein content which minimizes 
light refraction or scattering18. 
 
    In addition, the presence of AH generates a pressure within the eyeball, the so-called intraocular 
pressure (IOP). IOP is crucial for ensuring proper functioning of the eye. In particular, it dictates the 
shape of the eyeball which has a major influence on light refraction18. In addition, IOP provides 
support to inner tissues such as the choroid, which can otherwise detach19. Thus, the eye must rely 
on homeostatic mechanisms to tightly control IOP within its physiological range. In humans, IOP 
approaches 16 mmHg but oscillates by 2.7 mmHg due to choroidal blood pulsations20. IOP also 
experiences diurnal fluctuations21,22, as well as spontaneous changes caused by environmental 
factors and eye movements. 
 
    The eye adapts to such perturbations because IOP generation is a dynamic process. IOP is the 
result of the balance between the production and drainage of aqueous humour. Thus, tissues 
involved in aqueous humour turnover can directly participate in controlling IOP. In fact, IOP is 
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principally determined by the resistance to AH outflow through the conventional pathway. More 
specifically, the increased IOP often associated with glaucoma occurs following the abnormal 
increase of outflow resistance in the conventional pathway2, although the underlying mechanisms 
are unknown. In this project, we propose to improve the understanding of glaucoma by investigating 
AH outflow in the murine conventional pathway. 
3.1.2. Eye anatomy 
    This section reviews the basic structures of the human eye as depicted in Fig. 1, namely the 
cornea, the sclera, the lens, the retina and the optic nerve. Briefly, light penetrates the cornea and is 
focused by the lens onto the retina. The retina contains photoreceptors responsible for converting 
light into electrical signals, which are transmitted to the brain via the optic nerve.  
    The eye can be divided into the anterior segment which comprises the structures anterior to (and 
including) the lens, and the posterior segment which consists of the tissues posterior to the lens. 
The anterior segment is filled with aqueous humour, whereas the posterior segment contains 
vitreous humour. A more detailed description of the anterior segment, which is most relevant to this 
project, is found in the following section.  
 
Figure 1: Simplified anatomy of the eye, drawn by M. Boussommier-Calleja 
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95% of the human eye is covered by the sclera; the remaining 5% of the outer coat of the human 
eye is made up of the cornea23. The sclera is opaque and provides a structural scaffold for the eye, 
while the cornea is transparent so as to transmit light, and serves as a protective barrier to the 
environment24. The transition between the sclera and the cornea, called the limbus, contains the key 
structures for aqueous humour drainage. Importantly, the cornea generates up to two-thirds of the 
refractive power of the eye25,26, while the remainder is attributable to the lens.   
    The lens is a biconvex transparent structure whose curvature allows for light to be focused onto 
the retina27. In addition, its shape can be changed so as to focus light coming from far or near 
objects, a process called accommodation. This is performed by the ciliary muscle which transmits its 
tension to the lens via ligaments called zonules. 
    The iris extends into the anterior chamber but leaves a central aperture called the pupil, which 
participates in regulating the amount of light entering the lens28. Furthermore, the pupil divides the 
anterior segment into the anterior and posterior chambers. The iris is contiguous with the ciliary 
body, which is the attachment site of the zonules. Notably, the ciliary body contains the ciliary 
muscle, which possesses longitudinal, radial and circular fibres responsible for altering the shape of 
the lens 29,30.  
 
    The posterior segment is filled with a static and colourless gel called the vitreous humour which 
occupies 80% of the volume of the eye31. Consequently, it provides support to the eye globe but 
also to the retina, which consists of several layers of neural cells responsible for capturing and 
converting light into electrical signals. The neural signals are conveyed via the axons of the retinal 
ganglion cells, which converge into the optic nerve forming a depression, or optic disc cup. Finally, 
the optic nerve relays the information to the visual cortex.  Glaucoma is characterized by the loss of 
retinal ganglion cells axons, which leads to an excavation of the optic disc cup, and is accompanied 
by the thinning of the nerve fibre layer surrounding the cup1.  
3.1.3. Ocular circulation 
    Blood is supplied to the ocular structures through the retinal and uveal (or ciliary) vessels, which 
originate from three branches of the ophthalmic artery32. Retinal vessels branch from the central 
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retinal artery, while uveal vessels are supplied by the posterior and anterior ciliary arteries. 
Branches of the posterior ciliary arteries form most of the choroid which lies beneath the retina and 
serves its outer layer. Posterior and anterior ciliary arteries anastomose to form the anterior uveal 
circulation in the iris which vascularises the ciliary body and ciliary muscle.  
    The ciliary muscle‟s blood flow discharges into the anterior ciliary veins, whereas the rest of the 
uveal drainage from the iris, choroid and ciliary body occurs through the four vortex veins. The 
vortex veins eventually fuse with either the superior or inferior ophthalmic veins, although most of 
the venous flow uses the superior ophthalmic vein. Finally, the eye also has to recycle aqueous 
humour, most of which joins the venous system via a complex limbal vasculature, which leads to the 
episcleral veins and ultimately to the superior ophthalmic vein33. Some aqueous humour is thought 
to join the vortex veins via the uveal capillaries, although this point remains unclear34, as discussed 
in the next section.  
3.2. Aqueous Humour turnover 
    This section details the turnover of AH in the anterior segment, which is responsible for 
generating IOP. AH is produced in the posterior chamber at the ciliary processes, flows into the 
anterior chamber through the pupil and drains either via the trabecular or uveoscleral pathways, 
which are described below.   
3.2.1. Aqueous Humour production 
    AH is produced at the non-pigmented epithelium of the ciliary processes18, which consist of 
invaginations of the ciliary body. AH is derived from the plasma in the ciliary body capillaries, mostly 
via active secretion and less markedly by ultrafiltration and diffusion. This results in a unique 
composition of aqueous humour, characterized by a low concentration of proteins to minimize light 
refraction18.  
3.2.2. Aqueous humour outflow 
    AH can exit the anterior chamber at the limbus, found at the transition between the cornea and 
the sclera, either via the trabecular or uveoscleral pathway. It is important to note trabecular and 
uveoscleral routes are anatomical definitions. Alternatively, AH drainage can be divided into 
functional components, namely conventional and unconventional outflow, according to their 
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dependence on IOP. Specifically, conventional outflow is defined as the portion of aqueous outflow 
which is dependent on IOP, while unconventional outflow is associated with the IOP-independent 
portion of outflow. Importantly, such anatomical and functional definitions cannot necessarily be 
equated. Trabecular and conventional outflow are typically equated because it is known trabecular 
outflow is driven by the pressure drop between the anterior chamber and the episcleral veins. 
However, it is not clear whether the uveoscleral outflow is strictly independent of IOP and thus 
whether it can be entirely considered as unconventional outflow. Since this section focuses on the 
anatomical features of AH drainage, the terms trabecular and uveoscleral outflow will be used.  
    This section reviews the morphology of both pathways, with particular attention to the trabecular 
pathway because it accommodates up to 90% of AH outflow in humans, and is the site of impaired 
outflow which causes the increased IOP often associated with glaucoma2,35. 
3.2.2.1. Trabecular pathway 
    AH is driven through the trabecular pathway because of the pressure drop between the anterior 
chamber and the episcleral veins, which is approximately 6.9 mmHg in humans36. As AH enters the 
trabecular pathway, it flows through the trabecular meshwork (TM) and Schlemm‟s Canal (SC) prior 
to entering the post-trabecular pathway which eventually fuses with the venous system33,37–39 (Fig. 
2). The morphology of each of these tissues is discussed below since it influences their resistance 
to AH outflow. The characteristics of the SC inner wall are described in further detail as it is thought 
to be an important site of AH outflow resistance. 
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Figure 2: Scanning electron micrograph of the human conventional pathway.CM: corneoscleral meshwork, SC: 
Schlemm’s canal, JCT:  juxtacanalicular connective tissue. Asterisks show a collector channel. Arrowheads point 
to the inner wall of SC. White arrow represents the direction of aqueous humour flow from the anterior chamber 
towards the episcleral veins. Scale bar is 50 µm. Reproduced from Overby et al. 2009, Exp Eye Res. Reprinted 
with permission of Elsevier through the Copyright Clearance Centre (see Appendix 2).  
a- Trabecular meshwork 
    The TM is triangular-shaped and is attached to Schwalbe‟s line at the cornea anteriorly and to the 
scleral spur posteriorly. The scleral spur is a protrusion of the sclera into the TM, and provides an 
anchoring point for some of the longitudinal fibres of the ciliary muscle40 .  
    The TM consists of three different regions, namely the uveal meshwork, the corneoscleral 
meshwork and the juxtacanalicular tissue (JCT; Fig. 3A).The uveal and corneoscleral meshworks 
are porous structures made of collagen- and elastin-containing sheets or beams covered with 
endothelial cells (Fig. 3B) 40–42. The spaces between lamellae decrease from 25-75 µm in the uveal 
meshwork to 2-15 µm in the corneoscleral meshwork43. In contrast, the JCT is a more irregular 
tissue made of cells embedded in extracellular matrix, characterized by the presence of collagen IV, 
laminin, fibronectin, proteoglycans and glycosaminoglycans (GAGs)39.  
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Figure 3:Electron micrograph of the trabecular meshwork (A) and of a single trabecular beam in the corneoscleral 
meshwork(B). The core of the beam contains an elastic fibre (E). Open arrows point to the basal lamina of the 
trabecular meshwork cells which cover the beam, while solid arrows point to aggregates of long-spacing collagen 
in the cortical region of the beam. GV=Giant Vacuole, SC=Schlemm’s Canal. Image from Tamm 2009, Exp Eye 
Res. Reprinted with permission of Elsevier through the Copyright Clearance Centre (see Appendix 2).  
  
     
    The TM is also a contractile tissue, affected by three different groups of elastic tendons arising 
from the ciliary muscle:  (i) the first group attaches to the cribriform plexus in the JCT (ii) a second 
group traverses the TM to connect with the cornea and (iii) the third group connects with the scleral 
spur44. Moreover, elastic fibres from the scleral spur are continuous with the TM elastic fibres, 
thereby transmitting any force exerted on the scleral spur to the TM42. In addition, α-smooth muscle 
actin has been found in TM cells, suggesting they are contractile in their own right45,46. This was 
further supported by studies showing different agents caused either contraction or relaxation of 
isolated TM strips47. On the other hand, nerve terminals have been found in the TM48,49, which could 
potentially trigger contractions of TM cells. In addition, contractile cells in the sclera spur were 
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identified 50–52. Thus, the TM is likely affected by the antagonistic contractility actions of the ciliary 
muscle, the scleral spur and TM cells47.  
    Finally, TM cells are capable of phagocytosis; some TM cells contain pigment, most likely 
originating from the iris. Thus it is thought this process is important for the self-cleaning of the TM, 
which could otherwise become clogged with products such as pigment granules42,53,54.   
    In essence, the filter-like structure of the TM permits AH to percolate through its trabecular 
spaces, which become progressively less ordered and narrower as they approach SC. In addition, 
its morphology can be affected by contractile action at different levels, thereby affecting AH 
drainage and thus IOP.  
b- Schlemm’s Canal 
    SC is a channel lined with endothelial cells which runs circumferentially in the eye, adjacent to the 
TM. It is 33-35 mm long 55.  Its inner wall is in contact with the JCT in the TM (Fig. 3), and is 264 µm 
long in its anterior-posterior diameter in normal human eyes56; its opposite side is called the outer 
wall, which contains openings to CC found irregularly around the SC circumference. SC is infiltrated 
perpendicularly by AH via its inner wall as the humour flows from the TM towards the episcleral 
veins (Fig. 2). Once AH has entered the SC, it flows circumferentially inside the canal until it 
reaches the opening of an aqueous vein or a collector channel on the SC outer wall38,39. Thus, SC 
inner wall cells experience both a pressure drop as they are traversed by AH, and shear stress as 
AH flows in SC. 
    Even though SC has a vascular-like endothelium linked via tight junctions, its endothelial cells at 
the inner wall present several unusual characteristics. First, they experience a pressure drop from 
their basal to apical side as opposed to most endothelial cells in the human body37–39. Thus they are 
constantly being pushed away from their basement membrane. As a result, they balloon into the SC 
lumen, forming giant vacuoles39 (Fig. 4). In fact, SC cells are connected to the underlying JCT by 
cellular processes57, which were shown to distend at higher pressures58. In addition SC cells are 
connected to the cribriform plexus in the JCT by connecting fibrils44, thereby directly linking SC to 
the TM and the ciliary muscle.    
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    In addition, SC cells exhibit either trans-cellular or intracellular pores59–61 which are thought to 
accommodate aqueous humour outflow as it progresses from the TM towards the venous system 
(Fig. 4). In particular, intracellular pores form where the apical and basal membrane of SC cells fuse 
in giant vacuoles. However, studies have suggested pores might be an artefact from fixation59,62. 
Finally, SC cells lie on a discontinuous basement membrane39,40. Altogether, these characteristics 
make the SC endothelium a unique barrier which can significantly affect outflow resistance as 
discussed in section 3.4. 
 
Figure 4: Scanning Electron micrograph of the inner wall of Schlemm's Canal. Cells form giant vacuoles as they 
are pushed away from their basement membrane. Arrowheads point to pores which are thought to accommodate 
aqueous humour as it traverses the SC inner wall. Reproduced from Overby et al. 2009, Exp Eye Res. Reprinted 
with permission of Elsevier through the Copyright Clearance Centre (see Appendix 2).  
c- Post-trabecular pathway 
    After AH has penetrated SC, it continues its progression towards the venous system either via 
collector channels (CC) or aqueous veins, which depart directly from the outer wall of SC33. There 
are 20-30 CC or aqueous veins in humans55, which leave irregularly from around the SC.  Their 
openings in the SC outer wall are of variable size, ranging from 28 to 40 µm55. Both CC and 
aqueous veins eventually fuse with the venous system but differ in their trajectory, as discussed 
below. 
28 
 
    CCs are shorter channels which first join the deep intrascleral venous plexus33. From the deep 
intrascleral venous plexus, aqueous humour can either directly join the venous circulation, or 
progress via other CC to deeper venous plexi (mid and deep venous plexus) to eventually flow into 
the episcleral veins. In contrast, aqueous veins link directly SC to the episcleral veins33,63. Once the 
aqueous humour has reached the episcleral veins it is transported via the ophthalmic vein to the 
systemic circulation32. 
3.2.2.2. Uveoscleral pathway 
    The uveoscleral pathway is much less well understood than the trabecular pathway. It is however 
a major target of current anti-glaucoma therapies. It was first detected by Bill in 196564, and further 
documented in other tracer studies65–67 as an outflow entering the iris root, traversing the ciliary 
muscle, and finally discharging into the suprachoroidal space.  It was shown this was bulk flow 
rather than diffusion-based, caused by a pressure drop between the suprachoroidal space and the 
AC of approximately 3.5 mmHg.68  
    Thus unconventional outflow is dependent on IOP and will shut down at pressures lower than 4 
mmHg, as the pressure drop between anterior chamber and suprachoroidal space disappears. Yet 
Bill showed uveoscleral outflow was much less sensitive to IOP than the trabecular pathway, which 
explains why this route is often considered pressure-independent, and therefore typically equated to 
unconventional outflow. Indeed, when IOP was doubled from 11 to 22 mmHg, uveoscleral outflow 
increase was shown to change by only one-fold compared to five-fold for the trabecular outflow 65.  
The fate of AH once it has crossed the ciliary muscle and entered the ciliary body becomes less 
clear: tracer studies have either suggested it diffuses through the sclera69 or is reabsorbed by uveal 
circulation in the ciliary body34. However, it has been proposed the tracers detected in the sclera 
might have diffused separately from aqueous humour. The model based on uveal reabsorption of 
AH supposes aqueous humour is drawn into the capillaries due to both hydrostatic and osmotic 
pressure differences, according to Starling‟s hypothesis.  Interestingly, such a mechanism might 
exclude large molecules such as albumin from passively entering the capillaries, which would 
therefore progress alternatively through the sclera, as observed by Bill.  
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    Finally, it was recently suggested that lymphatics identified in the ciliary body might play a role in 
AH drainage70. This, however, remains controversial since it has long been thought that lymphatics 
did not exist in the eye, and that aqueous humour serves the typical functions of lymphatics (i.e. to 
provide egress for fluid and macromolecules to the veins, and to serve as a medium for the 
transport of immune cells)71. Thus, the trajectory of uveoscleral outflow remains poorly understood 
since it is experimentally challenging to visualize. However, in light of the pressure-insensitivity 
reported by Bill, the uveal reabsorption hypothesis could prevail, as it relies on osmotic pressure 
and would be therefore much less affected by changes in IOP than trans-scleral bulk flow. 
Alternatively, uveoscleral outflow might be only weakly pressure sensitive because increasing IOP 
might cause the compression of the suprachoroidal space thereby suppressing uveoscleral 
outflow69. 
    Regardless, it is accepted that uveoscleral outflow begins at the ciliary muscle, which seems to 
represent the rate-limiting step to outflow69. Indeed, structural changes of the ciliary muscle can 
appreciably affect uveoscleral outflow as demonstrated by the use of prostaglandins as a means to 
increase uveoscleral outflow. Prostaglandins are known to pharmacologically facilitate AH 
progression by digesting the ECM in the ciliary muscle or by relaxing the muscle, resulting in larger 
spaces between muscle bundles69,72. Similarly, extracellular debris found in the ciliary muscle of old 
human patients are thought to prevent AH flow and thus explain the corresponding low uveoscleral 
outflow measurements69,73.  
    Thus, despite being a major target of glaucoma drugs, the mechanisms underlying uveoscleral 
outflow still elude the scientific community. It is therefore urgent to develop protocols to visualize 
and measure uveoscleral dynamics directly to confirm its importance in normal and glaucomatous 
AH dynamics. 
3.3. IOP generation: Goldmann’s equation  
    IOP is a result of the balance between the rate of production (Fp) and drainage (Fd) of AH from 
the anterior segment of the eye, which at steady state are equal (Eq. 1).  
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Equation 1 
    More specifically, the rate of production of AH (Fp) matches both the pressure-dependent, or 
conventional outflow (Fc) and the pressure-independent, or unconventional outflow (Fu; Eq. 2).  
           
Equation 2 
    In particular, outflow in the conventional pathway is driven by the difference between the pressure 
in the anterior chamber (i.e. IOP), and in the episcleral veins (i.e. episcleral venous pressure, or 
EVP), and is limited by the resistance offered by the conventional pathway (or Rc).  It therefore 
emerges that IOP is governed by Eq. 3, called Goldmann‟s equation, which will be central to this 
thesis. 
   
         
  
    
Equation 3 
     
Equation 3 can also be expressed as a function of outflow facility of the conventional pathway (C), 
defined as the inverse of conventional outflow resistance, as shown in Eq. 4.  
                    
  
Equation 4 
     
Equation 4 can be re-arranged as a function of IOP, as shown in Eq. 5. 
     
     
 
       
Equation 5 
     
    In humans, Fp is typically 2.5
18 µL/min, IOP-EVP is 6.9 36 mmHg, C=0.22 µL/min.mmHg2 and 
Fu=0.28-1.52 µL/min
72,73.  Importantly, Rc and C refer to properties of the conventional pathway. In 
contrast, total resistance Rt (or total facility, Ct) refer to the total amount of AH which can be drained 
at a given pressure (both through the conventional and unconventional pathway), as described in 
Eq. 6: 
31 
 
   
         
  
 
Equation 6 
     
    Although Goldmann‟s equation is routinely used for analysis of aqueous dynamics, it is important 
to appreciate it is limited by important assumptions which postulate Fp, EVP, Fu and C are 
independent of IOP. Indeed, experimental studies suggest these quantities all change with IOP, 
albeit minimally65,74–76. Note some of these studies were conducted in primates65,74,75 and do 
therefore not necessarily apply to all species. In summary, Goldmann‟s equation simply divides 
outflow into pressure-dependent vs. -independent outflow, which is a division based on functional, 
rather than anatomical, routes.  
3.4. IOP regulation: Outflow resistance  
    Although Goldmann‟s equation shows several parameters can affect IOP, it has long been known 
that an increase in outflow resistance is responsible for the typical raised pressure in 
glaucoma2,37,38. In particular, Grant showed the increase in IOP is solely attributable to an increase 
in conventional outflow resistance, i.e. a decrease in conventional outflow facility2. More specifically, 
he showed C decreased from 0.22 µL/min/mmHg in normal eyes to lower values in glaucoma, 
ranging from 0 to 0.11 µL/min/mmHg. He also showed AH production was not higher in 
glaucomatous eyes (2.4 vs.1.5 µL/min in normal vs. glaucomatous eyes) and could therefore not 
explain their increased IOP. Importantly, pioneering studies have described outflow resistance as 
metabolic-independent77,78. Thus, outflow resistance is typically considered as being passively 
generated by the trabecular pathway‟s filter-like morphology. Such studies consisted of showing 
several poisonous substances had no effect on outflow resistance78, or that there were no 
temperature-related changes of outflow facility except for those attributable to changes in the 
viscosity of aqueous humour77. Surprisingly, this has not deterred many studies from investigating 
the role of enzymes or signal transduction 79–87 in outflow resistance generation, which should have 
been silenced by anti-metabolic agents. Thus, after more than a century of research, the 
mechanisms underlying outflow resistance generation remain unclear, thereby preventing the 
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design of efficient treatments for elevated IOP. This section reviews the current knowledge of 
outflow resistance generation and its pharmacology.  
3.4.1. Outflow resistance generation 
    The anatomy of the conventional pathway was previously described (cf. Section 3.2.2) as 
composed of the trabecular meshwork, Schlemm‟s Canal and the post-trabecular pathway.  The 
TM‟s first two layers, the uveal and corneoscleral meshworks, comprise openings too large to 
account for any significant resistance to outflow. In fact, this was demonstrated both theoretically 
using Poiseuille‟s law88 and experimentally by showing that their removal did not affect outflow 
resistance in enucleated human eyes89. On the other hand, Bill and Mäepea showed that more than 
50% of outflow resistance lies in the vicinity of the inner wall of the Schlemm‟s Canal, within the 
JCT75. The JCT was shown to have large pores apparently capable of generating only few percent 
of total outflow resistance, unless these pores were filled with a gel of GAGs90. However, the 
evidence for the presence of GAGs is debatable: in separate studies, GAG-degrading enzymes 
were shown to either decrease outflow resistance78 or leave it unaffected91. Moreover, GAGs were 
not detected either with transmission electron microscopy, although quick freeze deep etch revealed 
a richer ECM environment92. Furthermore, the dramatic effect of MMPs on increasing outflow 
facility93 supports an important role of ECM in outflow resistance generation. 
    As for the inner wall of SC, its only potential in generating outflow resistance lies in the presence 
of pores, since its basement membrane is largely discontinuous. However, calculations showed that 
pores could only account for 10% of total outflow resistance61; moreover, their role in shaping 
outflow resistance is undermined by studies which measured an increase in pore density with 
increasing outflow resistance caused by fixation59,62 or increased IOP94–97. Finally, it has been 
suggested pores could be an artefact from fixation59, although recent in vitro studies from our 
laboratory have shown pore density was not affected by fixation modes (immersion vs. perfusion 
fixation; personal communication, Dr. Pedrigi).  
    Finally, the post-trabecular pathway was thought to be negligibly involved in outflow resistance 
generation, ever since Mäepea and Bill measured a very small pressure drop between SC and 
episcleral veins75. Indeed, collector channels and aqueous veins are too large to generate 
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significant outflow resistance according to Poiseuille‟s law98. However, experimental studies showed 
that 25% of outflow resistance remained following a trabeculotomy, although these results were 
measured at relatively high pressures ranging from 15 to 25 mmHg89. Nonetheless, this work 
suggests the role of the post-trabecular pathway in outflow resistance generation might have been 
underestimated. 
    Altogether, studies suggest most of the outflow resistance is found in the vicinity of Schlemm‟s 
Canal, although it fails to explain all of the measured resistance.  
3.4.1.1. Synergistic model of outflow resistance 
    The observation that the sum of the outflow resistances generated by each region of the 
trabecular pathway did not equal the total outflow resistance led to a revised synergistic model of 
outflow resistance generation39,99. This approach postulates outflow resistance is defined by 
interactions between the different layers of the trabecular pathway, rather than by the sum of their 
individual effects. This further motivated the funnelling theory99 which hypothesized that effective 
outflow resistance is increased by the proximity of the JCT to the inner wall of SC. More specifically, 
pores force flow in the JCT to percolate towards them, which in turn forces flow to use only the 
regions of the JCT underlying the pores; since pores are found only every other 20-30 µm along SC 
inner wall on average39, the area available for AH filtration is therefore reduced, which in turn 
increases outflow resistance. This synergistic effect was also suggested by studies which showed 
that pharmacological disruption of the inner wall SC had a drastic effect on outflow resistance 
although the inner wall alone was supposed to only be able to generate a small part of outflow 
resistance100. Furthermore, the decrease in outflow resistance caused by drugs which specifically 
targeted the SC inner wall did not correlate with the loss of SC cells101. This suggested SC cells 
alone were not responsible for generating outflow resistance. Thus the evidence points towards a 
synergistic effect, such as the funnelling model, which however, still forecasted a resistance higher 
than that found in experimental studies99. A revised version of the funnelling theory which includes 
the effect of the increased area available for filtration provided by the giant vacuoles gave better but 
still high predictions of outflow resistance; it has been suggested the basement membrane 
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discontinuity could generate the remaining resistance, although this effect has never been 
quantified39.  
3.4.1.2. Outflow resistance and AH humour patterns 
    Finally, outflow resistance has been related to outflow patterns in the TM. Using fluorescent 
tracers to represent AH outflow, it was shown eyes with artificially high IOP and high outflow 
resistance showed less fluorescent tracers in their TM102,103. More specifically, fluorescent tracers 
were found only in preferential regions of the TM, which combined together were referred to as the 
effective filtration area. Interestingly, this area increased in eyes with lower IOPs and lower outflow 
resistance, such that much more of the TM was actively perfused with tracers, i.e. with AH. Thus, 
there seems to be a relationship between outflow resistance and effective filtration area, or AH 
outflow patterns. Similar results were found using a drug which decreased outflow resistance 
without affecting SC integrity, namely Y-27. Following treatment with Y-27104, tracers were found 
much more homogeneously along the inner wall of SC (Fig. 5B) than in the fellow untreated eye 
(Fig. 5A). Interestingly, this drug also caused a separation between the inner wall SC and the JCT, 
which supported previous speculations from the funnelling theory regarding the role of their 
mechanical coupling in generating outflow resistance. 
 
Figure 5:Confocal image of a frontal section of the bovine conventional pathway in a control eye (A) and a Y-27 
treated eyes (B).TM: Trabecular Meshwork AP: Aqueous plexus. Note AP is the equivalent of SC in bovine eyes. 
Scale bar is 100 µm.  Reproduced from Lu et al. 2008. Reprinted with permission of Elsevier through the 
Copyright Clearance Centre (see Appendix 2).  
     
35 
 
    These findings warrant further research into differences between the regions of the TM which are, 
or are not, actively perfused by AH to further understand outflow resistance generation. Yet, these 
analyses were only carried out on a limited number of histological sections, representing only a 
minimal part of the entire TM.  Thus, in spite of important advances in understanding outflow 
resistance generation at the tissue-scale, there is room for deeper understanding of the molecular 
and physical forces at play. Their unravelling would dramatically help the design of drugs which 
better target the mechanisms responsible for increased outflow resistance, and thus IOP in 
glaucoma. 
3.5. Glaucoma 
3.5.1. The disease  
    Glaucoma is the second leading cause of blindness worldwide, forecasted to affect 80 million 
people in 2020105. Importantly, half of the people affected by the disease are thought to be 
undiagnosed1, amongst other reasons because it is asymptomatic until its later stages. It typically 
appears in patients older than 40, after which its prevalence increases exponentially with age.  It is 
an important burden to healthcare, which for example drastically affects Europe with a total related 
annual cost of 2.7€ B106 yearly, or the United States which spent similarly 2.9 billion $ in 2004107.  
There are several forms of glaucoma which differ in their onset; yet they are all characterized by the 
death of a substantial number of retinal ganglion cells in the optic nerve in at least one eye, which 
leads to visual field loss1. The most common form of glaucoma is primary-open angle glaucoma 
(POAG), which is characterized by a slow and asymptomatic progression.  The main risk factor for 
POAG is an increased IOP caused by an impaired aqueous humour outflow within the trabecular 
pathway. In contrast, the second most common glaucoma is closed-angle glaucoma. Closed-angle 
glaucoma is caused by the closing of the angle between the iris and the cornea which prevents 
normal AH outflow, thereby increasing IOP.  
    Eventually, every form of glaucoma leads to retinal ganglion cell loss resulting into the excavation 
of the optic disc cup and the thinning of the nerve fibre layer surrounding it, which can be observed 
with different imaging modes such as Optical Coherence Tomography1. Glaucoma is typically 
associated with an IOP exceeding 21 mmHg, although this is not a definitive criterion. For example, 
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patients with high IOPs do not necessarily develop the pathology1, and glaucomatous patients from 
a Japanese study were shown to have an IOP comparable to that of healthy subjects108. However, it 
is recognized that an increased IOP is a causal risk factor for glaucoma, possibly by conveying 
stress to the sclera and the optic nerve: a clinical study has shown that patients with ocular 
hypertension with high IOP were at more risk of developing the disease109.  It has also been 
suggested that high-frequency IOP fluctuations (occurring over the time scale of minutes)  
measured by telemetry could contribute to the onset of the disease, as they might be accentuated in 
glaucomatous patients because of their stiffer sclera110.  In addition, large variations in diurnal IOP 
have been associated with the progression of the disease111, although other groups failed to find 
similar results112: therefore, is it still not clear whether diurnal variations in IOP are important in 
glaucoma113. Nevertheless, measuring IOP remains one of the only diagnostic tools to detect 
glaucoma, followed by imaging of the optic nerve head structure, whose thinning and cupping is 
characteristic of the disease. Thus diagnosis of glaucoma remains poorly developed, and could be 
dramatically improved thanks to a better understanding of its onset.  
3.5.2. Treatments 
    All current anti-glaucoma therapies aim to lower IOP, which has been shown to be beneficial to 
glaucomatous patients1. In particular, clinical studies have shown that IOP-lowering treatments 
delay the progression of the disease114–116, showing that each millimeter of mercury of IOP reduction 
from baseline decreased the progression risk of the disease by about 10%116. The available 
treatment options to tackle glaucoma consist of using daily eye-drops, laser surgery or conventional 
surgical procedures. Laser and surgical treatment lower IOP by facilitating AH drainage via the 
disruption of the TM or the creation of a new drainage route into the sub-conjunctival region of the 
eye (e.g. trabeculectomy). They are normally effective in lowering IOP but can lead to further 
complications, e.g. scarring or bacterial infections1.  
    Different drugs for increasing outflow facility and thus lowering of IOP have been used, such as 
muscarinic (pilocarpine), adrenergic (epinephrine) agents or prostaglandins117. Although the 
mechanisms underlying the action of epinephrine are not well understood, it is known that 
pilocarpine causes contraction of the ciliary muscle and the scleral spur, thereby causing SC to 
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open118,119. Interestingly, pilocarpine was still shown to have an effect on outflow facility after the 
separation of the ciliary muscle and sclera spur, suggesting it can directly affect TM cells too. This 
was further supported by studies identifying muscarinic receptors in the TM120,121, or by showing TM 
cells have contractile properties45–47.  In contrast, prostaglandins act by increasing the spaces 
between the ciliary muscle bundles and reducing the extracellular matrix in such areas, thus 
increasing uveoscleral outflow122,123.  Yet, there is still a need for a new generation of drugs which 
target the root problem in glaucoma located in the trabecular pathway. 
3.5.3. Increased outflow resistance in POAG 
    Although it is known the increased IOP which characterizes glaucoma is associated with an 
increased outflow resistance in the conventional pathway2, the underlying reasons remain poorly 
understood. In essence, the main lines of thoughts revolve around the potential role of increased 
extracellular matrix deposit in the JCT or changes in SC inner wall conductivity39.  
    Indeed, alterations in POAG occurring in other parts of the conventional pathway such as SC and 
post-trabecular pathway have somewhat been discarded.  A trabeculotomy performed by Grant in 
1963 on glaucomatous eyes removed all the excessive outflow resistance89, suggesting it belonged 
to the excised trabecular pathway rather than the aqueous veins which were left intact. Note 
however the remaining outflow resistance was still higher in glaucomatous than normal eyes 
following trabeculotomy (1.60±0.91 vs. 2.97±1.07 μL/min.mmHg). In addition, a recent study has 
shown morphological changes in CC between glaucomatous and normal samples which suggest 
their role in POAG might have been underestimated124. Although there were no fewer CC in 
glaucomatous samples, their orifice size and circumference was twice as small as in control eyes. In 
addition, Johnson and Kamm demonstrated a collapse of SC could not explain the abnormal 
increase in outflow resistance observed in POAG125; however, SC in POAG samples were found to 
be significantly smaller which undoubtedly worsens the condition56, although other studies failed to 
detect a correlation126.  
    Differences in the extracellular matrix of the JCT between healthy and POAG donors suggest an 
accumulation of debris could increase outflow resistance.  In particular, an increase in extracellular 
matrix and the presence of fibrillar elements called “plaque material” was identified in POAG 
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samples127,128. Such plaques were shown to be derived from the elastic fibres in the JCT and 
correlated with axonal loss in the optic nerve. However, they did not seem to be present in ocular 
hypertension or early glaucoma, and could therefore just be a symptom rather than a cause of the 
disease. Similarly, there is an acute interest in the role of TGF-β2 in glaucoma129 which is found at 
higher concentrations in AH samples from POAG patients130. TGF-β2 is known to participate in 
fibrosis, and was shown to increase ECM deposition when added to TM cells in culture131. 
Furthermore, anterior segment perfusion with TGF-β2 provoked an accumulation of fibrillar ECM 
which coincided with a decrease in outflow facility132. 
    Finally, changes in pore density could alter outflow resistance in POAG: both Johnson35 and 
Allingham60 measured a decrease in pore density in glaucomatous samples. These observations 
were also replicated in vitro, wherein pore density was shown to be three fold smaller in 
glaucomatous SC cells compared to normal SC cells under perfusion at a physiological pressure 
drop of 6 mmHg133.   
    In summary, although progress has been made, there is still no clear insight into the root problem 
occurring in the conventional pathway during POAG, undermining the design of efficient drugs. 
Thus, using an experimental model such as the mouse should prove tremendously useful to further 
investigate such mechanisms and create anti-glaucoma treatments.  
3.6. Mouse model for human aqueous dynamics 
3.6.1. Why? 
    The mouse is the animal model used for a great deal of scientific research, primarily because it 
can be routinely manipulated genetically4. In this way, the relevance of specific genes to any 
pathology can be studied by knocking them out and studying the corresponding phenotypic effects. 
The mouse genome is the best characterized within mammals except for humans, and shows 
important conservation with the human genome4. Other advantageous features of the mouse 
include being small and inexpensive, which facilitates their use and housing. Consequently, their 
tissue is much more readily available than human tissue. Furthermore, their tight genetic and 
environmental control allows for clearer studies, especially with regard to complex diseases4. 
Importantly, samples can be obtained immediately after death in contrast with long post mortem 
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times (24-48 hrs) associated with obtaining human tissue. In addition, their smaller tissues facilitate 
a more comprehensive analysis across the entire organ of interest, yielding a more representative 
analysis than would be obtained by analysing as much data in larger tissues from other animals. 
Similarly, their smaller organs can be more easily visualized in their entirety using imaging modes 
which can typically only capture a minimal field of view at a high resolution. Their relatively quick life 
cycle and high metabolism permits the faster study of diseases which would otherwise take 
decades to develop in humans4. Last but not least, the development of a wealth of different inbred 
strains of mice, each characterized by a unique and uniform genome, has made the mouse a 
unique and powerful research model. Effectively, phenotypic differences amongst inbred strains can 
be matched to their genomic polymorphisms via Quantitative Trait Loci analysis (QTL), giving insight 
into the molecular factors and genes responsible for the trait of interest134. 
    Nevertheless, care should be taken in drawing parallels between mice and humans in function of 
the organ and disease of interest. As far as glaucoma is concerned, its study in mice has been 
commonly performed in the posterior segment135, but less so in the anterior segment. This was 
because the murine anterior segment which was originally thought to be too dissimilar to that of 
humans, and also because techniques to measure aqueous dynamics had not been adapted to the 
smaller mouse eye. Now that these technical challenges have been met, the question that needs to 
be addressed is whether the mouse is a suitable model for human aqueous dynamics.  
3.6.2. Anatomy of the mouse eye  
    The mouse anterior chamber presents a general architecture similar to that of humans with 
respects to the lens, cornea, limbus and iris136. Note the lens is rounder and much larger than that of 
humans, occupying 75% of the intraocular space137. Importantly, several differences exist which 
must be taken into consideration for aqueous humour dynamics. First, the ciliary body in humans is 
directly attached to the sclera, whereas in mice only the posterior ciliary processes are, thereby 
bringing closer or almost exposing the external face of the ciliary body to the TM137. In mice, the iris 
often extends processes towards the cornea, which however does not block AH flow towards the 
irido-corneal angle136. Importantly, the mouse does not possess a scleral spur; yet it has muscle 
fibres departing from the ciliary body towards the posterior part of Schlemm‟s Canal137.  
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    Mice have a continuous SC (Fig. 6) which is however often divided by collagen bridges lined with 
endothelial cells. Interestingly, giant vacuoles have been detected in mouse SC, as observed in 
humans. Their TM exhibit similar trabeculae as humans, but are composed of only up to half as 
many beams137. Finally, the post-trabecular pathway in mice is simpler since it only possesses 
aqueous veins which link directly the SC to the episcleral veins33,138.  Altogether, the evidence 
suggests the mouse is a suitable anatomical model for anterior segment studies, although further 
detailed investigation of their aqueous humour physiology and dynamics is required.  
 
Figure 6: Histological image of the murine conventional pathway from a C57BL/6 mouse aged 2 months. SC: 
Schlemm’s Canal. cb: Ciliary body. Arrowheads demarcate the anterior and posterior ends of the Trabecular 
meshwork. Reproduced from Smith et al. 2001, BMC Developmental Biology (BioMed Central). BioMed Central is 
an open access publisher which does not require permission to reproduce figures. 
3.6.3. Physiology and aqueous dynamics 
    Pioneering studies for aqueous humour outflow have mostly used monkeys which share many 
similarities with humans. However, primates can be expensive and difficult to maintain. The 
numerous benefits of mouse models described earlier have prompted the research community to 
start using mice as a surrogate for human AH studies only in the last decade5–17. Perfusion studies 
have commonly been performed to investigate AH outflow in several species; such work is much 
more challenging in mouse eyes because of their small size. This results into flow rates as small as 
0.1 μL/min during perfusions, or 100 times smaller than that found in human eye perfusions, which 
therefore requires a much higher precision for measurements. In addition, there is a higher risk of 
damaging internal structures such as the iris during cannulation, since the anterior chamber is so 
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small. Finally, such experiments are much more sensitive to leakage issues because of the small 
volumes and flow rates involved.   
    Nonetheless, several laboratories5–17 have successfully measured AH outflow and a host of other 
related parameters, showing the mouse exhibits many similar characteristics to humans relevant to 
AH dynamics, as listed in Table 1. Note different strains of mice have been studied, yielding varying 
aqueous humour dynamics parameters (Table 1 reports the range of parameters measured in 
different strains such as C57BL/6J, BALB/cJ or NIH Swiss mice); interestingly, strains exhibiting 
different IOPs also seem to have different facility, although it remains unknown whether changes in 
IOP directly relate to changes in outflow facility. 
 Human Mice 
Eye Diameter [mm] 24 3.3139,140 
AH volume [µL] 200 5.9 5 
IOP [mmHg] 16.220 10-1917,141,142  
C [µL/min.mmHg] 0.222 0.0055-0.0185–17 
Fu [µL/min] 0.28-1.52
72,73 0.029-0.1485,6,10,12,13,15 
Fin [µL/min] 2.42 0.06-0.25,6,8–10,15 
EVP [mmHg] 7.6-11.4143 5.4-10.25,6,8,15,144 
Fu contribution [%] 4-54
73,145 21-82% 5,6,10,12,13,15 
Number of TM trabeculae[-] 12-20 2-4136 
Number of CC [-] 20-3033 8-2833 
Table 1: Aqueous dynamics characteristics of humans vs. mice. 
 
    However, a fundamental unanswered question still revolves around unconventional outflow in 
mice. Depending on the mouse strain, it has been reported to range from 21-82%5,6,10,12,13,15 
compared to 4-54% in humans73,145. It should be noted that Fu is typically measured indirectly, using 
amongst other parameters values of Fp which can be dramatically affected by anaesthetics
146, which 
vary between studies. There is therefore a pressing need for direct visualization of tracers to reveal 
outflow patterns across the entire eye in mice. This would mark a crucial step towards consolidating 
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the mouse as a model for human AH circulation, as its potentially larger Fu would certainly fail to 
mimic human eyes‟ physiology.  
3.6.4. Glaucoma in mice 
    Finally, naturally occurring mouse models of glaucoma exist, but the disease can also be 
genetically induced. In particular, the DBA/2J mouse strain has been shown to exhibit high 
intraocular pressures and corresponding lesions in the optic nerve similar to that observed in the 
human form of the disease4,147,148. However, its onset seems to be triggered by an angle-closure 
form of glaucoma wherein the iris forms synechias at the irido-corneal angle or with the lens, 
thereby impeding AH flow and increasing IOP148. Other murine models rely on altering the 
expression of genes identified in glaucomatous human patients such as Foxc, whose alterations 
were shown to replicate key features of the pathology148. Thus, the mouse is a promising model for 
glaucoma research, although its AH physiology still needs to be further investigated to confirm it 
behaves similarly to humans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
43 
 
Chapter 2: Characterization of murine outflow 
facility using an optimized perfusion system 
1. Introduction  
 
    In the last decade, there has been growing interest in perfusing mouse eyes to measure and 
study aqueous humour outflow5–17. However, mouse eyes are particularly challenging to perfuse 
because of their small size. Indeed, their diameter is 8-fold smaller than humans, and the volume of 
their anterior chamber is only 3% that of humans, resulting in perfusion flow rates up to 100 times 
smaller. Yet several laboratories have successfully measured aqueous humour outflow in vivo, 
providing promising insight into its fundamental mechanisms5–17. Similarly, our laboratory has 
developed a perfusion system for enucleated mouse eyes12,13 because they present less 
confounding factors than in vivo experiments. Notably enucleated mouse eyes lack episcleral 
venous pressure, aqueous humour production and eliminate the need for anaesthetics. In this 
study, we aimed to better mimic physiological conditions during our ex vivo perfusions, by including 
control of hydration and temperature. In order to fully characterise our system, their effects on 
outflow facility were further characterised, as well as the effects of post-mortem times. 
    The effects of temperature on outflow facility have been previously investigated in enucleated 
human eyes. Van Buskirk showed the change in outflow facility between eyes perfused at different 
temperatures could be attributed solely to changes in aqueous humour viscosity77. This further 
suggested there was no metabolic activity that caused aqueous outflow at physiological 
temperature.  
    In large enucleated eyes such as humans‟ or monkeys‟, hydration is typically maintained during 
perfusion by immersing the eye in saline up to its limbus and covering it with moist tissue. Yet, 
owing to their small size, mouse eyes might be more sensitive to hydration effects. For example, a 
study showed mouse eyes lose up to 13% of their weight within 15 min following enucleation149. 
This effect was reversed following rehydration, which suggests evaporation rates could be non-
negligible in mice. Finally, effects of post mortem times on outflow facility have been previously 
investigated to validate the viability of the tissue as a perfusion model. Results from two studies on 
44 
 
bovine eyes 78,150 revealed changes in outflow facility up to 24 hrs following death, although it is not 
clear whether they were statistically significant. In addition, the washout rate was more pronounced 
in eyes stored for 24 hrs in DMEM150.  
    Therefore, this study aimed at characterizing the effects of hydration, temperature and post-
mortem time on outflow facility measurements in enucleated mouse eyes. More specifically, paired 
eyes were perfused (a) while immersed or not in a saline bath, (b) in a saline bath at room or 
physiological temperature, (c) after storage in PBS or DMEM at the following post mortem times: 0, 
3 and 24 hrs. 
2. Methods 
    All experiments were performed using ex vivo tissue and were done in compliance with the ARVO 
Statement for the Use of Animals in Ophthalmic and Vision Research and the Animal Scientific 
Procedures Act 1986.  
2.1. Perfusion  
    Total outflow, represented by the sum of conventional and unconventional outflow, was 
measured in mice using a previously validated perfusion system for mouse eyes12,13. Following 
cervical dislocation, eyes were enucleated and stored in PBS at 4°C. Enucleation was performed 
either by (1) dissecting out the eye and its surrounding muscles with scissors or, (2) pulling out the 
eye with tweezers wedged behind the eye, in its socket.  Paired eyes were perfused sequentially, 
such that the first eye was perfused within 15 min post mortem, immediately followed by perfusion 
of its contralateral eye, within 3 hrs post mortem. For perfusion, the eye was placed on a custom-
made post filled with gauze using cyano-acrylate glue. A 33G needle (WPI, Stevenage, UK) was 
held with a special needle holder (MMP Kit, WPI, Stevenage, UK) which was inserted in a micro-
manipulator. The needle was inserted into the anterior chamber under a stereoscopic microscope 
using the micro-manipulator. The needle was connected to a pressure transducer (142PC01G; 
Honeywell, Fort Washington, PA) which recorded continuously the pressure inside the eye (Fig. 7). 
In addition, the needle was linked to a syringe (25 or 50 μL; Hamilton GasTight, Reno, NV) placed 
on a computer-controlled syringe pump (PhD Ultra; Harvard Apparatus, Holliston, MA). A custom 
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LabView program151 (National Instruments Corp., Austin, TX) allowed the user to define a pressure 
which was maintained by the variable flow-rate of perfusate delivered by the syringe-pump. The eye 
was perfused at 4, 8, 15 and 25 mmHg. Prior to each pressure step, the eye was pre-pressurized 
for up to 5 minutes with a PBS-filled reservoir connected to the tubing via a three way valve; the 
three way valve was thereafter closed such that the eye was no longer connected to the PBS-filled 
reservoir and was pressurized by the syringe pump only.  Eyes were perfused for up to 30 min at 
each pressure step to ensure at least 10 min of stable flow rate data was successfully obtained (Fig. 
8A).  The perfusion solution was Dulbecco‟s PBS with cations and 5.5 mM glucose filtered through 
a 0.22 µm filter, which will be referred to as filtered DBG. DBG was found to mimic more closely the 
composition of the mock aqueous humour optimized by Bárány 152 for acute perfusions (Table 2). 
The LabView software recorded the pressure inside the eye every 10 seconds, as well as the flow 
rate delivered and the cumulative volume injected by the syringe pump. 
 
Figure 7: Diagram of the mouse eye perfusion system. The pressure transducer is connected to a water-filled 
(dH2O) reservoir for calibration. The PBS-filled reservoir is used to pre-pressurize the eye at each increasing 
pressure step. Drawing by M. Boussommier-Calleja.  
 
 
 
 
 
 
 
 
46 
 
mM Mock aqueous 
humour 
dPBS+ 5.5 mM glucose DMEM* 
Inorganic Salts 
NaCl 
KCL 
CaCl2 
MgCl2 
Na2HPO4 
NaH2PO4 
KH2PO4 
Fe(NO3) 3 
MgSO4 
NaHCO3 
 
136.89 
4.69 
1.53 
0.67 
0.486 
0.114 
 
 
137.93 
2.67 
0.901 
0.493 
8.06 
 
1.47 
 
110.34 
5.33 
1.8 
 
 
0.916 
 
0.000248 
0.813 
44.05 
Glucose 5.5 5.5 5.5 
Table 2: Composition of dPBS and DMEM compared to the mock aqueous humour optimized by Bárány. *In 
addition, DMEM contains the following compounds: Amino Acids: Glycine L-Arginine hydrochloride, L-Cystine 
2HCl, L-Glutamine, L-Histidine hydrochloride-H2O, L-Isoleucine, L-Leucine, L-Lysine hydrochloride, L-Methionine, 
L-Phenylalanine, L-Serine, L-Threonine, L-Tryptophan, L-Tyrosine, L-Valine. Vitamins: Choline chloride, D-
Calcium pantothenate, Folic Acid, Niacinamide, Pyridoxine hydrochloride, Riboflavin, Thiamine hydrochloride, i-
Inositol. Other components: HEPES, Phenol Red, Sodium Pyruvate. Composition of products from 
LifeTechnology: DMEM (22320-022) and dPBS (14040-091).  
2.2. Conventional and unconventional facility measurement  
    As previously discussed, Goldmann‟s equation describes the balance of inflow and outflow inside 
the eye. During the perfusion, an additional source of inflow exists, denoted as F. Thus Goldmann‟s 
equation becomes: 
                       
Equation 7 
 
In enucleated eyes, it is assumed both Fp and EVP are zero, thereby simplifying Goldmann‟s 
equation as follows: 
             
Equation 8 
 
Thus, conventional (C) and unconventional facility (Fu) are calculated by fitting our flow-rate vs. 
pressure data to the simplified Goldmann‟s equation (Eq. 8). More specifically, steady flow-rates 
(red highlights in Fig. 8A) obtained at 4,8,15 and 25 mmHg are averaged and plotted against 
pressure for each eye (Fig. 8B). Data points at each pressure are averaged between all eyes for a 
given study, yielding a typical Flow Rate vs. IOP plot shown in Fig. 8C, which is fitted with a best-fit 
linear regression whose slope and intercept correspond to, respectively, the pressure-dependent or 
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conventional facility (C), and the pressure-independent or unconventional facility (Fu). Note 8 mmHg 
is considered to represent the physiological pressure drop across the conventional pathway. For 
example, it was measured to be 6 mmHg in C57BL/6J15. Since there is no episcleral venous 
pressure in enucleated eyes, the pressure drop they experience is solely defined by their IOP. 
Importantly, Goldmann‟s equation assumes F and IOP have reached steady state, and C and Fu do 
not change with IOP. A more detailed analysis of some of the latter assumptions can be found in the 
last chapter of this thesis (Chapter 7).  
    For each mouse eye the conventional and unconventional facility is calculated as explained (see 
Fig. 8B-C). An average conventional and unconventional facility is then computed over the entire 
cohort of mouse. For every cohort, the range of R2 values of the best fit obtained for each mouse is 
given as an indication of the accuracy of the linear best-fit to our data. 
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Figure 8: Typical perfusion tracings. A) Example of a perfusion tracing showing the flow rates of the perfusate 
being delivered by the syringe pump (blue line) to maintain IOP steady at 4, 8, 15 and 25 mmHg (black line). Red 
highlights show the flow rates deemed steady and averaged at each pressure step. B) Flow rate vs. IOP tracing 
obtained from the data shown in A, wherein the averages of the steady flow rates are plotted against their 
pressure level. C) Diagram showing how C and Fu are obtained from a typical F vs. IOP plot. The slope of the best-
fit linear equation to the average data is used to estimate conventional facility C, whereas its intercept is used to 
estimate unconventional outflow Fu. Thus, conventional facility in this example (B) was 0.0126 μL/min/mmHg and 
Fu was 0.0252 μL/min. For each study, we report the range of R
2 
values calculated for each individual eye. 
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2.3. Experimental design 
    Male and female C57BL/6 mice supplied by Charles Rivers aged 2-24 weeks were used for this 
study. Mice were fed ad libitum and maintained at 21°C with a 12-hour light (6 AM to 6 PM) and 12-
hour dark cycle. Eyes were enucleated 10-15 min following cervical dislocation and placed in PBS 
at 4 °C.  Paired eyes were sequentially perfused in a randomized order, such that one eye acted as 
the control for its contralateral eye. Table 3 shows the total number of eyes perfused in each cohort, 
showing most eyes were paired, although data from some unpaired eyes was also used when the 
perfusion of their contralateral eye failed. Thus, 24 mice were used for this study; 5 out of 48 
experiments failed, representing a 90% success rate. 
 Total number 
of eyes 
Unpaired eyes Paired eyes 
Cohort 1  7 1 6 
Cohort 2  12 4 8 
Cohort 3A 10 - 10 
Cohort 3B 8 - 8 
Cohort 3C 6 - 6 
Table 3: Number of mouse eyes perfused in cohorts 1,2 and 3. 
 
    Three cohorts of animals were used to investigate the effects of hydration, temperature and post 
mortem times, as described below. Throughout this report, each cohort will be identified with a 
unique number, so as to be able to distinguish them. 
   The first cohort of mice (Cohort 1) was used to investigate the effects of hydration on AH outflow 
in enucleated mouse eyes. More specifically, during perfusions, eyes were either immersed in a 
bath of isotonic saline up to their limbus and covered with a tissue paper, or simply covered with a 
tissue paper moistened every 15 min with a drop of PBS as done previously (Fig. 9 A and B). Eyes 
perfused in the former and latter configurations will be referred to as “in” or “out” of isotonic saline 
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bath, respectively. For perfusion, 50 µL of filtered DBG (5.5 mM glucose in DPBS) was backfilled 
from the needle tip. More specifically, the needle was placed into a 50 µL drop of DBG placed with a 
pipette on a Petri dish. Once the needle tip was in the drop of DBG, the PBS-filled reservoir 
connected to the needle was lowered so as to draw the solution into the needle and the tubing. This 
procedure was used in every study to backfill the needle with the solution of interest. This was 
typically done to avoid having to fill the entire tubing with the solution of interest. This was 
particularly important when using expensive or hazardous substances such as pharmacological 
agents, anti-metabolic agents or fluorescent tracers (cf. Chapter 3, 5, 6). 
    The effects of temperature on outflow were investigated in a second cohort (Cohort 2) of 
enucleated mouse eyes. Paired eyes were immersed in isotonic saline and perfused either at room 
or physiological temperature (i.e. 20 vs. 35 °C; Fig. 9C). A custom-made temperature controller was 
used to maintain the eye at physiological temperature, which was recorded via a thermocouple 
placed in the immediate vicinity of the eye. For eyes perfused at room temperature, the temperature 
controller was not used and a thermometer was generally used to assess temperature at the 
beginning and end of the perfusion which was approximately 20 °C.  50 µL of filtered DBG was 
backfilled from the needle tip for perfusion, as previously described.  
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Figure 9: Different configurations for enucleated eyes during perfusions. A) Originally, eyes were covered with a 
tissue kept moist with PBS drops every 15 min. B) Alternatively, eyes were immersed in an isotonic saline 
(Dulbecco’s PBS) bath up to their limbus as well as covered with a tissue continuously soaked in saline. C) 
Finally, eyes immersed in the isotonic saline bath were kept at physiological temperature (35 °C) with a 
customized temperature-controller system which tracked the temperature next to the eye via a thermocouple. 
After cannulation, the chamber was covered with a lid to help maintain a steady and homogeneous temperature 
in the bath. Drawing by M. Boussommier-Calleja. 
     
    The last cohort (Cohort 3) was used to test the effects of post-mortem times on outflow facility in 
enucleated mouse eyes. Three sub-groups examined different post mortem times in eyes covered 
with a tissue paper moistened with saline (Fig. 9A). The first and second sub-group examined 
outflow facility of eyes stored in PBS at 4°C for 0 vs. 3hrs post mortem (Cohort 3A), or for 0 vs. 24 
hrs post mortem (Cohort 3B). The last sub group measured outflow resistance in eyes stored for 0 
vs. 24 hrs in DMEM at 4°C (Cohort 3C). 150 µL of filtered DBG was backfilled from the needle tip for 
perfusion, as previously described. Experiments on Cohorts 3B and 3C were performed by Mr. 
Jacques Bertrand. 
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2.4. Statistical analysis 
    Within each cohort, unpaired two-sided students t-tests were performed to assess whether the 
difference in conventional and unconventional outflow between eyes perfused under different 
conditions was statistically significant. A paired t-test was used for groups containing only paired 
eyes (Cohort C1, C2 and C3). A similar analysis was carried out on the flow rates measured at each 
pressure step, which represent total facility. A one sided t-test was used to assess whether 
unconventional outflow was significantly different from 0.  
3. Results 
3.1. Cohort 1, Fu is negligible in enucleated eyes placed in the isotonic saline bath 
    Our flow rate vs. pressure data revealed a linear relationship, accurately explained by our best fit 
linear regressions, whose R² values ranges from  (0.783 R2 0.997; Fig. 10). The intercept of the 
best fit linear regression, or Fu, was -0.0003±0.0041 (N=3) vs. 0.0810±0.0295 (N =4) µL/min in eyes 
in or out of the isotonic saline bath, respectively. The difference between eyes in or out of the 
isotonic saline bath was statistically significant (p =0.011; unpaired t-test). Furthermore, Fu was 
statistically different from 0 in eyes out of the isotonic saline bath (p =0.006; one-sided t-test), but 
not in eyes placed in the isotonic saline bath (p =0.46; one-sided t-test).  
    In contrast, the slope of our best fit linear regressions, or C, was unaffected by hydration 
(0.0056±0.0016 vs. 0.0063±0.0036 μL/min.mmHg in eyes in or out of the isotonic saline bath; p 
=0.75, unpaired t-test). In addition, flow rates were statistically different at each pressure level (p 
 0.009; unpaired t-test) except at 25 mmHg (p =0.134; unpaired t-test).  
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Figure 10: Flow Rate vs. IOP data from Cohort 1. Average flow rate at each IOP level for eyes out of (open circles) 
or in (filled circles) the isotonic saline bath.  The R
2
 values of the linear best-fit regression lines computed for 
each individual mouse ranged between 0.783 and 0.997. Bars are standard deviations and lines represent the 
best-fit linear regressions to average data.  
3.2. Cohort 2, temperature effects on C are larger than viscosity effects 
    The flow-rate vs. pressure data for Cohort 2 was also well explained by our best-fit linear 
regression, which explained most of the variability of the data for each eye (i.e. 0.949  R2 0.999). 
The unconventional outflow, or Fu, of eyes placed in the isotonic saline bath perfused at 35 °C or 
20°C was -0.0155 ±0.0385 (N =6) and 0.0113±0.0248 (N =6) μL/min (Fig. 11). The difference was 
not statistically significant (p =0.19; unpaired t-test). In addition, neither Fu were statistically different 
from 0 (p ≥0.16; one-sided t-test), similarly to eyes in the isotonic saline bath from Cohort 1.  
    Conventional outflow, or C, was 0.0069±0.0021 (N =6) vs. 0.0172±0.0028 (N =6) μL/min.mmHg 
in eyes placed in the isotonic saline bath perfused at 20 or 35 °C (Fig. 11). Therefore, the change in 
temperature caused a 2.5 ±0.86-fold increase in C which was statistically significant (p =4x10-5; 
unpaired t-test). Importantly, this increase was significantly higher than the 1.4 fold increase 
predicted by changes in viscosity (p = 0.004; two-sided t-test). This is illustrated in Fig. 11, wherein 
the conventional facility expected based on the increase in viscosity from 20 to 35°C is shown in 
green, which is obviously smaller than that measured at 35 °C. The difference in flow rates was 
statistically significant at 15 and 25 mmHg (p ≤0.003; unpaired t-test), only barely significant at 8 
mmHg (p =0.054; unpaired t-test) and not significant at 4 mmHg (p =0.268; unpaired t-test). 
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Figure 11: Flow Rate vs. IOP data from Cohort 2. Average flow rate at each IOP level for eyes in isotonic saline 
bath perfused either at 20°C (open circles) or 35°C (filled circles). The green line shows the increased slope or 
conventional facility expected based on the decrease in viscosity from 20 to 35 °C. The R
2
 values of the linear 
best-fit regression lines computed for each individual mouse ranged between 0.949 and 0.999. Bars are standard 
deviations and lines represent the best-fit linear regressions to average data. 
3.3. Cohort 3, Post mortem times of 24 hrs affect C  
    Conventional outflow facility in Cohort 3A was 0.0053±0.0025 (N =5) in eyes perfused 
immediately after death and 0.0050±0.0025 (N =5) μL/min.mmHg in paired eyes perfused 2-3 hours 
later. Therefore, post mortem times of 3 hrs did not affect outflow facility (p =0.65; paired t-test). 
More specifically, the normalized difference in conventional facility (Cdiff; see Eq. 9) between paired 
eyes was in average 10.2±9.7%. This normalized difference was calculated as the difference in 
conventional facility measured in the eye perfused immediately after death (Ct0) and the eye 
perfused after longer storage times (Ct), normalized by their sum (Eq. 9).  
      
       
        
  
Equation 9 
    Conventional facility in eyes perfused after death was 0.0064±0.0011 (N =4) μL/min.mmHg and 
became 0.0055±0.0027(N =4) μL/min.mmHg in their contralateral eyes stored in PBS at 4°C for 24 
hrs after death (Cohort 3B).  Thus, storage in PBS for 24 hrs post mortem caused a decrease in 
conventional facility, although it was not statistically different (p =0.55; paired t-test). The average 
change in conventional facility between contralateral eyes (Cdiff) caused by storage in PBS for 24 
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hrs was 22.0±15.3%. Thus the average difference between eyes perfused at 0 vs. 24 hrs after death 
became two-fold larger than that found between eyes perfused at 0 vs. 3 hrs post mortem.  
    In Cohort 3C, we investigated whether storing eyes in DMEM rather than PBS helped maintain 
conventional outflow facility. Conventional outflow facility in eyes stored in DMEM for 24 hrs was 
0.0044±0.0013 (N =3) μL/min.mmHg, compared to 0.0046±0.0005 (N =3) μL/min.mmHg in their 
contralateral eyes perfused immediately after death (p =0.66; paired t-test). Thus storing eyes in 
DMEM for 24 hrs only caused a 4.7±5.2% change in conventional facility (Cdiff) compared to their 
contralateral eyes perfused immediately after death. Note the conventional facility of eyes perfused 
immediately after death in this cohort was significantly smaller than that of eyes perfused right after 
death in Cohort 3A or 3B (0.0046 in cohort 3C vs. 0.0053 or 0.0064 in cohorts 3A and 3B 
respectively). The difference might be attributable to the use of mice with varying age, or of different 
gender, which we show in the last chapter might have an effect on conventional facility (Chapter 7). 
Thus conventional facility was unchanged following 3 hrs of storage in PBS, and became much 
larger following storage in PBS for 24 hrs (10.2 vs. 22.0%; Cohort 3A vs. Cohort 3B). In contrast, 
eyes stored in DMEM for 24 hrs showed a conventional facility very similar to their paired eyes 
perfused immediately after death (4.7% difference; Cohort 3C). This is further illustrated in Fig. 12, 
wherein the conventional facility of eyes perfused immediately after death is plotted against that of 
their paired eyes perfused either 3 or 24 hrs post mortem, following storage in PBS or DMEM. One 
data point represents one pair of eyes; the closer the data point is to the unity line, the more similar 
are the conventional facility of the paired eyes. It is clear the data points from pairs of eyes within 
Cohort 3B differ the most from the unity line, whereas those from Cohort 3C are found significantly 
closer to it.  
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Figure 12: Conventional facility data from cohort 3.  Conventional facility of the eye perfused immediately after 
death (x-axis)  plotted against that of its contralateral eye (y-axis) perfused following storage at 4°C  in PBS for 3 
hrs (filled squares), in PBS for 24 hrs (open squares), or in DMEM for 24 hours (open circles). One data point 
corresponds to one mouse. The closer data points are to the unity line (dashed line), the more similar are the 
conventional facilities of the contralateral eyes.  
 
    Note unconventional outflow in cohort 3 varied from 0.0093 to 0.0290 μL/min (Table 4) and was 
only statistically different from 0 in eyes from Cohort 3C perfused following 24 hrs storage in DMEM 
(p =0.017; one-sided t-test). This variability in unconventional outflow is most likely attributable to 
the eyes being hydrated variably. Neither post mortem times of 3 or 24 hrs following storage in 
DMEM or PBS caused a statistically significant change in unconventional outflow (p ≥0.27; paired t-
test). 
Fu [μL/min] 0 hrs post mortem 3 or 24 hrs post mortem 
Cohort 3A 0.0191±0.0169 0.0200±0.0256 
Cohort 3B 0.0250±0.0103 0.0178±0.0117 
Cohort 3C 0.0093±0.0084 0.0290±0.0094 
Table 4: Unconventional outflow in Cohort 3 
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4- Discussion 
    We successfully included hydration and temperature-control to mimic physiological conditions in a 
previously developed perfusion system12 for enucleated mouse eyes. In vivo, the cornea is hydrated 
by a tear film and temperature in the eye lies between 35 and 37°C. Both hydration and temperature 
were shown to have important effects on outflow facility: a thorough hydration eliminated 
unconventional outflow, while a physiological temperature dramatically increased conventional 
outflow. Conventional facility measured in enucleated C57BL/6J mouse eyes with our system at 
35°C(0.0172±0.0028 μL/min.mmHg, Cohort 2)  lay well within the range of outflow facility measured 
in vivo reported in the literature (0.005-0.0185–11,14–16 μL/min.mmHg). Thus, we present a technique 
to measure conventional facility in enucleated mouse eyes in a physiologically-relevant manner so 
as to investigate its fundamental mechanisms.  
    An interesting finding was that the magnitude of the increase in conventional facility caused by 
temperature changes exceeded that expected based on viscosity changes. Indeed, the viscosity of 
water is known to be highly dependent on temperature, and will therefore intrinsically increase 
aqueous humour outflow facility at higher temperatures. Accordingly, an increase from 20 to 35°C 
should only increase viscosity, and thus outflow facility, by a factor of 1.4. However, we observed a 
much larger increase (2.5±0.86, see Cohort 2) which, importantly, was significantly different from 
that predicted based on viscosity effects (p= 0.004; two-sided t-test). Therefore, our findings 
suggest the additional increase in outflow facility that we observed could be attributed to metabolic 
activity, as opposed to the passive increase caused by changes in physical properties of aqueous 
humour. This finding is highly interesting as it contradicts previous studies performed in enucleated 
human eyes, which showed changes in outflow facility with temperature could be entirely explained 
by changes in viscosity77. Studies showing anti-metabolic agents had little or indirect effects on 
conventional facility reinforced the concept of the trabecular pathway being a passive rather than a 
metabolic-dependent filter78,153,154. However, such studies suffered from limitations such as long 
post-mortem times or lack of physiological temperature control during perfusions. This prompted us 
to test the hypothetical metabolic-dependence of outflow facility, as discussed in Chapter 5.  
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    In addition, our results show unconventional outflow in enucleated mouse eyes might have been 
overestimated in previous studies12,13 due to incomplete hydration.  More specifically, 
unconventional outflow went from representing 31% of outflow at 8 mmHg in eyes covered with a 
moist tissue to zero in eyes immersed in an isotonic bath (Cohort 1). This is somewhat similar to the 
relatively high unconventional outflow (~66%) obtained in previous similar studies where enucleated 
mouse eyes were only covered with a moist tissue12,13.The fraction of unconventional outflow (Fu%) 
at a given pressure (IOP) was calculated according to Eq. 10, where Fu and C are respectively, 
unconventional and conventional outflow. 
    
  
         
 
Equation 10 
    
    It is rather difficult to ascertain the reasons underlying the effects of hydration on unconventional 
outflow, as the mechanisms of unconventional outflow remain unknown. In our opinion, a lack of 
hydration could fail to prevent evaporation of perfusion fluid through the cornea. In other words, 
there could be a constant loss of perfusion fluid during perfusion due to evaporation which is 
compensated by increased flow rates of perfusate injected by the syringe pump.  Thus at every 
pressure level, the pump has to deliver higher flow rates which shifts the flow rate vs. pressure plot 
upwards, resulting in a higher intercept or unconventional outflow. Measurements of weight loss in 
enucleated eyes due to evaporation in another study support this hypothesis149. Mouse eyes were 
weighed repeatedly within 13 min following death and enucleation at room temperature, showing a 
progressive loss of weight of up to 13%, which corresponds to a rate of perfusion fluid loss of 0.18 
µL/min (if perfusion fluid density is equated to that of water). This rate of evaporation is similar, 
although somewhat larger, than unconventional outflow measurements from the current or previous 
studies12,13 (0.09-0.11 µL/min), most likely because eyes in our studies were still partially hydrated 
with PBS drops every 15 min. In addition, Wisard et al. showed the original weight of the mouse eye 
was restored following immersion in PBS for 1 hr149, suggesting these evaporation mechanisms are 
reversible. This agrees with our hypothesis that hydrating the eyes similarly prevented the loss of 
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perfusion fluid, thereby eliminating the need for higher flow rates during perfusion, thus eliminating 
the intercept of the flow rate vs. IOP relationship, or Fu.  
    Our data showing a negligible unconventional outflow in enucleated mouse eyes could be 
consistent with stoppage of uveal adsorption of aqueous humour following stoppage of blood 
perfusion, as shown previously in enucleated porcine eyes155. However, unconventional outflow is 
alternatively thought to rely on trans-scleral passive or bulk flow66,69, which should not be affected by 
enucleation and thus still be present in enucleated eyes. Regardless, our results demonstrate 
hydration is an important physical parameter for perfusions which might have been overlooked in 
past studies. Indeed, only one study specified they applied drops of PBS on mouse eyes during in 
vivo perfusions9, which might be similarly susceptible to evaporation.  This in turn could explain the 
high variability in unconventional outflow reported in the literature ranging from 21 to 82%5,6,10,12,13,15, 
although this effect could also be attributed to strain differences.  In contrast, conventional facility 
measured in the current study in enucleated mouse eyes was similar to values reported in vivo5–
11,14–16, suggesting death or enucleation do not affect conventional facility. This is further supported 
by a previous study which reported similar values for conventional facility in living mouse eyes under 
anaesthesia and following a lethal dose of anaesthetics6. Further, human studies have also reported 
similar conventional facility values for human eyes in vivo using tonography and shortly after 
enucleation156–158. 
    Another important aspect of this study concerned the changes of conventional facility caused by 
post-mortem times. This has only been investigated in bovine eyes, first by Bárány in 195478 and 
more recently by Gual150. Both studies reported mild changes in AH outflow with post mortem times, 
without specifying whether the difference was statistically significant. More specifically, data from 
Gual et al. suggests conventional outflow facility was 30% lower in eyes stored in DMEM at 4 °C for 
24 hrs. However, both studies used unpaired eyes, which could have had naturally different facilities 
regardless of post mortem times. In contrast, our study consisted of using paired eyes which are 
more likely to have intrinsically similar conventional facilities (see below). In our study, one eye 
perfused immediately after death was compared to its contralateral eye perfused 3 or 24 hrs later. 
Our experiments showed the change in conventional facility was 10.2±9.7% within 3hrs post 
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mortem. In contrast, it was 22.0±15.3% after 24hrs of storage in PBS at 4 °C., although the change 
was not statistically significant (p =0.55; paired t-test). Finally, we show storing eyes in DMEM 
minimizes the average difference between paired eyes to 4.7±5.2%, similar to the value obtained for 
eyes perfused within 3 hrs. Thus, although the effects are not statistically significant, our results 
show post mortem time can still potentially change outflow facility, and introduce large variability in 
the results. Indeed, the coefficient of variation for conventional facility was 48% in eyes stored in 
PBS for 24 hrs as opposed to 17% for eyes perfused immediately after death (Cohort 3B). This can 
potentially blur results, especially in studies measuring differences following pharmacological 
treatment, as shown in Chapter 3. 
    The reasons underlying the change of AH outflow with post mortem times could obviously relate 
to anatomical changes. Yet Bárány showed total resistance in eyes perfused with hyaluronidase did 
not change with post mortem times78. Thus he proposed post mortem times were promoting the 
depolymerisation of the hyaluronidase-sensitive outflow resistance, which equates to the resistance 
generated by the ground substance of the outflow pathway. However, studies showed GAG-profiles 
of human corneoscleral explants were well maintained within 7 to 14 days post mortem159.  
Interestingly, this study also reported ultra structural changes in the TM of human eyes stored in 
PBS at 5°C for 48 hrs post mortem159. 
    Bárány further proposed post mortem times might cause the loss of carbon dioxide in the 
aqueous, thereby reducing its acidity and affecting tissue hydration78. Note changes of aqueous 
humour composition cannot explain our results as mouse eyes are always exposed to mock 
aqueous humour (DBG) during our perfusions since the anterior chamber is typically turned over at 
least 2-3 times during a perfusion. In light of our previous findings, we hypothesize the decrease in 
conventional facility we observed could be partially caused by the loss of metabolic activity following 
death. Interestingly, storing eyes in DMEM minimised the effects of post-mortem times on 
conventional facility. This agrees with previous studies showing storing TM samples in PBS at 5 °C 
for up to 2 days caused advanced degradation, which could be reversed following culture in DMEM 
for a week159. This further suggests conventional facility might deteriorate because of lack of 
metabolic activity, which in turn is somewhat better maintained by DMEM.  Altogether, our results 
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show that eyes should be perfused within 3hrs following death in agreement with previous 
studies150, or if otherwise unavoidable, within 24hrs if stored in DMEM at 4 °C. This further 
emphasises the mouse as a powerful model for eye perfusions as eyes can readily be obtained 
immediately after death. 
    Importantly, the natural variability in conventional facility between paired eyes can also be 
inferred from our post-mortem study. Thus, we show the difference in conventional facility between 
paired eyes perfused either immediately after death or 3 hrs later is only 10.2%. This corresponded 
to a coefficient of variation for the change in conventional facility between paired eyes of 31.5% 
(Cohort 3A). In comparison, the coefficient of variation was 54% between unpaired eyes of different 
animals from Cohort 3A perfused under identical conditions, immediately after death. This agrees 
with observations made by Bárány who showed the coefficient of variation between paired cattle 
eyes was 14% as opposed to 24% for unpaired eyes78, although he measured total outflow 
resistance rather than conventional facility. Thus, our results confirm there can be important 
variations in conventional facilities between different mice which become dramatically reduced 
between paired eyes. Thus, any difference observed in conventional facility between paired eyes 
will be much more likely attributable to the treatment of interest than between unpaired eyes which 
can possess intrinsically different facilities. Consequently, every study described in this thesis has 
used paired eyes, although a few unpaired eyes were included when their contralateral eye‟s 
perfusion failed. 
    In conclusion, a perfusion system has been designed to measure outflow facility in enucleated 
mouse eyes in a physiologically relevant manner.  Importantly, unconventional outflow was shown 
to be minimal under efficient hydration conditions, providing a more direct measurement of 
conventional facility alone. Owing to the sensitivity of unconventional outflow to hydration, most of 
our subsequent studies mainly focus on conventional facility measurements. This study also 
demonstrates that eyes should be perfused within few hours following death, or else it could affect 
results, in particular pharmacological effects as further shown in Chapter 3. Thus we have 
developed a powerful system to reliably measure conventional facility in mouse eyes, which should 
prove invaluable to unravelling underlying mechanisms of IOP regulation.   
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Chapter 3: Pharmacological Manipulation of 
Conventional Outflow Facility in Ex Vivo Mouse 
Eyes 
 
    This chapter consists of a paper published in IOVS79, reproduced with permission from 
Association for Research in Vision and Ophthalmology (ARVO; see Appendix 2).  
1- Introduction 
    Mice provide important models for glaucoma research, due to their genetic malleability and the 
extensive catalogue of molecular tools that may be exploited to investigate disease mechanisms4. 
While most glaucoma research involving mice has focused on the effect of elevated intraocular 
pressure (IOP) on the optic nerve, a small but growing community 5–17 has begun using mice to 
investigate the physiology of aqueous humour outflow, with the aim to better understand the 
mechanisms of IOP regulation. In fact, recent data show that the morphology and behaviour of the 
murine conventional outflow pathway is more similar in some ways to humans than are non-human 
primates (e.g., like humans160, mice do not appear to exhibit „washout‟12, while „washout‟ is observed 
in monkeys160). Notwithstanding the utility of mouse models, it remains an open question whether 
mice are appropriate models for IOP regulation at the level of the conventional outflow pathway as 
occurs within human eyes. 
    Compounds that affect IOP in humans tend to have similar effects in mice, however the response 
is not always through the same mechanisms, as noted previously. For example, latanoprost lowers 
IOP6,10,144,161,162 and increases conventional outflow facility in mice6,10 without any detectible effects 
on unconventional outflow6,10, unlike the response in human eyes where latanoprost increases both 
conventional163 and unconventional outflow164. This suggests that the physiology and pharmacology 
of aqueous humour outflow may differ substantially between mice and humans, and should be 
carefully examined before accepting the mouse as a reliable model for human IOP regulation.  
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    The goal of this project was to determine whether pharmacological compounds that are known to 
affect conventional outflow facility in human eyes exert similar effects on conventional outflow facility 
in C57BL/6 mice. We specifically examined the facility response to two G-protein coupled receptor 
agonists, sphingosine 1-phosphate (S1P) and the prostanoid EP4 agonist 3,7-dithia PGE1, that 
respectively decrease80 and increase86 outflow facility in human eyes. By comparing the facility 
response measured in enucleated murine eyes against previous reports in enucleated human 
eyes80,86, we aimed to determine whether C57BL/6 mice mimic aspects of human conventional 
outflow pathway pharmacology, which would identify this strain as a promising animal model for 
S1P and EP4-based regulation of IOP as occurs within human eyes. We also examined whether the 
pharmacological response is affected by prolonged post-mortem times, which is an important 
consideration for using the mouse model as a research tool when doing ex vivo perfusions. 
2- Methods 
    All experiments were performed using ex vivo tissue and were done in compliance with the ARVO 
Statement for the Use of Animals in Ophthalmic and Vision Research and the Animal Scientific 
Procedures Act 1986.  
2.1. Ex Vivo Mouse Eye Perfusion   
    C57BL/6 mice of either sex, aged 8-15 weeks, were killed by cervical dislocation. Eyes were 
enucleated within 10 minutes of death and perfused immediately or stored in phosphate buffered 
saline (PBS) at 4C for 2-3 hours. For perfusion, each eye was mounted on a single well of a 96-
well Stripwell plate (Corning) using cyanoacrylate glue to affix the extra ocular muscles to the plastic 
sidewalls of a well. Eyes were perfused outside of the isotonic saline bath (Fig. 9A). Special 
attention was given to maintain hydration throughout the experiment by covering the eye with tissue 
paper that was kept moist by regular drops of PBS. The perfusion solution was Dulbecco‟s PBS 
including divalent cations and 5.5 mM glucose (referred to as “DBG”) filtered through a 0.22 µm filter 
before use. All perfusions were done at room temperature, with a post hoc correction to account for 
the viscosity difference between room and physiologic temperature12,77. 
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    Our perfusion method follows previously described techniques12. Briefly, a 33-gauge needle was 
used to cannulate the anterior chamber under a stereomicroscope using a micromanipulator. The 
needle was connected via rigid pressure tubing to a glass syringe (25 µL, Hamilton GasTight) 
placed on the rack of a motorized syringe pump (Pump33; Harvard Apparatus) under computer 
control. A pressure transducer (142PC01G, Honeywell) monitored IOP through a three-way 
connector placed in the perfusion line. Custom written LabVIEW software151 was used to 
automatically vary the flow rate from the syringe pump to maintain the eye at a user-defined IOP. 
Eyes were perfused at sequential pressure steps of 4, 8, 15, and 25 mmHg; we refer to this as our 
“standard perfusion regimen.” Eyes were typically perfused for 20 minutes at each pressure step to 
obtain at least 10 minutes of stable perfusion data, and an average stable flow rate was calculated 
at each pressure step (Fig. 13A). Data were considered acceptable if a stable flow rate was 
achieved in at least 3 of the 4 pressure steps. Based on this criterion, we rejected 12 eyes out of 88 
valid perfusions. Selected eyes were fixed by removing the perfusion needle and immediately 
immersing the eye in 4% paraformaldehyde (PFA) in isotonic saline for 1 hour, followed by long-
term storage in 0.1% PFA. For histology (performed by Lawrence Lorraine), eyes were processed 
for paraffin embedding, sectioned and stained using hematoxylin and eosin. 
2.2. Outflow Facility Analysis 
    We calculated a pressure-dependent or “conventional outflow facility” (C) by fitting our pressure-
flow rate data to the modified Goldmann‟s equation165:  
                   
              Equation 4 
where F represents the stable flow rate at each corresponding IOP. Fu in Equation 4 is usually taken 
as an estimate of the pressure-independent or “unconventional” outflow rate12. Equation 4 is valid 
only when (i) episcleral venous pressure is zero (appropriate for enucleated eyes); (ii) F reaches 
equilibrium at each value of IOP; and (iii) C and Fu are independent of IOP. The values of C and Fu 
are defined as the slope and intercept, respectively, of the best-fit linear regression to our measured 
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F versus IOP data (Fig. 8B-C). In principle, C would be consistent with values obtained from a 2-
level perfusion5,8,10,16, except that the additional pressure steps give a much stronger confidence for 
estimating C. In this study eyes were perfused at room temperature, while covered with a tissue 
paper kept moist with PBS drops during the experiment (Fig. 9A). Thus, both C and Fu were 
multiplied by a factor of 1.38 to account for viscosity differences between physiologic and room 
temperatures, as previously described12,77. 
2.3. Experimental Design 
    We conducted three sets of perfusion experiments to measure how conventional outflow facility in 
the mouse eye responded to receptor-mediated compounds known to affect conventional outflow in 
human eyes. These were performed in three cohorts of mice, referred to a Cohort 4, 5 and 6, as a 
continuation of the first three cohorts of mice used in Chapter 2.  Most experiments used paired 
eyes (treated vs. untreated contralateral controls), except for cases where data from one eye were 
rejected based on the stability criterion described above (Table 5). Paired eyes were perfused 
sequentially (one eye immediately after enucleation, the contralateral eye 2-3 hrs after enucleation), 
where we randomised whether the control or experimental eye was perfused first. We also 
examined whether prolonged post-mortem time (24 hrs storage after enucleation at 4C) affected 
the pharmacologic response between paired eyes.  
 Total number of eyes Unpaired eyes Paired eyes 
Cohort 4 14 2 12 
Cohort 5A 15 1 14 
Cohort 5B 14 2 12 
Cohort 5C 10 4 6 
Cohort 6A 13 5 8 
Cohort 6B 10 2 8 
Table 5: Number of mouse eyes perfused in cohorts 4, 5 and 6. 
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    In the first set of experiments (Cohort 4), we examined the effect of sphingosine 1-phosphate 
(S1P), a bioactive lipid that decreases outflow facility by 31% in porcine eyes81 and 36% in human 
eyes80. Experimental eyes were perfused with 5 µM S1P in DBG containing fatty acid free bovine 
serum albumin (FAF-BSA; 2 mg/mL; Sigma-Aldrich A8806) and 17 µM sodium hydroxide (NaOH), 
while control eyes received DBG and FAF-BSA alone without S1P or NaOH. Independent studies 
demonstrated that 17 µM NaOH had a negligible effect on the pH of DBG (7.137±0.031 vs. 
7.107±0.012 for Dulbecco‟s PBS with or without 17 µM NaOH, respectively, N = 3 independent trials 
each, p = 0.23; Student‟s t-test), and therefore NaOH was not included in the control solution. S1P 
(CAS 26993-30-6 from Sigma-Aldrich, UK) was dissolved from powder into 10 mM NaOH in water 
to give a 3 mM S1P stock solution that was stored at -20C. Prior to cannulation, each needle was 
backfilled from the tip with 150 µL of the appropriate perfusion solution, a volume sufficient to last 
several hours even at the highest measured flow rates (~0.3 µL/min). The experimental eye was 
pre-treated with S1P-containing solution from a reservoir at 8 mmHg for 45 minutes to expose the 
outflow pathway to the drug prior to the start of the standard perfusion regimen. Control eyes were 
perfused from a reservoir for the same time with solution without S1P. Data from 14 individual eyes 
(8 S1P-treated and 6 controls, containing 6 pairs) passed the stability criterion and were included in 
Cohort 4. 
    The aim of the second set of experiments (Cohort 5) was to investigate the role of S1P1 and S1P2 
receptors in mediating the S1P response. Following a previous study in human eyes82, we used 
W146 (Avanti Polar Lipids) or JTE-013 (Cayman Chemical) that are selective antagonists to S1P1 or 
S1P2 receptors, respectively. W146 was dissolved in water as a 1 mM stock solution containing 
10.6 mM cyclodextrin and 100 mM sodium carbonate (Na2CO3) as vehicle, and was stored at -20C. 
JTE-013 was dissolved in DMSO as a 1 mM stock solution and stored at -20C. Experimental eyes 
were pre-treated with antagonist and S1P-containing solution (45 minutes at 8 mmHg from a 
reservoir) followed by perfusion with the same solution over the standard perfusion regimen. For 
JTE-treated experimental eyes (Cohort 5A), the perfusion solution contained 5 µM JTE-013 in DBG 
+ 5 µM S1P + 2 mg/mL FAF-BSA + 17 µM NaOH + 70 mM DMSO. For W146-treated experimental 
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eyes (Cohort 5B), the perfusion solution contained 5 µM W146 in DBG + 5 µM S1P + 2 mg/mL FAF-
BSA + 17 µM NaOH + 53 µM cyclodextrin + 500 µM Na2CO3.Antagonist concentrations (5 µM) were 
chosen to be consistent with concentrations used in prior perfusion studies with porcine and human 
eyes and were several fold larger than reported IC50 values (0.83 µM for W146
166 and 1.0 µM for 
JTE-01382). Control eyes were perfused with 5 µM S1P in DBG + 2 mg/mL FAF-BSA + 17 µM 
NaOH, without antagonist, cyclodextrin, Na2CO3 or DMSO vehicle and without pre-treatment. Data 
from 8 eyes were included in the JTE study (4 JTE-treated and 4 controls, containing 4 pairs), and 
data from 7 eyes were included in the W146 study (3 W146-treated and 4 controls, containing 3 
pairs). 
    To account for possible vehicle effects caused by cyclodextrin, Na2CO3 or DMSO, we repeated 
the W146 and JTE-013 antagonist studies using the same vehicle formulations in the control eyes. 
For these studies, the control eyes from the W146 study received 5 µM S1P in DBG + 2 mg/mL 
FAF-BSA + 17 µM NaOH + 53 µM cyclodextrin + 500 µM Na2CO3, while the experimental eyes from 
the W146 study received the same solution with 5 µM W146. The control eyes from the JTE study 
received 5 µM S1P in DBG + 2 mg/mL FAF-BSA + 17 µM NaOH + 70 mM DMSO, while the 
experimental eyes from the JTE study received the same solution with 5 µM JTE-013. Data from 7 
eyes were included in the JTE vehicle-controlled study (3 JTE-treated and 4 controls, containing 3 
pairs), and data from 7 eyes were included in the W146 vehicle-controlled study (4 W146-treated 
and 3 controls, containing 3 pairs). 
    In an additional 10 eyes (3 pairs and 4 unpaired eyes), we examined the influence of JTE 
antagonist alone on outflow facility (Cohort 5C). For these studies, experimental eyes were perfused 
with 5 µM JTE-013 + 70 mM DMSO in DBG without FAF-BSA (N = 5 eyes), while the control eyes 
were perfused with DBG alone without JTE, DMSO, or FAF-BSA (N = 5) using the standard 
perfusion regimen. Because 70 mM DMSO was found not to affect the facility response in JTE-
treated eyes in the presence of S1P (see below), it was not included in the perfusion solution for the 
control eyes.  
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    In the third set of experiments (Cohort 6A), we examined the influence of prostaglandin EP4 
receptor activation on conventional outflow in the mouse eye by perfusion with 3,7-dithia PGE1, a 
highly selective PG-EP4 receptor agonist
167 that increases conventional outflow facility in human86 
and monkey eyes87 without affecting unconventional outflow. 3,7-dithia PGE1 was dissolved in 
ethanol as a 10 mM stock solution and stored at -20C. Experimental eyes were pre-treated (45 min 
at 8 mmHg from a reservoir) and perfused with 10 nM 3,7-dithia PGE1 in DBG + 17 µM ethanol 
without FAF-BSA. Control eyes were perfused with DBG alone without ethanol or pre-treatment. 
Ethanol was not included in the perfusion solution of the control eyes because 17 µM ethanol is 
approximately 1000-fold smaller than typical millimolar concentrations shown to have minimal 
effects on cultured cells168,169. Data examining the effects of 3,7-dithia PGE1 included 13 eyes (7 
treated and 6 untreated control eyes, containing 4 pairs). 
    In an additional 10 eyes (including 4 pairs and 2 unpaired eyes), we examined whether the 
response to 3,7-dithia PGE1 was affected by post-mortem time (Cohort 6B). For these studies, eyes 
were enucleated and stored for 24 hrs at 4C in Dulbecco‟s modified Eagle‟s medium (DMEM) and 
then perfused with 10 nM 3,7-dithia PGE1 in DBG + 17 µM ethanol (N = 6) or with DBG + 17 µM 
ethanol (N = 4) using the standard perfusion regimen. We chose to examine the post-mortem facility 
response to 3,7-dithia PGE1, rather than to S1P, for two reasons. First, 3,7-dithia PGE1 causes a 
larger change in outflow facility compared to S1P (e.g., 69% increase following 3,7-dithia PGE1
86 
versus 36% decrease following S1P in human eyes, respectively), and therefore 3,7-dithia PGE1 
would provide a more conservative test to detect smaller differences in facility that might occur with 
prolonged post-mortem times. Second, 3,7-dithia PGE1 is an exogenous compound (unlike S1P) 
and is therefore more representative of potential candidate drugs that may affect conventional 
outflow. Therefore, by looking at how the facility response to 3,7-dithia PGE1 changes with post-
mortem time, we can gain some insight into how post-mortem time may affect the interpretation of 
drug efficacy in perfusion experiments (that often incorporate eyes with post-mortem times up to 24 
hours or use transgenic models where eyes are shipped overnight between laboratories). 
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2.4. Statistical Methods 
    All experiments included in this study contained some portion of unpaired eyes caused by one 
eye of a pair failing to pass the stability criterion. To analyze our data, we performed two statistical 
analyses: (i) a Welch‟s t-test that included the full set of eyes (accounting for unequal sample sizes); 
and (ii) a paired, 2-tailed Student‟s t-test that included only the subset of paired contralateral eyes. 
Wherever appropriate, we indicate whether a paired Student‟s t-test or a Welch‟s t-test was 
performed. The statistical significance threshold was taken to be a p-value of 0.05. 
    All facility values quoted in the text were temperature-corrected to account for viscosity 
differences, as described above. Figures showing flow rate data, however, were not corrected and 
represent the true flow rate output from the syringe pump. 
3- Results 
3.1. Cohort 4, S1P Decreases Conventional Outflow Facility in Mice 
    Perfusion with 5 µM S1P caused a reduction in flow rate at each perfusion pressure (Fig. 13A). 
Compiling data from all eyes revealed a linear relationship between flow rate and IOP (Fig. 13B), 
consistent with the modified Goldmann equation (Eq. 8). In response to S1P, conventional outflow 
facility (C; slope of the linear regression) decreased by 38.9 ± 24.2% (mean ± SD; p = 0.029, paired 
Student‟s t-test, N = 6 pairs) compared to paired contralateral eyes perfused without S1P. After 
temperature correction, conventional outflow facility was 0.0125 ± 0.0037 and 0.0073 ± 0.0035 
µL/min/mmHg for control and S1P-treated eyes (p = 0.024, Welch‟s t-test, N = 8 S1P-treated eyes 
and 6 controls), respectively. We observed no statistical difference in the intercept of the linear 
regression in response to S1P in either paired (p = 0.71) or unpaired analyses (p = 0.56, Welch‟s t-
test). We observed no obvious differences in the morphology of the trabecular meshwork or 
Schlemm‟s canal following treatment with S1P (Fig. 14).  
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Figure 13: Flow rate vs. IOP data from Cohort 4. Panel A) Typical perfusion tracings showing IOP (blue) and flow 
rate data for a control (solid black) and an S1P treated (dashed black) eye as a function of time (data taken from 
unpaired eyes). Yellow highlighted regions represent data used to calculate the average flow rate at each 
pressure level (4, 8, 15, 25 mmHg). To enable flow traces from both control and experimental eyes to be seen on 
the same graph, flow rate tracings for the S1P treated eye were shifted by several minutes, and the pressure 
curve for the S1P-treated eye was omitted. Panel B) the average flow rate at each pressure level for all control 
(filled circles) and S1P treated eyes (open circles) from Cohort 4. Bars are standard deviations and lines 
represent the best-fit linear regressions to average data. The R
2
 values of the linear best-fit regression lines 
computed for each individual mouse ranged between 0.846 and 0.990. FAF-BSA was included in the perfusion 
medium for all eyes represented in Panel B. Flow rate data are not temperature corrected. 
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Figure 14: Mouse eye histology for S1P treated or untreated eye. No obvious differences are observed in the 
histology of the iridocorneal angle from control (A) and S1P-treated (B) mouse eyes. AC, anterior chamber; TM, 
trabecular meshwork; SC, Schlemm’s canal; I, iris; C, cornea; S, sclera. Bars are 50 µm. The absence of giant 
vacuoles in the inner wall of Schlemm’s canal may reflect the fact that the eyes were fixed by immersion. 
3.2. Cohort 5, The S1P2 Receptor Mediates the S1P Response 
    To determine which receptor mediates the S1P response measured in Cohort 4, we perfused 
contralateral eyes with either S1P or S1P in combination with either an antagonist to the S1P2 
receptor (5 µM JTE-013; Fig. 15A) or an antagonist to the S1P1 receptor (5 µM W146; Fig. 15B). In 
eyes treated with S1P without antagonist, the conventional outflow facility was 0.0074 ± 0.0034 
µL/min/mmHg (N = 15 control eyes from the JTE and W146 experiments; temperature-corrected), 
which was similar to the conventional facility measured for S1P-treated eyes in Group A. There was 
no difference in conventional outflow facility caused by vehicle, either for 70 mM DMSO 
(0.0072 ± 0.0052 vs. 0.0068 ± 0.0017 µL/min/mmHg in S1P-treated control eyes from the JTE 
studies with or without DMSO, respectively; temperature-corrected; p = 0.90, Welch‟s t-test, N = 4 
for each group) or for 53 µM cyclodextrin and 500 µM Na2CO3 (0.0078 ± 0.0040 vs. 0.0079 ± 0.0035 
µL/min/mmHg in S1P-treated control eyes from the W146 study with or without cyclodextrin + 
Na2CO3, respectively; temperature-corrected; p = 0.97, Welch‟s t-test, N = 3 or 4, respectively). For 
this reason, we compiled all data with and without vehicle control from the W146 or JTE perfusions 
with S1P. The compiled data shown in Figures 3A and 3B include 15 eyes for the JTE antagonist 
studies (8 controls + 7 experimentals, including 7 pairs) and 14 eyes for the W146 antagonist 
studies (7 controls + 7 experimentals, including 6 pairs). 
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    In eyes perfused with both S1P and JTE, the temperature-corrected conventional facility was 
0.0133 ± 0.0019 µL/min/mmHg, nearly 2-fold larger than eyes treated with S1P without antagonist 
(0.0070 ± 0.0036 µL/min/mmHg; p = 0.0012, Welch‟s t-test , N = 8 S1P vs. 7 S1P + JTE,) and 
similar to the conventional facility of control eyes from Group A. In contrast, conventional facility was 
unchanged between eyes perfused with S1P or S1P and W146 (0.0079 ± 0.0034 vs. 0.0094 ± 
0.0032 µL/min/mmHg; temperature-corrected; p = 0.41, Welch‟s t-test, N = 7 S1P vs. 7 S1P + 
W146; p = 0.145, p = 0.05, assuming the facility values for S1P-treated and untreated eyes from 
Group A with N = 7 for each group). These data demonstrate that JTE largely blocks the facility-
reducing effect of S1P, while W146 has little effect, suggesting that the S1P2 receptor, and not the 
S1P1 receptor, is principally responsible for mediating the S1P response in C57BL/6 mice. We did 
not observe significant effects of JTE or W146 in the presence of S1P on the intercept of the 
pressure-flow relationship (p ≥ 0.27). 
    In eyes perfused with 5 µM JTE without S1P, temperature-corrected conventional facility was 
nearly 2-fold greater than in untreated control eyes (Fig. 15C), increasing from 0.0096 ± 0.0026 to 
0.0194 ± 0.0056 µL/min/mmHg (p = 0.017; N = 5 control and N = 5 JTE-treated eyes, Welch‟s t-
test). There was no significant difference in the intercept of the pressure-flow relationship between 
JTE-treated and untreated eyes (p = 0.19). These data suggest that endogenous S1P signalling 
may be regulating conventional outflow facility in the mouse trabecular meshwork, which can be 
blocked by S1P2 receptor antagonist JTE-013. 
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Figure 15: Flow rate vs. IOP data from Cohort 5. Panel A) Average flow rate at each pressure level for S1P (open 
circles) and S1P+JTE-013-treated eyes (filled circles). Controls for Panels A and B include eyes with and without 
vehicle formulations, as described in the text. The R
2
 values of the linear best-fit regression lines computed for 
each individual mouse ranged between 0.357 and 0.990.  Panel B) Average flow rate at each pressure level for 
S1P (open circles) and S1P+W146-treated eyes (filled triangles). The R
2
 values of the linear best-fit regression 
lines computed for each individual mouse ranged between 0.842 and 1.  Panel C) Average flow rate at each 
pressure level for control (open diamonds) and JTE-treated eyes without S1P (filled circles). The R
2
 values ranged 
between 0.962 and 1. Bars are standard deviations and lines represent the best-fit linear regression to average 
data. FAF-BSA was included in the perfusion medium for all eyes represented in Panels A and B, but no FAF-BSA 
was included in the perfusion medium for Panel C. Flow rate data are not temperature corrected. 
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3.3. Cohort 6, EP4 Receptor Agonist Increases Conventional Outflow Facility in Mice 
    We measured a two-fold increase in conventional outflow facility following perfusion with 10 nM 
3,7-dithia PGE1 (Fig. 16A), with the temperature-corrected facility increasing from 0.0062 ± 0.0005 
to 0.0131 ± 0.0024 µL/min/mmHg (p = 0.0003; Welch‟s t-test; N = 6 or 7 for untreated eyes or eyes 
treated with 3,7-dithia PGE1, respectively). Considering only paired eyes, the conventional facility 
increased by 105.8 ± 48.4% following 3,7-dithia PGE1 treatment compared to untreated 
contralateral eyes (p = 0.02; paired Student‟s t-test, N = 4 pairs). In contrast, 3,7-dithia PGE1 
inconsistently affected the intercept of the pressure-flow relationship. More specifically, while we 
observed a statistically detectable decrease in the intercept between treated and untreated groups 
using unpaired analysis (p = 0.04), we observed no difference using paired analysis (p = 0.31). 
    After 24 hrs post-enucleation and storage at 4C in DMEM, eyes appeared well preserved with 
clear corneas and constricted pupils. In contrast, eyes stored for the same period in PBS at 4C 
appeared “mushy” with cloudy corneas and dilated pupils. Following 24 hr storage in DMEM, 
conventional outflow facility in eyes perfused with 3,7-dithia PGE1 was 0.0128 ± 0.0034 
µL/min/mmHg (N = 6 eyes; Fig. 16B), which was significantly larger (p = 0.037, Welch‟s t-test) than 
the baseline facility of untreated eyes (0.0087 ± 0.0014 µL/min/mmHg, N = 4 eyes) by unpaired 
analysis. When considering only paired eyes, the relative facility increase following 3,7-dithia PGE1 
was nearly 3-fold smaller after 24 hrs (38.1 ± 34.5%; N = 4 pairs) versus after 3 hrs (see above) and 
failed to achieve statistical significance (p = 0.126, paired Student‟s t-test). Similarly, after 24 hrs for 
pressures of 8 mmHg and above, there was a tendency for 3,7-dithia PGE1 to increase the flow 
rate, but even at 25 mmHg the flow rate increase failed to achieve statistical significance (p = 0.10). 
This is in contrast to eyes perfused within 3 hrs post-mortem, when 3,7-dithia PGE1 caused a 
statistically significant increase in flow rate for all pressures of 8 mmHg or larger (p < 0.05). This 
suggests that while the facility-increasing effect of 3,7-dithia PGE1 was present 24 hrs after 
enucleation, the effect was subtle and detectable only when flow rates were measured over several 
perfusion pressures and linear regression analysis was used to calculate the slope of the flow rate-
pressure relationship. 
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Figure 16: Flow rate vs. IOP data from Cohort 6. Average flow rate at each pressure level for control (filled circles) 
and 3,7-dithia PGE1 (open squares) treated eyes, within 3 hrs (Panel A) or after 24 hrs post-mortem storage at 4°C 
(Panel B). The R
2
 values of the linear best-fit regression lines computed for each individual mouse ranged 
between 0.786 and 1 for Cohort 6A and 0.839-0.997 for cohort 6B. Bars are standard deviations and lines 
represent the best-fit linear regressions to average data. For Panels A and B, there was no FAF-BSA in the 
perfusion medium. Flow rate data are not temperature corrected. 
4- Discussion 
    This study demonstrates that C57BL/6 mouse eyes respond to S1P and EP4 agonist in a similar 
manner as that previously reported for human eyes. Specifically, S1P decreased murine outflow 
facility by 39%, which was nearly identical to the 36% decrease previously reported in human 
eyes80. The prostanoid EP4 agonist, 3,7-dithia PGE1, caused a facility increase of 106% in mice, 
which was somewhat larger than the 69% increase observed in human eyes86. Quantitative 
differences aside, the similarity in qualitative response between species suggests that similar 
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pharmacological signalling mechanisms underlie the facility response to S1P and 3,7-dithia PGE1 
between C57BL/6 mice and human eyes. 
    S1P is known to bind to one of five G protein-coupled receptors (S1P1-5) each of which exhibit 
different downstream signalling events and are differentially regulated in different tissues170. S1P 
rapidly decreases outflow facility80,81, and lysophospholipids similar to S1P are found in aqueous 
humour171, possibly acting as endogenous regulators of outflow facility172.  In C57BL/6 mice, we 
detected expression of S1P1 and negligible levels of S1P2 and S1P3 in Schlemm‟s canal 
endothelium by in situ confocal immunofluorescence (Supplemental Figure 1). The relative absence 
of S1P2 and S1P3 labelling could be attributed to reduced antibody sensitivity compared to prior 
studies by our group80 that reported relatively low levels of S1P2 and S1P3 expression, compared to 
S1P1, by human Schlemm‟s canal cells in situ. Despite the seemingly low levels of S1P2 expression, 
the facility-decreasing effect of S1P in mice was almost completely abolished by JTE-013, an 
antagonist to the S1P2 receptor, but not by W146, an antagonist to the S1P1 receptor. Similar 
effects were observed in human eyes82, where JTE-013 blocked facility reduction as well as 
phosphorylated myosin light chain (pMLC) in response to S1P, while no blocking effect on pMLC 
was observed in the presence of either W146 or VPC23019 (a dual antagonist to S1P1 and S1P3). 
Perfusion with JTE-013 alone increased conventional outflow by two-fold in C57BL/6 mice, yielding 
a conventional outflow facility (0.0194 ± 0.0056 µL/min/mmHg, N = 5) that was larger than that 
measured in either untreated eyes (0.0125 ± 0.0037 µL/min/mmHg, N = 6, from Cohort 4; p = 0.056, 
Welch‟s t-test) or eyes perfused with 3,7-dithia PGE1 (0.0131 ± 0.0024 µL/min/mmHg, N = 7, from 
Cohort 6; p = 0.063, Welch‟s t test). These data strongly implicate the S1P2 receptor as a key 
mediator of the facility-regulating effect of S1P and suggest an endogenous concentration of S1P 
within the trabecular meshwork. It should be noted however, that the selectivity of JTE-013 to the 
S1P2 receptor has been recently called into question based on data reporting an effect of JTE-013 
in S1P2 knock-out mice
173,174. Therefore, future studies should account for potential off-target 
effects, possibly by incorporating genetically altered mice to better understand the underlying 
mechanisms by which S1P regulates outflow facility.  
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    3,7-dithia PGE1 was the first selective agonist developed against the EP4 receptor
167 and has 
been shown to lower IOP by nearly 40% in cynomolgus monkeys by increasing trabecular outflow 
facility without affecting uveoscleral outflow87. Other examples of agonists for this receptor include:  
PGE2
175, PGF2α
176, ONO-4819177 or carbacyclin178. Similarly, 3,7-dithia PGE1 increases conventional 
outflow facility in post-mortem human eyes by 69%86, consistent with the expression of PG-EP4 in 
human trabecular meshwork and Schlemm‟s canal in situ86,179. At 10 nM concentration, however, 
the effect of 3,7-dithia PGE1 appears to be selective for Schlemm‟s canal cells, with no observed 
effect on trabecular meshwork cells, based on cell culture assays of cAMP accumulation following 
PG-EP4 receptor activation
86. Compared to humans, our data show that 3,7-dithia PGE1 had a 
nearly two-fold larger effect in C57BL/6 mice (106% vs. 69%86), and expression of PG-EP4 has 
already been demonstrated within the trabecular meshwork and Schlemm‟s canal in other strains of 
mice.  The larger facility increase in mice may reflect differences in EP4 sensitivity between species 
or with age, or it may be due to improved preservation of mouse tissue due to shorter post-mortem 
times. Alternatively, because mice have a more prominent Schlemm‟s canal with only 2-4 trabecular 
beams compared to 12-20 in humans40, mice may be predisposed to exhibit a more robust facility 
response to compounds such as 3,7-dithia PGE1 that preferentially affect Schlemm‟s canal (see 
above), as opposed to trabecular meshwork, cells86. Regardless, the robust facility-increasing 
response following 3,7-dithia PGE1 strongly suggests that C57BL/6 mice are a good 
pharmacological model for investigating the contribution of EP4, and possibly other prostanoid 
receptors, in the regulation of conventional outflow. This may be particularly interesting given that 
prostaglandin PGE2, a natural ligand for EP4 receptors
180, is present within aqueous humour at 
reduced concentrations in eyes from patients with primary open-angle and steroid-induced 
glaucoma181. 
    Post hoc comparison of facility data revealed that conventional outflow facility was, rather 
surprisingly, nearly 60% larger in eyes perfused with 0.2% FAF-BSA in DBG compared to eyes 
perfused with DBG alone. More specifically, there was a statistical difference (p = 0.028, Welsh‟s t-
test) between eyes perfused with 0.2% FAF-BSA from Cohort 4 (0.0125 ± 0.0037 µL/min/mmHg, 
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N = 6) compared to eyes perfused without FAF-BSA aggregated from Cohorts 5 and 6 
(0.0078 ± 0.0025 µL/min/mmHg, N = 11). FAF-BSA was included as a carrier for S1P in the 
perfusion medium, following prior studies in human eyes80, and therefore FAF-BSA was excluded 
from experiments that did not contain S1P (i.e., all experiments from Cohort 6 and experiments from 
Cohort 5 examining JTE alone). We are not certain as to the cause of this difference, nor were there 
any obvious differences in the gender, age or genetic background of the mice that could explain this 
difference. Because elevated FAF-BSA would be expected to decrease (due to possible 
obstruction), rather than increase, outflow facility182, these data may indicate a potential trace 
contaminant carried from the FAF-BSA source (e.g., lipoprotein, phospholipid or lipopolysaccharide) 
that may itself increase facility. We observed that the effect of FAF-BSA on facility persisted through 
two different batches from the supplier (lot numbers 040M7715V and 108k7425), suggesting a 
potential widespread, rather than batch-dependent, contaminant. Nevertheless, because our 
experiments used a paired perfusion approach, in which we compared the relative effects of 
selective receptor agonists or antagonists diluted in otherwise identical perfusion solutions (both 
control and experimental), we conclude that the facility effects we observed were in fact due to drug 
treatment, and not to the presence or absence of FAF-BSA in the perfusion media.  
    Data from the current study suggest that the fraction of unconventional outflow in mice may be 
significantly smaller than previously estimated5,8,10,12. We calculate the unconventional fraction of 
total outflow as 
  
           
 
Equation 10 
Using the regression parameters from control eyes from Cohort 6 (perfused within 3 hrs post-
enucleation without FAF-BSA; Fig. 16A) yields a relative contribution of 37.9 ± 15.6% 
unconventional to total outflow at 8 mmHg. In contrast, our previous work estimated that 
unconventional outflow represents 66% of total outflow in C57BL/6 mice12. This difference is largely 
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attributable to the 5-fold difference in FU between our current study (0.035 ± 0.025 µL/min; 
temperature-corrected; control eyes of Cohort 6 at 3 hrs) and our previous study (0.157 ± 0.026 
µL/min)12, with a more modest difference observed in conventional outflow facility (0.0062 ± 0.0005 
vs. 0.0091 ± 0.0012 µL/min/mmHg12). We do not understand the reasons for such a large 
discrepancy in FU, but it may be related to differences in experimental techniques, and in particular 
the hydration of the eye, between the two studies. In the current study, the eye was covered with 
tissue paper that was kept moist by regular drops of saline, while our previous study12 used regular 
drops of saline without tissue paper. It is thus possible that evaporation from the eye contributed to 
overestimation of FU, as suggested by our previous study in Chapter 2 (see Fig. 10). Along these 
lines, a recent study6 has reported that the fraction of unconventional outflow in BALB/cJ mice 
(20.5%) is more consistent with the lower range of unconventional outflow estimated in human eyes 
(4 – 14%145), while unconventional outflow may be larger in other strains of mice (e.g., ~80% in NIH 
Swiss White mice5,10) and more consistent with the upper range of unconventional outflow estimated 
in human eyes (46-54%73). This suggests that particular strains of mice (e.g., C57BL/6 or other 
strains that exhibit similar pharmacological behaviour) may serve as better models for the 
physiology or pharmacology of IOP regulation as occurs within the conventional outflow pathway of 
human eyes. 
    The conventional outflow pathway is sensitive to post-mortem degradation159, and enucleated 
whole human globes are routinely accepted for perfusion studies up to 24 hrs or longer after death. 
After 24 hrs post-enucleation and storage in DMEM at 4C, the facility-increasing effect of 3,7-dithia 
PGE1 remained statistically detectable in C57BL/6 mouse eyes, but only in the larger data set 
(unpaired set with 10 eyes) when conventional facility was measured as the slope of the flow rate-
pressure relationship. When considering only perfusion data at individual pressures, the flow rate 
increase caused by 3,7-dithia PGE1 failed to achieve statistical significance at 24 hrs (p ≥ 0.10). 
This suggests that a 24 hr post-mortem delay likely represents an upper limit for detection of 
pharmacological effects in ex vivo mouse eyes. More to this point, post-hoc analysis of conventional 
facility in DBG-perfused mouse eyes after 24 hrs (0.0087 µL/min/mmHg, temperature-corrected, 
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from Cohort 6) was approximately 40% greater (p = 0.043; Welch‟s t-test) than the facility measured 
in eyes within 3 hrs after enucleation (0.0062 µL/min/mmHg, temperature-corrected, from Cohort 6). 
This change in baseline facility explains why the relative facility increase following 3,7-dithia PGE1 
after 24 hrs (38%) was nearly 3-fold less than that measured within 3 hrs (106%). Taken together, 
these data demonstrate that post-mortem changes occurring within 24 hrs can affect both 
conventional facility and the relative facility response to pharmacological compounds. We are not 
aware of any studies that have examined outflow facility as a function of post-mortem time in human 
eyes, but if the post-mortem response of human and mouse eyes are similar, then these data 
suggest that there may be a considerable loss of sensitivity for detecting pharmacologically-induced 
changes in outflow facility using human eyes even at 24 hrs post-mortem. 
    In conclusion, we demonstrate that conventional outflow facility in C57BL/6 mice mimics the 
pharmacological response of human eyes to PG-EP4 and S1P receptor agonists that respectively 
increase and decrease outflow facility. These data strongly support the mouse eye (and possibly 
C57BL/6 or other strains) as a promising and robust model for the pharmacology of PG-EP4 and 
S1P receptor activity on IOP regulation as occurs within the conventional outflow tract of human 
eyes, as well as for investigating the basic mechanisms of outflow resistance generation as relevant 
for glaucoma. 
Supplementary figure 1: Confocal immunofluorescence microscopy of S1P receptor expression in angle tissues 
of the C57BL/6 mouse eye.  Slides containing frozen sections of mouse eyes (10 µm; embedded in OCT) were 
probed with polyclonal antibodies raised against peptides that correspond to carboxyl terminus of human S1P 
receptors 1 (sc-25489), 2 (sc-30024) and 3 (sc-25491), but cross react with mouse.  Binding of primary antibodies 
to mouse tissues was visualized using goat anti-rabbit antibodies conjugated to Dylight that were excited and 
fluorescence signals digitally captured by a Leica SP5 confocal microscope.  Images from all sections were 
recorded during the same session using identical confocal settings. As a positive control for tissue quality and 
localization of Schlemm's canal endothelia (asterisks), slides containing mouse eye sections were probed with 
monoclonal antibodies that specifically recognize PECAM-1, followed by goat anti-mouse secondary antibodies 
conjugated to Dylight.  As a negative control, some slides containing mouse sections were probed only with goat 
anti-rabbit antibodies conjugated to Dylight (2). This work was performed by Kristin Perkumas, in Prof. Stamer’s 
laboratory. 
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Chapter 4: The Influence of Genetic Background 
on Conventional Outflow Facility in Mice 
1- Introduction 
 
    The facility of aqueous humour drainage through the conventional or trabecular outflow pathway 
is a major determinant of intraocular pressure (IOP), and decreased conventional facility is the 
underlying cause of ocular hypertension associated with primary open-angle glaucoma2. The 
physiology of IOP regulation by aqueous humour outflow, however, has remained relatively obscure 
compared to the significant body of knowledge assembled on inflow (reviewed e.g. by Civan183). An 
improved understanding of aqueous outflow physiology may identify targetable outflow mechanisms 
that more successfully lower IOP as part of glaucoma therapy. 
    Because mice exhibit anatomical and functional similarities to humans in regards to aqueous 
outflow, there is growing interest in using mice as animal models to investigate the physiology of 
outflow facility regulation. Despite size differences, the murine conventional outflow pathway has a 
trabecular meshwork and a continuous Schlemm‟s canal136 that is lined by endothelial cells 
containing giant vacuoles and presumably pores. Conventional outflow facility in mice responds to 
receptor-mediated compounds that affect outflow facility in humans79, including sphingosine 1-
phosphate80,82 and an EP4 agonist86. Like humans, mice do not appear to exhibit a “washout” 
effect12, the characteristic increase in conventional outflow facility that occurs during prolonged 
ocular perfusion151. Importantly, washout has been observed in all non-human species examined to 
date, including even monkeys160,184, except mice. On the other hand, mice have been described as 
having a high unconventional fraction (21 – 82%)5,6,10,12,13,15 representing the proportion of aqueous 
outflow passing through the pressure-independent or uveoscleral outflow pathway. Whether the 
bulk of outflow in mice drains through the conventional outflow pathway (like humans) or through a 
separate unconventional pathway remains unclear, but this is an important issue for establishing 
whether the mouse accurately represents outflow physiology and IOP regulation as occurs in 
humans. 
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    In mice, IOP depends strongly on genetic background, with IOP values spanning nearly a 2-fold 
range between inbred strains (e.g., 11 vs. 19 mmHg between BALB/cJ vs. CBA/CaJ141,142). Because 
phenotypic differences can be linked to genomic polymorphisms134, there is an opportunity to exploit 
the natural phenotypic diversity of IOP to gain insight into the genetic basis of IOP regulation. 
According to Goldmann‟s equation, differences in IOP could be attributed to differences in any of 
the four parameters describing aqueous humour dynamics: aqueous humour production rate (Fp), 
episcleral venous pressure (EVP), conventional outflow facility (C) and unconventional outflow rate 
(Fu). While several studies have measured these parameters for a particular strain
5,6,8,10 only one 
has measured parameters across different strains9, and post-hoc comparison between studies is 
complicated by differences in technique or environmental conditions. For example, C measured in a 
single inbred strain (BALB/cJ) varies 3-fold between different reports (0.005511 vs. 0.01806 
µL/min/mmHg). Thus, there is a need for a study that explicitly examines aqueous humour 
dynamics between different inbred strains of mice. 
    The aim of this project was to test the hypothesis that differences in IOP between different inbred 
strains of mice are attributable to differences in C. To test this hypothesis, we measured IOP in 
BALB/cJ, C57BL/6J and CBA/J mice, strains selected based on previous studies141,142 as exhibiting 
a low, medium, and high IOP, respectively. We then measured C in ex vivo enucleated eyes from 
the same cohort of animals, and we examined the relationship between C and IOP as predicted 
based on Goldmann‟s equation. 
2- Methods  
    All experiments were done in compliance with the ARVO Statement for the Use of Animals in 
Ophthalmic and Vision Research and the Animal Scientific Procedures Act 1986.  
2.1. Animal Husbandry 
    This study used three strains of mice chosen as strains typically exhibiting low, medium and high 
IOP141,142: BALB/cJ (N = 13 animals), C57BL/6J (N = 13) and CBA/J (N = 15), respectively. 
Preliminary studies used CBA/CaJ (N = 10), but this strain did not exhibit as high an IOP as 
expected based on previous reports141; we therefore replaced CBA/CaJ with CBA/J. All mice were 
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female and were purchased from Jackson Laboratories at 6 weeks of age. Mice were housed in 
individually ventilated cages, fed ad libitum and maintained at 21°C with a 12-hour light (6 AM to 6 
PM) and 12-hour dark cycle. IOP measurements were attempted on 30 mice aged between 3 and 4 
months, while facility measurements were attempted on all 41 mice aged between 4 and 7 months. 
There was a 1-3 month gap between IOP and facility measurement during which the perfusion 
system was improved as described in Chapter 2.  Between IOP and facility measurements, there 
was an outbreak of pinworm in the room where our mice were housed. There was no evidence as to 
whether our mice contracted the parasite, and Fenbendazole Prophylaxis was refused to avoid 
potential effects on facility. 
2.2. IOP Measurements 
    IOP was measured non-invasively using a commercially available rebound tonometer (TonoLab, 
iCare UK) in conscious or anaesthetized mice. The device measures IOP as a function of the 
deceleration of a plastic probe propelled against the central cornea. All IOP measurements were 
performed on the right eye between 12:00 and 16:00 to minimize the influence of diurnal 
variations185. The tonometer was held by hand for consecutive rebound measurements used to 
calculate a single IOP value, following manufacturer‟s instructions, and tonometer readings were 
repeated if there was any sign of error or large variability between consecutive rebound 
measurements. 
    The tonometer was calibrated in two eyes of different mice from each strain to validate the 
tonometer readings and to account for potential inter-strain differences in corneal biomechanics that 
may affect the rebound measurement. Calibration was performed on cadaveric eyes that were 
pressurized between 6 and 30 mmHg via a cannula connected to an adjustable height reservoir. 
The hydrostatic pressure imposed on the eye was estimated as that resulting from the weight of the 
fluid column extending from the reservoir meniscus to the level of the needle in the limbus. The 
eyelids were removed and the cannula was inserted into the anterior chamber near the limbus so as 
to minimize interference with the tonometer probe that rebounds against the central cornea. At each 
of 10 pressure levels, the eye was hydrated with a drop of PBS and left to equilibrate for at least 3 
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minutes prior to tonometric measurements. The drop of PBS was removed with tissue paper prior to 
rebound measurements.  
    IOP was calculated using two techniques. First, following manufacturer‟s instructions, a single 
IOP value was read from the tonometer display following 6 consecutive rebound measurements. We 
refer to this as the “tonometer-reported IOP”. However, the manufacturer provides no information on 
the algorithm used to calculate the tonometer-reported IOP, and our separate calibration studies 
suggest that the tonometer-reported IOP is not a simple average of the 6 measurements nor an 
average after excluding the highest and lowest values as previously suggested186. Because of the 
ambiguity in how the tonometer-reported IOP is calculated, we used a second technique to obtain 
IOP by manually calculating the average of the 5 initial rebound measurements as presented on the 
tonometer display after each rebound (the 6th rebound measurement is not actually displayed, but 
rather is replaced with the tonometer-reported IOP described above). We refer to this as the 
“manually calculated IOP”. A calibration study using one cadaveric mouse eye of each strain 
suggested that when applied to the same sequence of 6 tonometer rebounds, the manually 
calculated IOP was slightly more accurate than the tonometer-reported IOP (Supplemental Figure 2). 
For this reason, we used the manually calculated IOP for all further IOP measurements in this study. 
No obvious corneal changes appeared during the consecutive measurements taken at each 
pressure level. 
    For each strain, the true manometric pressure (IOPm) was expressed as a linear regression of the 
tonometric pressure (IOPt) measured in each of the two eyes according to the following relationship: 
               
Equation 11 
where the slope (α) and intercept (β) values are given in Table 6. 
Strain α 
β 
(mmHg) 
R2 
BALB/cJ (N = 2) 0.97  1.10 0.984 
C57BL/6J (N = 2) 0.95 0.47 0.978 
CBA/J (N = 2) 1.07 -0.57 0.990 
All Strains (N = 6) 1.00 0.27 0.990 
Table 6: Parameters of the linear regression between IOPm and IOPt. 
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In agreement with previous studies187, there was no statistical difference in the parameters of the 
linear regression between strains (p = 0.45; one-way ANOVA), and data from all strains were 
therefore lumped together for a single regression (Figure 17). All IOP values reported in this study 
were therefore corrected by the following relationship: 
 
                     
Equation 12 
where IOPt is the manually calculated tonometric IOP. This amounts to a small correction of 1-2% at 
physiologic IOP with the tonometer tending to slightly underestimate the true pressure. 
 
 
Figure 17: Tonometric pressure (IOPt) measured in cadaveric mouse eyes pressurized at different manometric 
pressures (IOPm). Bars are standard deviation. 
 
    To investigate the effects of anaesthesia, IOP measurements were attempted in 10 conscious 
mice of each strain and again in the same mice under anaesthesia. For conscious measurements, 
mice were placed in a customized restraining device and allowed to settle for 3 minutes prior to 
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tonometry. Despite attempts at training, conscious IOP measurements were possible in only 21 
mice (6-8 per strain) because either the mice did not remain still or IOP values were unreasonably 
large (>20 mmHg). For anesthetized measurements, mice were exposed to 4% isoflurane (IsoFlo, 
Abott Animal Health, Green Oaks, IL, USA) and 2% oxygen for 3 minutes in a sealed box, and then 
3.5% isoflurane and 0.7% oxygen via a nose cone for 2 minutes. IOP was measured in the right eye 
between 5 to 6 minutes after the initial exposure to anaesthesia. Previous studies reveal that 
anaesthesia lowers IOP in mice142, and that IOP measurements should be made within minutes 
following the onset of anaesthesia to minimize the IOP-lowering effect. Animals were then allowed 
to recover under a steady flow of oxygen without isofluorane. 
2.3. Outflow Facility Measurements 
    Outflow facility was measured in ex vivo mouse eyes using a computer-controlled perfusion 
system modified from previous studies12,13,79 to allow the eye to be submerged in a heated bath of 
isotonic saline (Fig. 9C). On a typical experimental day, one eye was perfused from each strain, with 
the order of perfusion randomized. Eyes were enucleated within 15 minutes of death by cervical 
dislocation, and eyes were stored in PBS at 4C for no longer than 6 hours before perfusion. All 3 
strains were euthanized and enucleated at approximately the same time of day, and facility was 
measured in only one eye per mouse. Typically, the right eye was perfused (N = 20 mice), unless 
failure of the right eye required the left eye to be perfused (N = 8). Perfusion was unsuccessful in 
either eye in 13 mice. 
    For perfusion, the eye was mounted in a plastic tube trimmed from a 0.2 mL standard centrifuge 
tube that was filled with gauze, with the extra ocular muscles affixed to the sides of the tube using 
cyanoacrylate glue. Eyes were immersed to the limbus in a PBS bath and covered with tissue paper 
to provide thorough hydration (Fig. 9C). The PBS bath was indirectly heated with a custom-built 
temperature-controller to maintain bath temperature in the physiological range of 35±1ºC. A 33G 
needle was inserted into the anterior chamber under a stereomicroscope using a micromanipulator. 
The needle was connected via rigid pressure tubing to a pressure transducer (142PC01G, 
Honeywell; Columbus, OH) and a 25 μL syringe (Hamilton, Gastight; Reno, NV) placed on a 
computer-controlled syringe pump (PhD Ultra; Harvard Apparatus; Holliston, MA). Custom-written 
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software151 was used to maintain IOP at a user-defined pressure by adjusting the variable flow rate 
of the syringe-pump. All eyes were perfused with Dulbecco‟s PBS including divalent cations and 5.5 
mM glucose passed through a 0.22 μm filter (referred to as “DBG”). 
    To measure conventional outflow facility (C), eyes were perfused at sequential pressure steps of 
4, 8, 15 and 25 mmHg, typically 20 minutes at each step to allow at least 10 minutes of steady flow 
rate data (typical tracing shown in Figure 19). The average flow rate (F) at each pressure step was 
then fit to a simplified version of Goldmann‟s equation: 
             
Equation 8 
where episcleral venous pressure and aqueous humour production are assumed to be zero for an 
enucleated eye. According to Eq. 8, C is equal to the slope of the least-squares linear regression for 
F versus IOP, and Fu is the zero-pressure intercept that is often interpreted as unconventional or 
pressure-independent outflow. Equation 8 assumes that C and Fu are independent of IOP and that F 
reaches a steady state at each pressure step. In order for perfusion to be accepted into this study, 
we required there to be a stable flow rate in at least 3 of the 4 pressure steps. According to these 
criteria, C was successfully measured in 28 of 41 mice (9-10 per strain). Three cohorts of mouse 
eyes were perfused for outflow facility measurements. In Cohort 7, 10 BALB/cJ mouse eyes were 
used. In Cohort 8, 9 C57BL/6J mouse eyes were perfused. Cohort 9 consisted of 9 CBA/J mouse 
eyes. Of the 28 mice where C was measured, 14 mice also had measurements of IOP without 
anaesthesia (3-6 per strain). Of these 14 mice, 11 mice had facility measured in the right eye (the 
same eye as IOP was measured) and 3 mice had facility measured in the contralateral eye.  
2.4. Ocular Compliance Measurements 
    Ocular compliance (K) is expressed in units of µL/mmHg and represents the incremental 
intraocular volume necessary to increase IOP by 1 mmHg. K was measured immediately after 
perfusion in 17 mice (4-7 per strain), following previously described techniques12. Briefly, with the 
perfusion needle still in the anterior chamber, pressure was recorded during 6 sequential injections 
of 1 µL DBG, with one minute between injections. The total compliance was then calculated as the 
change in volume (1 µL) divided by the change in pressure at each injection, averaged over the 6 
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injections. The total compliance, however, is the sum of the ocular compliance and the system 
compliance arising from the tubing and transducers. The system compliance was measured by 
repeating the same procedure without an eye using a blocked needle, and system compliance was 
subtracted from the total compliance to obtain K. All compliance measurements were done at 35ºC 
with the eye immersed in isotonic saline. 
2.5. Statistical Analysis 
    IOP was analyzed using a linear mixed model (LMM) to test for statistical differences between 
strains with or without anaesthesia. LMM yields three p-values (corresponding to the probability of a 
type I error) describing the influence of: (1) strain, (2) anaesthesia and (3) any possible interaction 
on IOP. If a significant influence is detected, SPSS performs a Bonferroni test to evaluate statistical 
differences between any two strains (SPSS, IBM).  To further investigate the interaction effect, i.e. 
whether anaesthetics had different effects depending on the mouse strain, we performed separate 
paired t-tests in each strain between IOP data measured with and without anaesthetics on the same 
eye. The statistical significance threshold was taken as 0.05 divided by the number of comparisons, 
i.e. 0.016 (Bonferroni correction).   
    In addition, we analysed IOP data either in conscious or anaesthetized mice separately to assess 
whether IOP difference was still statistically significant in anaesthetized mice only. Thus, we 
performed a 1-way ANOVA in two separate cases, in conscious (N =21) or anaesthetized (N =30) 
animals, followed by a Bonferroni test to indicate which sets of strains had statistically different IOP.  
    We also carried out statistical tests on quantities other than IOP, namely on C, Fu, α, β and K 
between strains. Such tests were carried out using a one-way ANOVA, followed by a post-hoc 
Bonferroni test for detecting pair-wise differences between any two strains. 
    Data points were considered outliers for the IOP vs. 1/C regression if their Cook‟s distance was 
larger than 1, or if the probability of their studentized deleted residual was lower than 0.05/N188, 
where N was taken as the number of data points used for the regression (N =14). If one of these 
criteria was met for any data point, it was removed from the analysis. 
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3. Results 
3.1. IOP Measurements 
    IOP in conscious mice was significantly different between strains (Fig. 18; p = 1x10-4, one-way 
ANOVA). Consistent with prior reports141,142, IOP was lowest for BALB/cJ and highest for CBA/J, 
with an intermediate value of IOP for C57BL/6J (Table 7). According to a post-hoc Bonferroni test, 
IOP was statistically different between BALB/cJ versus CBA/J and C57BL/6J versus CBA/J, but not 
between BALB/cJ versus C57BL/6J. Compared to IOP in conscious mice, anaesthesia (i.e. 
isoflurane) caused a reduction in IOP (Fig. 18 and Table 7; p = 0.046, linear mixed analysis) that 
eliminated any detectable difference between strains (p = 0.254; one-way ANOVA). Comparing IOP 
in individual eyes with and without anaesthesia, the IOP reduction was significant for CBA/J 
(25.8 ± 18.1%; p = 0.008, paired Student‟s t-test with Bonferroni correction) but smaller or 
insignificant for C57BL/6J (8.2 ± 11.0%; p = 0.14) and BALB/cJ (-0.9 ± 28.8%; p = 0.86). These 
results are consistent with a previous report 11,141,142 which show anaesthesia has an IOP lowering 
effect that varies between strains.  
 
Figure 18: IOP data measured with TonoLab in conscious (white) or anaesthetized (grey) mice. Fewer mice had 
their IOP measured without anaesthesia because 9 animals were too stressed (see methods) 
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3.2. Outflow Facility Measurements  
    Our flow-rate vs. pressure data was well described by the linear best-fit regression (Fig. 20), 
whose R2 values ranged from 0.935-1.00 in BALB/cJ, 0.958-1.00 in C57BL/6J and 0.931-1.00 in 
CBA/J. Conventional outflow facility was significantly different between strains (p = 0.049; one-way 
ANOVA), as indicated by different slopes of the flow rate versus pressure relationship (Fig. 20). A 
post-hoc Bonferroni test revealed that C was significantly larger in BALB/cJ compared to CBA/J, 
with C57BL/6J having an intermediate value of C (Table 7). Importantly, the ranking of C between 
strains was opposite to the ranking of IOP, suggesting that strains that had a higher conscious IOP 
also had a lower conventional outflow facility. There was no difference in Fu between strains (p = 
0.363; 1-Way ANOVA) and the values measured for Fu were not statistically different from zero in 2 
of the 3 strains (p >0.05 for BALB/cJ and CBA/J, p =0.02 for C57BL/6J; one-sided t-test). 
 
 
Figure 19: Perfusion tracing showing pressure (blue line) vs. flow rate for an enucleated eye from CBA/J (dashed 
black line) and BALB/cJ mouse (continuous black line).The flow-rate tracings from the BALB/cJ and CBA/J have 
been shifted in time such that flow rates overlap at each pressure level. More specifically, the tracing for the 
CBA/J mouse has been shifted to coincide with the pressure and flow rate tracing from the BALB/cJ tracing. 
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Figure 20: Average flow rate at each pressure step for BALB/cJ (black circles), C57BL/6J (white circles) and 
CBA/J (white squares). Lines correspond to the best-fit linear regression to the average flow-rate vs. pressure of 
each strain. The slope and intercept reported in the figure represent the best linear fit to the average flow-rate at 
each pressure step. R
2
 values computed on individual eyes ranged from 0.935-1.00 in BALB/cJ, 0.958-1.00 in 
C57BL/6J and 0.931-1.00 in CBA/J. 
 
Strain 
IOP (mmHg) C 
(µL/min/mmHg) 
Fu 
(µL/min) 
Ocular 
Compliance 
(µL/mmHg) Conscious Anesthetized 
BALB/cJ 10.7 ± 1.8 
(N = 8) 
10.3 ± 2.3 
(N = 10) 
0.0164 ± 0.0059 
(N = 10) 
-0.0290 ± 
0.0411 
(N = 10) 
0.028 ± 
0.021 
(N = 4) 
C57BL/6J 12.4 ± 1.0 
(N = 6) 
11.6 ± 2.4 
(N = 10) 
0.0147± 0.0029 
(N = 9) 
-0.0306 ± 
0.0317 
(N = 9) 
0.022 ± 
0.014 (N = 7) 
CBA/J 14.6 ± 0.9 
(N = 7) 
12.2 ± 3.2 
(N = 10) 
0.0113 ± 0.0031 
(N = 9) 
-0.0104 ± 
0.0219 
(N = 9) 
0.029 ± 
0.018 (N = 6) 
Table 7: Measured IOP, conventional outflow facility (C) and ocular compliance (mean ± SD). N refers to the 
number of eyes the parameters were measured in. 
 
    To investigate the relationship between IOP and facility, conscious IOP was plotted against 
outflow resistance (the mathematical inverse of C or 1/C) as measured within individual mice (Fig. 
21; see Discussion for rationale). The relationship between IOP and 1/C was statistically significant 
(p = 0.0004; Welch‟s t-test), demonstrating that larger conscious IOP was associated with 
decreased outflow facility in individual mice across all three strains. One data point from a CBA/J 
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(filled symbol in Fig. 21) was determined to be an outlier (based upon its studentized deleted 
residual probability) and was not included in the regression, but regardless the regression remained 
significant even if the outlier was retained (p = 0.007). The R2 value of the regression in Figure 21 
indicates that 70% of the variation in IOP between mice of 3 different strains can be attributed to 
variation in outflow resistance (excluding the single outlier). 
 
Figure 21: IOP vs. conventional outflow resistance in individual mice. IOP was measured in conscious animals, 
whereas outflow resistance was measured ex vivo. The filled symbol is an outlier, which was excluded from the 
best linear fit analysis.  
3.3. Ocular Compliance Measurements 
    Ocular compliance was not significantly different between strains (Table 7, p = 0.796, one-way 
ANOVA). The system compliance was 0.011 ± 0.007 µL/mmHg. Somewhat strikingly, K measured 
with the eye in a bath of isotonic saline at physiologic temperature was approximately 3-fold smaller 
than previously reported by our group12 with the eye outside of a bath at room temperature 
(0.086 ± 0.017 µL/mmHg for C57BL/6). This suggests that environmental conditions strongly affect 
at least some biomechanical measurements in mouse eyes. 
4. Discussion 
    In this study, we provide evidence that differences in IOP between 3 genetically distinct strains of 
mice are largely attributable to differences in conventional outflow facility. Our data show that the 
strain having highest IOP (CBA/J) had lowest outflow facility, and conversely the strain having the 
lowest IOP (BALB/cJ) had the highest outflow facility. The strain having an intermediate value of 
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IOP (C57BL/6J) had an intermediate value of facility. Regression analysis applied to individual mice 
from all 3 strains, revealed a highly significant correlation between conscious IOP and conventional 
outflow resistance (1/C), with 70% of the variability in IOP being attributable to differences in 
conventional outflow resistance as predicted by Goldmann‟s equation. 
4.1. IOP 
    Our IOP data show clear differences between three inbred strains, in good agreement with prior 
reports. As described by Savinova et al.141, IOP for BALB/cJ, C57BL/6J and CBA/J under 
anaesthesia was approximately 11, 13 and 16 mmHg, respectively (read from Figure 1 of 
Savinova141). Similarly, Wang et al.142 reported IOP in conscious BALB/c, C57BL/6 and CBA as 10.6, 
13.3, and 16.4 mmHg. These values are in good agreement with our conscious IOP measurements 
reported in Table 7. In regards to anaesthesia, our results suggest that the IOP-lowering effect of 
isofluorane anaesthesia varies between inbred strains, with a larger IOP reduction observed in 
strains having a higher baseline IOP, consistent with prior reports11,142. Importantly, these data 
demonstrate that IOP differences between strains can be masked by anaesthesia, and thus the 
anaesthetic regimen is an important consideration for future studies examining aqueous humour 
dynamics in mice11. 
    Our preliminary studies examined IOP in a fourth strain, CBA/CaJ, chosen based on prior 
reports141 suggesting that CBA/CaJ mice exhibit a high baseline IOP (19.3 mmHg). In our hands, 
however, CBA/CaJ mice exhibited an intermediate IOP of 11.8 ± 1.3 mmHg (N =4) that was not 
dissimilar from IOP in C57BL/6J (12.4 ± 1.0 mmHg), and we therefore replaced CBA/CaJ with 
CBA/J. It is unclear why our IOP measurements in CBA/CaJ were lower than reported by Savinova 
141, but these difference may be attributable to mouse age since that previous study141 used mice 
aged between 6-12 months, as compared to our study that used mice between 3-4 months old. In 
addition, data measured on CBA/CaJ by Savinova et al. also disagreed with results measured 
telemetrically in the same strain by another group189. The latter study 189 measured an IOP of 12.4 ± 
2 mmHg averaged over the entire light cycle (6 AM- 6 PM) in adult mice whose age is not specified, 
which was very similar to our IOP measurements. 
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4.2. Conventional Outflow Facility in cohorts 7,8,9 
    Our data raise the interesting question of whether morphological differences in the conventional 
outflow pathway between strains may underlie the difference in C between strains. Savinova141 
examined this question in context of strain-dependent differences in IOP, and found no obvious 
anatomical or pathological differences in the drainage angle structures between strains, although 
other studies have shown differences in gross ocular anatomy between strains, including anterior 
chamber depth, axial length and corneal thickness140. It should be noted that our measurements of 
C were done ex vivo using enucleated eyes, while most other studies measured C in vivo under 
anaesthesia. Following enucleation, one may safely assume that aqueous production is eliminated 
(Fp = 0) and EVP = 0 mmHg. Enucleated eyes therefore provide a somewhat more direct means to 
measure C without possible confounding effects of Fp or EVP that may influence in vivo 
measurements. However, we must assume that C measured in enucleated eyes is similar to C in 
vivo. This assumption is often taken for granted in eyes of larger species, such as humans and 
rabbits190, where measurements of C in enucleated eyes are consistent with in vivo measurements 
of C by tonography or intracameral perfusion under anaesthesia. For mice, however, no studies 
have yet directly compared C between enucleated and in vivo eyes, but Millar and colleagues6 have 
shown that C is unaffected by euthanization via anaesthetic overdose in BALB/cJ mice. 
    Somewhat surprisingly, values of C measured in this study were significantly larger than 
previously reported by our own group12,13,79 for enucleated C57BL/6 eyes (0.0045 - 0.0070 
µL/min/mmHg). These differences were likely caused by differences in the temperature and 
hydration of the eye during perfusion. In the current study, the eye was immersed in a bath of 
isotonic saline at physiological temperature (Fig. 9C). However, in our previous studies12,13,79 the 
eyes were perfused at room temperature without a bath (Fig. 9A), where the facility was corrected 
for temperature-dependent viscosity77 and the eyes were kept hydrated by covering with a tissue 
paper moistened with isotonic saline. Furthermore, the zero-pressure intercept (Fu of Eq. 8) in this 
study was not significantly different from zero in every strain, in contrast to our previous studies 
where this intercept was larger than zero (0.0160 – 0.11412,13,79 µL/min). This intercept is often 
interpreted as the amount of outflow passing through the unconventional or pressure-independent 
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pathway (see Introduction, section 3.2.2.2). However, if in fact this intercept is strongly dependent 
upon temperature and hydration (Fig. 10&11; Chapter 2), the interpretation of the measurement is 
drawn into question, and the true in vivo value of unconventional outflow becomes ambiguous, at 
least based on measurements in enucleated eyes. For this reason, we do not analyze it and focus 
only on conventional facility measurements.  
4.3. Relationship between IOP and C 
    Plotting IOP versus 1/C as shown in Figure 21 provides a physically meaningful interpretation, as 
can be seen using Goldmann‟s equation: 
                    
Equation 4 
where Fp is the aqueous production rate, EVP is episcleral venous pressure, and Fu is the outflow 
rate through the unconventional or pressure-independent pathway. All parameters in Eq. 4 apply to 
conscious mice. Solving Eq. 4 for IOP yields: 
          
 
 
      
Equation 13 
where Fc is the outflow rate through the conventional pathway (Fc = Fp – Fu). Assuming that C 
measured in enucleated eyes represents C in vivo (see above), Goldmann‟s equation predicts a 
linear relationship between IOP and conventional outflow resistance (1/C), with the slope of the 
relationship equal to Fc and the zero-IOP intercept equal to EVP, as previously pointed out
76. This 
method therefore allows indirect estimates of Fc and EVP based on measurements of C and IOP 
from a sample population of mice. 
    If we assume that Fc and EVP are the same between C57BL/6J, BALB/cJ and CBA/J mice, then 
the regression in Figure 21 predicts (excluding the outlier) that Fc = 0.068 ± 0.013 µL/min and EVP = 
7.3 ± 1 mmHg (mean ± stdev). Whether Fc and EVP are truly the same between strains is an open 
question, however the strong agreement between Eq. 13 and our data (R2 = 0.70; N = 13 mice) 
suggests that Fc and EVP are reasonably consistent between C57BL/6, BALB/cJ and CBA/J strains 
or that any variation in Fc and EVP between strains has relatively minor influence (< 30%) on IOP 
compared to the principal dependence of IOP on C. Furthermore, the value of EVP estimated by 
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linear regression (7.3 mmHg) agrees fairly well, but is slightly higher than published values from the 
same strains using the blood-reflux technique that requires anaesthesia (where IOP may be 
artificially depressed11,142) (cf. 5.4 mmHg for BALB/cJ6 and 6.315 mmHg for C57BL/6J). The value of 
Fc estimated by linear regression (0.068 µL/min) also fits within the published range, however the 
range of published Fc values varies 3-fold between strains (0.032 µL/min in NIH Swiss White
5, 0.062 
µL/min for C57BL/615, and 0.111 µL/min for BALB/cJ6) which may be related to methodological 
differences between studies or true physiologic differences between strains. It should be pointed out 
that Fc lumps effects of Fp and Fu such that variations in Fp between strains may be masked by 
compensatory differences in Fu (or vice versa). We attempted to perform regression analysis on 
each strain individually, so as to estimate values of Fc and EVP for each strain, but the small 
numbers of mice (3 - 6 per strain) made this analysis unreliable. 
    As an alternative to the regression-based approach presented above, one may also examine a 
population-based approach to investigate whether differences in the mean value of C can account 
for differences in mean conscious IOP between strains. One advantage of the population approach 
is that it uses all of our data for C and conscious IOP (N = 32 mice), not just data limited to when C 
and conscious IOP were both measured in the same mouse (N = 14 mice). Because Goldmann‟s 
equation is essentially a statement of the conservation of mass that is strictly true only for individual 
eyes (and not populations of eyes), Goldmann‟s equation must first be expressed in terms of 
population averages (or expected values). Taking the expected value of Eq. 4 and neglecting the 
covariance between C and IOP or EVP yields: 
  

Fc  C IOP EVP  
Equation 14 
where the overbars indicate population averages as given in Table 7 for   

C  and   

IOP . We did not 
measure   

Fc  or   

EVP , however, let us assume that   

Fc  and   

EVP  are the same for all strains. Using 
the estimated value of EVP from the linear regression analysis above (7.3 mmHg), yields the 
following values of   

Fc  that should be consistent between strains if the assumptions of this scenario 
hold: 0.056 ± 0.067 µL/min for BALB/cJ, 0.075 ± 0.052 µL/min for C57BL/6J, and 0.083 ± 0.045 
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µL/min for CBA/J. These values are in reasonably good agreement (within 25% relative to 
C57BL/6J), consistent with the regression analysis that also assumes consistency of   

Fc  and   

EVP  
between strains. In addition, the differences in   

Fc  between strains was not statistically significant 
(p>0.38; unpaired t-test). 
    In conclusion, our data suggest that differences in IOP between genetically distinct strains of mice 
are largely attributable to differences in conventional outflow facility, rather than to differences in 
aqueous inflow, episcleral venous pressure or unconventional outflow. These data motivate further 
studies to identify the morphological or genetic basis that may underlie the differences in outflow 
facility between inbred strains, which may provide a promising tool for unravelling the mechanisms 
of IOP regulation as occurs in the conventional outflow pathway.     
 
Supplementary figure 2: Bland-Altman plot, showing the difference between tonometric and manometric IOP (y-
axis) against the manometric IOP (x-axis). The smaller the difference between tonometric and manometric IOP, 
the closer the data points are to 0. We show data points corresponding to two tonometric measurements: filled 
symbols are based on the automatic average tonometric value reported by the tonometer, while empty symbols 
are based on our manually calculated IOP (corresponding to the average of the first 5 measurements provided by 
the tonometer). Filled symbols show a larger spread, especially at high manometric pressures. The sold line 
represents the average difference between tonometer reported and manometric IOP (-0.27). The dashed line 
represents the average difference between the manually calculated and manometric IOP (-0.21). The dashed line 
is closer to 0 by 22%, suggesting the manually calculated IOP gives results which are more similar to the 
manometric pressure than that reported by the tonometer. 
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Chapter 5: The Role of Cellular Metabolism in 
Aqueous Humour Outflow in Mice 
1- Introduction 
    Aqueous humour drainage through the trabecular meshwork has long been considered to occur 
passively, i.e. independently of cellular metabolism. The first evidence on this topic was provided by 
Bárány, who showed that outflow facility in enucleated cattle eyes was unaffected by several anti-
metabolic agents78. A subsequent study by Van Buskirk and Grant showed that changes in outflow 
facility between 4°C and physiological temperature could be fully explained by temperature-
dependent changes in the viscosity of aqueous humor77. These studies consolidated the concept 
that aqueous humour outflow was independent of cellular metabolism.  As a result, the trabecular 
meshwork (TM) and Schlemm‟s canal (SC) have largely been considered to function as passive 
filter-like tissues without significant active regulation of outflow by the TM or SC cells themselves. 
    The idea of metabolically-independent outflow de-emphasized the potential role of active cellular 
processes that may modulate outflow facility. Paradoxically, there has been growing interest in the 
role of cell contractility 79–84, exocytosis85, and signal transduction79,86,87 in conventional outflow 
regulation, despite the fact that these processes require metabolic energy. Moreover, our data from 
Chapter 2, in contrast to Van Buskirk‟s original study77, reveal that the facility increase between 
20°C and physiological temperature was four times greater than expected based on viscosity 
differences alone, suggesting a significant metabolic contribution to conventional outflow in mice. 
    In this study, we hypothesize that cellular metabolism contributes to the regulation of 
conventional aqueous humour outflow in mice. We test this hypothesis by measuring conventional 
outflow facility in two cohorts of mouse eyes perfused with mock aqueous humour at 20 or 35°C, 
with or without anti-metabolic agents. The anti-metabolic agents were a cocktail of 2-dideoxy-D-
glucose and sodium azide that together inhibit glycolysis and block electron transport to prevent 
further ATP production. In the first cohort, we examined the effect of temperature in the presence of 
anti-metabolic agents to determine whether the additional increase in facility beyond that predicted 
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based on viscosity alone could be eliminated by anti-metabolic agents. In the second cohort, we 
examined the effect of anti-metabolic agents at physiological temperature, so as to estimate the 
portion of aqueous humour outflow associated with metabolic activity. Finally, we performed 
histology to analyze the effects of the anti-metabolic agents on the morphology of the TM and SC.  
2- Methods 
    All experiments were performed using ex vivo tissue and were done in compliance with the ARVO 
Statement for the Use of Animals in Ophthalmic and Vision Research the Animal Scientific 
Procedures Act 1986.  
2.1. Ex vivo mouse eye perfusion 
    This study used either C57BL/6 male mice from Charles River or C57BL/6J female mice from 
Jackson Labs. Mice were aged 9-16 weeks at the time of outflow facility measurement, and were 
housed at 21°C in individually ventilated cages and fed ad libitum under a 12-hour light (6 AM to 6 
PM) and 12-hour dark cycle. Eyes were enucleated within 15 min of death following cervical 
dislocation, and stored in PBS at 4°C for up to 3 hrs to await perfusion. To mount an eye for 
perfusion, its posterior pole was set upon a post covered with a minimal amount of cyanoacrylate 
glue. As previously described (see Chapter 2, Section 2.1), a 33G needle was mounted on a 
customized holder (MMP Kit, Harvard Apparatus, Holliston, MA, USA) and inserted into the anterior 
chamber using a micromanipulator while visualized by a microscope. For hydration, the eye was 
submerged in isotonic saline (PBS) to the limbus and covered with a wet tissue paper. The PBS 
was contained in a chamber and placed in a custom-made water-bath to maintain the temperature 
of the eye at 35 °C during the experiment (see Fig. 9C, Chapter 2). Room temperature experiments 
were done in the same way except the PBS bath was left at room temperature, at 20 ±1°C.  
    The needle was connected via tubing to a 25 µL syringe placed on a computer-controlled syringe 
pump (Ultra Pump, Harvard Apparatus, Holliston, MA, USA) and to a pressure transducer 
(142PC01G, Honeywell, Fort Washington, PA, USA) which continuously read the pressure inside 
the eye. Customized LabView151 (National Instruments Corp., Austin, TX) software controlled the 
flow-rate of the perfusion fluid into the eye such that the intraocular pressure was maintained at a 
100 
 
user-defined level. Eyes were perfused at four increasing pressure steps (4, 8, 15 and 25 mmHg) 
over 1.5-3 hours. Each pressure step lasted 20-30 min to allow the flow rate to reach steady-state 
conditions for at least 10 min. The flow rate was subsequently averaged for each pressure, unless it 
failed to stabilize. Only experiments where a stable flow rate was obtained in at least 3 of the 4 
pressure steps were used for outflow facility measurement.  
2.2. Outflow Facility Measurement 
    Conventional, or pressure-dependent, facility (C) was calculated as previously described (see 
Chapter 2, section 2.2). Briefly, the average stable flow-rate (F) measured at each pressure step 
(IOP) was fit to the simplified Goldmann‟s equation (Eq. 4):  
              
Equation 8 
where C corresponds to the slope of the F versus IOP relationship and Fu corresponds to flow rate 
intercept at zero IOP that represents the unconventional, or pressure-independent, outflow. The 
simplified Goldmann‟s equation is valid for enucleated eyes where episcleral venous pressure (EVP) 
and aqueous humour production (Fp) can safely be assumed to equal zero. Importantly, it assumes 
C and Fu do not change with pressure, and F and IOP have reached steady-state. Thus C was 
calculated as the slope of the best-fit linear regression to our flow-rate (F) vs. pressure (IOP) data 
for each individual eye (see Fig. 8, Chapter 2). 
2.3. Experimental Design 
    Two cohorts of mice were perfused under different conditions, referred to as Cohort 10 and 11, 
as a continuation of the cohort numbering used in the previous studies. Paired eyes were used, 
such that one eye was perfused within 15 min post mortem while its contralateral eye was kept at 
4°C in PBS to await perfusion 2-3 hrs later. Assignment of control or experimental treatment was 
randomised between paired eyes. Data from unpaired eyes was accepted when the perfusion of 
their contralateral eyes failed. Overall, data from 12 unpaired eyes out of 36 eyes were accepted 
because perfusions of their contralateral eyes failed (Table 8).  
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 Total number of eyes Unpaired eyes Paired eyes 
Cohort 10 12 6 6 
Cohort 11 12 2 10 
Table 8: Number of paired or unpaired eyes perfused in cohorts 10 and 11. Eyes were occasionally unpaired 
because the perfusion of their contralateral eye was unsuccessful. In both cohorts, at least half of the data were 
based on paired eyes. 
 
    The anti-metabolic agents were a cocktail of 10 mM dideoxy-D-glucose (Sigma-Aldrich, D8375) 
and 2 mM sodium azide (NaN3, Sigma-Aldrich, S8032), as described in previous studies191. 2-
dideoxy-D-glucose is a glucose-analogue that is phosphorylated by hexokinase but cannot be 
processed by the next enzyme in the glycolytic pathway, phosphoglucose isomerase, thereby 
halting glycolytic production of ATP (see supplementary figure 3). Sodium azide blocks the electron 
transport chain by binding irreversibly to cytochrome oxidase to prevent ATP production in the 
mitochondria (see supplementary figure 4). Both agents were diluted into Dulbecco‟s PBS from 
stock solutions of 20 and 40 mM, respectively. Because sodium azide is light-sensitive, all azide-
containing solutions and the MMP Kit were covered with foil. For consistency, the MMP Kit was also 
covered with foil for perfusion of the untreated contralateral eye. For both cohorts, 150 µL of either 
anti-metabolic agent or DBG was backfilled from the tip of the needle prior to cannulation. 
    Eyes were perfused with an open reservoir at 8 mmHg for 1 hr prior to perfusion via the syringe 
pump. This pre-pressurization aimed at exposing the outflow pathway to the drug prior to the 
measurement of outflow. For consistency, eyes perfused with DBG were similarly pre-pressurized. 
2.4. Histology 
    Histological analysis was performed on eyes from Cohort 11, perfused at 35 °C either with (N =3) 
or without (N =4) anti-metabolic agents. Following perfusion, the needle was removed and eyes 
were immediately immersed either in PFA 4% for fixation or in Karnovsky‟s solution for 2 hrs prior to 
changing it to PFA 0.1% for long-term storage. Eyes were shipped to Dr. A. Thomas Read 
(University of Toronto, Dept. of Ophthalmology) who performed all further histological processing 
and imaging. The eyes were sectioned near the equator, the lens was removed, and the anterior 
corneoscleral tissue was cut in quadrants. Tissue was fixed overnight in Sorenson's phosphate 
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buffer (containing 2.4% glutaraldehyde and 2% formaldehyde) and post-fixed in 4% osmium 
tetroxide. Quadrants were dehydrated through a graded ethanol series, transferred to propylene 
oxide, embedded in epon-araldite, and cured for 48 hours at 60°C. The tissue was sectioned 
radially into semi-thin sections (0.5 µm) using an ultramicrotome (Leica EM UC7, Wetzlar, 
Germany) and stained with toluidene blue. Sections were affixed to glass slides, examined and 
photographed at 63x (Zeiss Axioplan, Oberkochen, Germany). One to two quadrants were 
examined per eye; in each quadrant, approximately 20 sections were cut, and examined under the 
microscope. Histology was performed by Dr. Thomas Read, at University of Toronto. 
2.5. Statistical analysis 
    Unpaired t-tests were used to assess the statistical significance of differences in conventional 
facility between eyes perfused under different conditions within cohorts.  A two-sided t-test was 
used to test whether the increase in conventional facility was different from the 1.4 increase 
expected based on viscosity changes alone.  
    Outliers within each cohort were identified according to Dixon‟s test. A linear mixed model (LMM) 
approach (SPSS, IBM, Armonk, New York, U.S.) was used to analyse the entire dataset combining 
conventional facility from the two cohorts of mouse eyes perfused in this study as well as that 
perfused at 20 and 35 °C with DBG, from Chapter 2 (Cohort 2; Fig. 11). This allowed an analysis of 
all the data to examine the effects of temperature and anti-metabolic agents as well as their 
interaction, while accounting for the covariance between paired eyes as well as random variations in 
facility between cohorts and between individual mice. We used a LMM which modelled random 
effects arising from differences between cohorts and the random nesting of mice within cohorts. The 
covariance of paired eyes was taken into account by grouping data from paired eyes to their 
corresponding mouse. The test used a maximum likelihood estimation method to estimate the 
parameters of the statistical model. The threshold for statistical significance was 0.05.  
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3- Results 
3.1. Cohort 10, anti-metabolic agents reduces temperature-related increase in C  
    All eyes in this cohort were perfused with anti-metabolic agents at room (20°C) or physiological 
temperature (35°C). At room temperature C was 0.0080±0.0021 µL/min/mmHg (mean ± SD; N =7), 
while at physiological temperature C increased to 0.0132±0.0046 µL/min/mmHg (N =5; Fig. 22B). 
The difference in C was only borderline significant (p = 0.063; unpaired t-test) with a relative 
increase of 1.65±0.72 between room and physiological temperatures. In contrast, earlier studies 
from Chapter 2 without anti-metabolic agents showed a much larger facility increase between room 
and physiological temperature (2.50±0.86, Figure 22A), well beyond that expected based on 
viscosity differences alone (1.4). In the current study, however, the measured facility increase (1.65) 
was not statistically different from the 1.4-fold increase based on viscosity (p=0.46; two-sided t-test). 
Taken together, these data suggest that the temperature-associated facility change beyond that 
caused by viscosity is attributable to active cellular metabolism. 
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Figure 22: Flow Rate vs. pressure data for eyes from Cohort 2 and 10, perfused at 20 or 35°C with DBG (A) without 
anti-metabolic agents, (B) with anti-metabolic agents (2 mM dideoxy-D-glucose + 10 mM sodium azide). The green 
dashed line represents the expected flow-pressure relationship slope, or conventional facility, expected at 35 °C 
based on the facility measured at 20°C and the decrease in aqueous humour viscosity. Bars are standard 
deviations. R
2
 values ranged from 0.955-0.996 for eyes from Cohort 10 perfused at 20C with anti-metabolic agents 
and from 0.897-0.999 for eyes perfused at 35C with anti-metabolic agents (Panel B).  
3.2. Cohort 11, anti-metabolic agents reduce C by 30% 
    All eyes in this cohort were perfused at physiological temperature (35°C) with or without anti-
metabolic agents. At physiological temperature without anti-metabolic agents, C was 0.0290±0.0068 
µL/min/mmHg (N =6), while with anti-metabolic agents C was 0.0203±0.0055  µL/min/mmHg (N = 6; 
Fig. 23). The difference was statistically significant (p = 0.036, unpaired t-test), with anti-metabolic 
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agents decreasing C by 30 %. These data suggest that cellular metabolism contributes to 
conventional outflow in the mouse eye and inhibiting cellular metabolism decreases outflow facility 
by 30%. 
 
Figure 23: Flow Rate vs. pressure data for eyes from Cohort 11, perfused at 35°C with or without anti-metabolic 
agents (2 mM dideoxy-D-glucose + 10 mM sodium azide). Bars are standard deviations. R
2
 value ranged from 
0.900-0.979 for eyes perfused with anti-metabolic agents and 0.969-0.998 for eyes perfused with DBG. 
3.3. Pooled statistical analysis 
    Surprisingly, we found unexpected differences in outflow facility between mice from different 
cohorts perfused under similar conditions (0.0132±0.0046 vs. 0.0203±0.0055 µL/min/mmHg for 
eyes perfused at 35 °C with anti-metabolic agents in Cohort 10 and 11; 0.0172±0.0028 vs. 
0.0290±0.0068 µL/min/mmHg for eyes perfused at 35 °C with DBG in Cohort 2 vs. Cohort 11). Thus 
we performed an LMM analysis (see Methods section) on the entire dataset including data from 
Cohorts 10 and 11 of this study, and data from Cohort 2 of Chapter 2, to determine whether anti-
metabolic agents and temperature were consistently affecting outflow facility, regardless of the 
variability found between cohorts. This analysis upheld the significant effects of temperature (p 
=1x10-6) and anti-metabolic agents (p =0.018) on C, despite the fact that there were fairly large 
differences in baseline C between cohorts. Moreover, the LMM analysis revealed that the effect of 
anti-metabolic agents was significantly different between 20 and 35°C (p =0.009; interaction effect), 
consistent with anti-metabolic agents having a greater influence on C at physiological versus room 
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temperature. The dependence of anti-metabolic agents‟ effect on temperature is attributable to a 
greater metabolic activity (and hence greater sensitivity to anti-metabolic agents) at physiological 
versus room temperature because enzymatic reactions are suppressed at lower temperatures 
according to the Arrhenius equation. 
3.4. Histology 
    The qualitative analysis of histological sections of treated vs. untreated eyes revealed some 
apparent changes in TM and SC (Fig. 24- 25). In general, there were more giant vacuoles in eyes 
treated with anti-metabolic agents which extended to the outer wall of SC. Another interesting 
observation was to find extensive vacuolization of SC in a treated eye (Fig. 25A). Interestingly, the 
other quadrant of the same eye did not show such an extensive vacuolization but still presented 
abnormal giant vacuoles, irregularly shaped and almost extending to the outer wall (Fig. 25B).  In 
addition, the TM and SC seemed well-preserved in all eyes; the integrity of the SC endothelium did 
not seem obviously damaged by the anti-metabolic agents. 
 
Figure 24: Histological section of SC of a mouse eye perfused with DBG. The eye was immersed in fixative prior 
to embedding. SC is open and shows a few giant vacuoles. X100 magnification. Asterisks show Giant Vacuoles. 
TM: Trabecular Meshwork. SC: Schlemm’s Canal. 
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Figure 25: Histological section of SC perfused with anti-metabolic agents from two different quadrants of the 
same eye (A,B). A) SC is apparently smaller and filled with many more giant vacuoles which extend across the 
canal, to the outer wall. (x63 magnification), B) SC shows a more open lumen but with an abnormally large giant 
vacuole, shown by the asterisk(x100 magnification). Red arrows point to the outer wall of SC. Asterisks show 
selected Giant Vacuoles. TM: Trabecular Meshwork. 
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4. Discussion 
    In this study, we present data showing conventional outflow in the mouse eye depends on active 
cellular metabolism and is reduced by 30% in the presence of anti-metabolic agents. We had 
originally shown that the increase in conventional facility with temperature in mice was four times 
larger than that predicted based on viscosity effects alone (see Chapter 2). Our current findings 
show that anti-metabolic agents eliminate the temperature-related facility change beyond that 
caused by viscosity. In addition, anti-metabolic agents were shown to decrease conventional facility 
at physiological temperature by 30%.  To the best of our knowledge, this is the first evidence that 
conventional aqueous humour outflow in mice depends on cellular metabolism, which contradicts 
findings from previous studies using anti-metabolic agents in bovine eyes78 or analysing 
temperature effects on outflow facility in human eyes77.  
    One possible explanation for our results being different from previous studies77,78 could be 
species-related differences. For example, Bárány78 tested anti-metabolic agents on bovine eyes 
which, unlike mice, lack a true SC and possess a disorganized TM. Van Buskirk and Grant77 used 
human eyes which, like mice have a true SC, yet differ in the TM which is much thinner in mice137. 
However, we propose the discrepancies with past reports could lie in the different post mortem 
times of the tissues or in the use of different poisonous substances, as discussed below. 
    Notably, Van Buskirk and Grant77 used human eyes up to 48 hrs following death; in contrast, our 
study used eyes obtained within 3 hrs post mortem.  Long post mortem times could have caused 
reduction of tissue metabolic activity as well as an advanced degradation of the outflow pathway, as 
previously reported in human eyes stored at 5 °C for 48 hrs159. As a result, Van Buskirk and Grant‟s 
study might have failed to detect any changes in metabolic activity which had already disappeared 
or was markedly attenuated. This is further supported by our results showing conventional outflow 
facility is decreased in mice following long post mortem times (see Chapter 2). Note Grant158 
showed outflow facility was similar in human living and enucleated eyes. Yet he did not specify the 
post mortem times of the enucleated eyes at the time of facility measurement. In a separate cohort 
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of enucleated eyes used for a different purpose in that same paper, Grant indicates they were 
perfused within 24 hrs post mortem. Thus, we can assume the same for the eyes used for facility 
measurement. The similarity in outflow facility between living and enucleated eyes perfused within 
24 hrs post mortem suggests there is no loss of metabolic activity associated with outflow facility 
with post mortem times < 24 hours. This is different to the situation reported by Van Buskirk77, who 
used enucleated human eyes within 48 hrs post mortem. This suggests that metabolic activity is not 
dramatically reduced within 24 hrs but might have significantly degraded by 48 hrs in human eyes. 
This is consistent with our data showing conventional facility in enucleated mouse eyes changed 
after 24 but not after 3 hrs post mortem (Chapter 2; Cohorts 3A&B). 
    On the other hand, we propose that Bárány78 did not detect a similar effect from the multiple anti-
metabolic agents he used because they had a limited efficiency at inhibiting production of ATP in 
the outflow pathway. Metabolic energy (or ATP) is typically produced in cells by glycolysis. One of 
the end-products of glycolysis is pyruvate, which is used to produce additional ATP through cellular 
respiration. Per molecule of glucose broken down, glycolysis produces 2 molecules ATP while 
oxidative phosphorylation produces 34-36 molecules of ATP (see supplementary figures 3-4). Still, 
the TM has been shown to preferentially harvest most of its energy preferably from glycolysis, while 
cellular respiration provided only up to 25% of its energetic requirements192. Most anti-metabolic 
agents Bárány used were targeted at either glycolysis or cellular respiration, but not both (see Table 
9). Therefore, blocking only one of the metabolic pathways (glycolysis or cellular respiration) could 
allow the other to compensate for the loss of ATP. This assumes cellular respiration could occur 
without the simultaneous production of pyruvate by glycolysis, by using the available pool of 
pyruvate left in the eye. Only one anti-metabolic agent used by Bárány (called Sodium arsenite) is 
known to affect both pathways, yet it only disturbs glycolysis mildly. Specifically, it does not prevent 
glycolysis from proceeding, but inhibits the production of some ATP in the process (Supplementary 
figure 3). Interestingly, the only anti-metabolic agent targeting glycolysis at its early stage 
(Iodoacetate) had an effect on total resistance. This anti-metabolic agent stops glycolysis after two 
molecules of ATP have been used, thereby depleting the tissue of the available ATP. Yet the effect 
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of this anti-metabolic agent on resistance measured by Bárány was later attributed to its ability to 
affect cellular permeability because it is a sulfhydryl agent, rather than metabolic activity. This was 
supported by showing other similar sulfhydryl agents also increased outflow facility in spite of not 
affecting metabolic activity153,154. In contrast, we used a anti-metabolic agent that blocks both 
metabolic pathways in its early stages, thus ensuring total inhibition of ATP production 
(Supplementary figures 3-4). Altogether, we suggest the anti-metabolic agents used in our study 
might have been more appropriately targeted at the metabolic activity of the TM than those used by 
Bárány. 
 
111 
 
Anti-metabolic 
agents  
Effects on glycolysis Effects on cellular respiration Effects on total 
resistance 
Sodium Cyanide 
(NaCN) 
None Blocks oxidative phosphorylation by 
acting on cytochrome oxidase. 
None 
Sodium Azide 
(NaN3) 
None Blocks oxidative phosphorylation by 
acting on cytochrome oxidase. 
None 
2-4- Dinitrophenol None Blocks oxidative phosphorylation by 
uncoupling it. 
None 
Sodium Fluoride 
(NaF) 
Interrupts glycoslysis by inhibiting Enolase, resulting in only 1 ATP 
produced. 
None None 
Sodium Arsenite 
(NaAsO2) 
Does not prevent glycolysis to proceed but inhibits the formation of 2 ATP 
molecules. Causes the production of 1-arseno-3-phosphoglycerate instead 
of 1,3 biphosphate glycerate, which hydrolyzes directly into 3-
phosphoglycerate without forming ATP.
193
  
Inhibits the conversion 
of pyruvate into acetyl-CoA thus 
blocking Krebs cycle and oxidative 
phosphorylation. 
None 
Iodoacetate  Inhibits GPD, by which time one ATP molecule has been already used
194
.  None Decrease by 40%.  
Table 9: Effects of anti-metabolic agents used in Bárány’s study
78
 on metabolic energy production derived either from glycolysis or cellular respiration
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    Note that previous studies reported the effects of temperature77 or anti-metabolic agents 78 
on total outflow facility, while we reported the effects of anti-metabolic agents on 
conventional facility. These metrics are different because total outflow facility takes into 
account all of the entire aqueous humour outflow, that is, both in the conventional and 
unconventional pathways. We focused on conventional facility since we have shown the 
measurement of unconventional outflow in enucleated mouse eyes is strongly influenced by 
physical parameters such as hydration and temperature (see Chapter 2). Moreover, we 
assume conventional facility can be directly related to total outflow facility in human eyes, 
since the majority of aqueous outflow passes through the conventional pathway in the 
human eye39,72. Therefore the changes in conventional facility that we describe should be 
comparable to changes in total outflow facility reported in previous reports.  
    On the other hand, our histological analysis suggests anti-metabolic agents might be 
affecting the morphology of the conventional pathway. We analyzed a total of 12 quadrants 
from N =3 eyes treated with anti-metabolic agents and N =4 control eyes from Cohort 11. 
We noticed there were more giant vacuoles in eyes perfused with anti-metabolic agents, 
which extended to the outer wall of SC. In particular, one out of five quadrants showed 
extensive vacuolization (Fig. 25A). Although our analysis is only qualitative, a possible 
interpretation could consist in AH being retained by GVs, thus increasing outflow resistance 
and forcing AH to attempt to enter SC via as many GVs as possible. Since it is assumed AH 
leaves GVs through intracellular pores, their failure to facilitate AH might stem from the 
absence of intracellular pores caused by anti-metabolic agents. Note anti-metabolic agents 
could also affect the tone of the ciliary muscle, or TM cell contractility. A more detailed 
analysis, using EM, will be required to confirm the effects of anti-metabolic agents on outflow 
facility are not attributable to damage to the TM or SC. On the other hand, our results show 
giant vacuoles are passive structures, since they were not inhibited by anti-metabolic agents. 
This is consistent with previous studies showing GVs form even in low temperature 
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perfusions77. Thus, our findings point towards interesting morphological changes caused by 
anti-metabolic agents which need to be investigated in further detail.  
    An additional observation arising from this study was the non-negligible variability in 
conventional facility measured between cohorts of eyes perfused under apparently similar 
conditions. In particular, the average conventional facility in eyes perfused at 35 °C with 
DBG in Cohort 2 was markedly different to that measured in eyes similarly perfused Cohort 
11 (e.g. 0.0172±0.0028 vs. 0.0290±0.0068 µL/min.mmHg for eyes perfused at 35 °C with 
DBG in Cohort 2 and 11 respectively).  In order to ensure the effects of anti-metabolic 
agents and temperature were not an artefact from such variability, we used a linear mixed 
model to analyse their effects statistically while taking into account such random variability. 
The results confirmed anti-metabolic agents and temperature had a significant effect 
regardless of the variability between cohorts. In any case, it prompted us to investigate the 
possible reasons explaining such variability in conventional facility between cohorts, as 
described in the following and last chapters of this thesis. 
 
    In conclusion, we present data which suggests outflow resistance is metabolic-dependent 
in mouse eyes, thus possibly overturning existing dogma. Our data shows future perfusion 
studies should be carried out at physiological temperature to take into account metabolic 
activity. Finally, this study highlights the benefits of using the mouse as a model for studying 
outflow resistance, notably because of the short post mortem times associated with 
obtaining tissue.   
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Glucose 
 
Hexokinase 
Fructose-6-phosphate 
Phospho- 
fructokinase 
Fructose-1,6-biphosphate 
Aldolase 
Glyceraldehyde 
Phosphate 
Dehydrogenase (GPD) 
 1,3- Biphosphate glycerate    x2 
Phosphoglycerate  
Kinase 
3-Phosphoglycerate            x2 
Phosphoglycerate  
Mutase 
2-Phosphoglycerate           x2  
Enolase 
Phosphoenol-pyruvate         x2 
Pyruvate 
kinase 
Pyruvate                         x2 
Glucose-6-phosphate     
Phosphoglucose 
isomerase 
IAA 
NaAsO2 
NaF 
Total ATP : 
Glycolysis 
Supplementary figure 3: Effects of anti-metabolic agents used by Bárány on ATP production in glycolytic cycle. 
On the left hand side, a diagram describes the subsequent products of glycolysis (separated by black arrows), 
transformed by the enzymes written in italic.  Blue arrows show at which stage ATP is normally produced (i.e. + 
ATP) or used (i.e. – ATP), as indicated by the first column of the table on the right hand side. The remaining 
columns indicate the amount of ATP produced in presence of either of the anti-glycolytic agent used by Bárány 
(IAA: Iodoacetate; NaAsO2: Sodium Arsenite; NaF: Sodium Fluoride). Red boxes indicate at which stage of 
glycolysis the anti-metabolic agents act. x2 indicates the reactions occurs twice. 
Normally, a total of 2 molecules of ATP are produced when glucose is transformed into two molecules of pyruvate. 
IAA inhibits the enzyme GPD, resulting in the final depletion of 2 ATP molecules. NaAsO2 prevents the formation of 
2 ATP molecules from the substitution of 1,3-biphosphate glycerate into 3- phosphoglycerate, without preventing 
glycolysis from proceeding, resulting in 0 ATP produced. NaF inhibits Enolase, resulting in no ATP produced. 
Therefore, although NaAsO2 and NaF prevent formation of new ATP, they do not deplete the available ATP. In 
contrast, IAA and our anti-metabolic agent (2-dideoxy-D-glucose) interrupt glycolysis before any ATP has been 
produced, and after one or two ATP molecules has been used, resulting in ATP depletion.  
Glyceraldehyde-3-phosphate 
2- dideoxy-
D-glucose 
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Acetyl-CoA 
Pyruvate 
Krebb‟s Cycle 
Oxidative 
phosphorylation 
+ 2 ATP 
+ 32-34 ATP NaCN, NaN3, 2-4-
Dinitrophenol 
NaAsO2 
Supplementary figure 4: Effects of anti-metabolic agents used by Bárány on cellular respiration. 
Pyruvate, produced by glycolysis is first converted in Acetyl-CoA in the mitochondria. Acetyl-CoA is 
used in the Krebb’s cycle to produce 2 molecules of ATP. Subsequently, the oxidative phosphorylation 
creates 32-34 ATP using a by-product of the Krebb’s cycle. The red boxes show where the anti-metabolic 
agents used by Bárány (and ours, i.e. NaN3) interrupt cellular respiration. NaAsO2: Sodium Arsenite, 
NaCN: Sodium cyanide, NaN3: Sodium Azide.  
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Chapter 6: Effects of IOP on AH outflow, SC 
morphology and tracer patterns in enucleated 
mouse eyes 
1- Introduction   
    In recent studies, conventional facility of enucleated mouse eyes was shown to increase 
at high pressures 12,13. Flow-rate vs. IOP data was shown to follow a linear trend line up to 
40 mmHg, which represents a constant conventional facility (solid trend line, Fig. 26). Yet, at 
higher pressures, flow-rates diverged from the linear trend-line, possibly corresponding to an 
increased conventional facility (red data point, Fig.  26). 
  
Figure 26: Flow rate vs. IOP data for C57BL/6 enucleated mouse eyes, reproduced from Lei et al. 2010. 
The solid trend line represents conventional facility from 8 to 40 mmHg, corresponding to 0.0068 
µL/min/mmHg. The dashed trend corresponds to the extrapolation of the linear trend line up to 45 mmHg 
showing that flow rate data at 45 mmHg is not well explained by the linear slope calculated in the 
pressures ranging from 8 to 40 mmHg.  Eyes were perfused at room temperature with the same system 
described in Chapter 2, Fig. 9A. Bars are standard errors of the means.  
 
    Strikingly, this differs from humans and other species which exhibit a decrease in 
conventional facility at high perfusion pressures76. This decrease in conventional facility is 
associated with the collapse of SC195. Yet originally, human outflow facility was reported to 
increase at high pressures because of an artefact from the perfusion process89,195. More 
specifically, perfusing fluid directly into the AC pressurized the AC but not the posterior 
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chamber. This pressure gradient across the iris caused posterior displacement of both the 
iris and the lens, which applies tension on the TM, thus pulling open SC, resulting in an 
artificial increase of conventional facility89,195. Precautions are commonly taken in human 
eyes to prevent this effect, called anterior chamber deepening, but never in mouse eyes. 
Therefore it is possible that mouse eyes suffer from the same artefact, explaining why 
conventional facility was shown to increase at high pressures in mouse eyes. This needs to 
be determined for ensuring the viability of the mouse as a model for studying human 
conventional facility.  
    In humans or primates eyes where AC deepening is prevented by re-establishing a 
connection between the posterior and anterior chamber, there is evidence that IOP affects 
SC morphology. Following iridotomy, Van Buskirk195 showed SC cross sectional area was 
significantly decreased at high pressures (20-40 mmHg).  On the other hand, studies have 
shown pressure affects AH outflow patterns in the TM. More specifically, fluorescent tracers 
were perfused in the eye to reveal outflow patterns. This showed a smaller area of the TM 
was perfused by tracers, i.e. by flow, at high pressures102,103. This prompted us to analyse 
the effects of IOP on outflow facility, SC morphology and outflow patterns in mouse eyes to 
investigate whether the effects are similar in mice as in other species. We hypothesize the 
observed increase in conventional facility in enucleated mouse eyes is caused by AC 
deepening and correlates with an increase in SC dimensions and a larger TM area perfused 
by AH. 
    We performed detailed measurements of AH outflow at increasing pressures in 
enucleated mouse eyes to confirm that conventional facility increases at high pressures, as 
suggested by a previous study (Fig. 2612). Furthermore, eyes were perfused with fixative at 
pressures corresponding to high, mid and low outflow facility, and imaged to investigate 
corresponding changes in the morphology of SC. Specifically, an automated 3D histological 
device (Histo-Cutter)196 was used to visualize and reconstruct SC in enucleated mouse eyes. 
Secondly, fluorescent outflow patterns were visualized in whole mouse eyes by Optical 
Projection Tomography197. Note outflow patterns were not analyzed at different pressures 
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because we are still in the process of validating this novel protocol. This chapter provides 
preliminary data acquired with both techniques, which are still the subject of ongoing studies.   
2- Methods 
    All experiments were performed using ex vivo tissue and were done in compliance with 
the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research the Animal 
Scientific Procedures Act 1986.  
 
    This study includes three cohorts of mice, which are the twelfth, thirteenth and fourteenth 
cohorts of mice used for this thesis. The first cohort (Cohort 12) was used to investigate 
changes of AH outflow at increasing pressures. In a second cohort (Cohort 13), we analyzed 
changes in SC size at different pressures. The last cohort (Cohort 14) was used for 
analyzing tracer patterns in whole mouse eyes in 3D. In this section, we describe the 
experimental design for each cohort. 
 2.1. AH outflow measurements at increasing pressures 
    In Cohort 12, we measured AH outflow at increasing pressures to identify the pressure 
levels at which conventional facility started increasing. The aim was to select three pressure 
levels corresponding to low, mid and high outflow facility which might be associated with 
morphological changes. A previous study had shown AH outflow increased at pressures 
above 40 mmHg in enucleated mouse eyes (Fig. 2612). We replicated the study using the 
improved perfusion system described in Ch.2 (see section 2.1; Fig. 9C), with hydration and 
temperature control. Briefly, a computer-controlled syringe-pump delivered a variable flow 
rate to the enucleated mouse eye required to maintain the eye at a user-defined pressure. 
Conventional facility was calculated as the slope of the best-fit linear trend line to our flow 
rate vs. pressure data (see Eq. 8 and Fig. 9). Our study used numerous pressure steps to 
more precisely detect changes in outflow resistance.  Specifically, flow measurements were 
performed every 3-4 mmHg, from 8 to 40 mmHg (8,12,15,18,22,25,28,31,34,47,40 mmHg; 
Fig. 27). 4 unpaired eyes from C57BL/6 mice were used for this study.  
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Figure 27: Typical perfusion tracing for experiments performed on mouse eyes from Cohort 12. Pressure 
is shown in black while flow rate is shown in blue. The red highlights show the regions deemed steady at 
each pressure level and averaged for the measurement of conventional facility (see Figure 9). In this 
cohort, we perfused eyes up to 40 mmHg at many more pressure levels than previous cohorts, resulting 
in longer experiments (200 min vs. approximately 120 for previous cohorts). 
2.2. SC imaging at different pressures with the Histo-Cutter 
    Mouse eyes from Cohort 13 were used for imaging SC in 3D with the Histo-cutter196. In 
particular, we hypothesized changes in AH outflow would be associated with structural 
changes in SC.  Thus, eyes perfusion-fixed at 3 different pressures were imaged to reveal 
changes in SC dimensions. The pressure levels were chosen according to the results from 
Cohort 12, as those associated with high, mid and low outflow resistance (or, respectively, 8, 
25 and 40 mmHg). Below we describe the functioning of the Histo-Cutter as well as the 
preparation and imaging of the sample, and the processing of the results.  
2.2.1. Perfusion fixation of mouse eyes at different pressures 
    Eyes were enucleated and placed in PBS at 4 °C until perfusion. Eyes were perfused with 
the perfusion system previously described (Chapter 2, section 2.1). Briefly, eyes were 
cannulated with a 33G needle connected to a pressure transducer and a computer 
controlled syringe pump. The syringe pump delivered variable flow rates required to maintain 
the pressure inside the eye steady at any user-defined level, thanks to custom LabView 
software151. The eye was perfused at a single pressure level. Eyes were briefly pressurized 
with a PBS-filled reservoir for than less than a minute prior to the perfusion with the pump. 
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Eyes were perfused at 35 °C, immersed in isotonic saline as described in Fig. 9C of Chapter 
2. 
In order to prevent fixation before the eye equilibrates at the desired pressure, the eye was 
first perfused with a 5 µL bolus of DBG (PBS with 5.5 mM glucose) followed by a bolus of 4% 
PFA, which allowed the measurement of AH outflow prior to PFA entering the eye. This was 
done by backfilling 5 µL of DBG from the tip of needle into the tubing filled with 4% PFA. As 
the fixative is delivered to the outflow pathway it will cross-link the tissue, thus decreasing 
the flow rates required to maintain the same pressure. Accordingly, the eye was considered 
fixed when the flow rates required to maintain the eye pressurized had decreased by 40% 
from the baseline level (Fig. 28). A total of 3 eyes were examined, one eye per pressure 
level, two of which were paired.  
 
Figure 28: Typical tracing for perfusion-fixation of a mouse eye. The eye was pressurized at a single 
pressure level (blue tracing) which was maintained steady by the flow rate injected by the syringe pump 
(black tracing). Red highlights show the steady regions considered to represent the baseline and final 
flow rate prior to and following fixation.  Steady highlighted flow rates were averaged and used as an 
indication of the drop in flow rate caused by fixation, estimated as 40%. The first red arrow indicates the 
time by which the 5 µL of DBG had been perfused, and PFA started entering the eye. The second arrow 
indicates the time point at which 6 µL of PFA had been perfused into the eye, such that the entire AC was 
filled only with PFA. If no PFA had been perfused, we expect the flow rate to remain steady and not 
decrease. 
2.2.2. Histo-cutter  
    The Histo-cutter is a 3D histological device that performs automated serial sectioning to 
image the morphology of tissues embedded within a paraffin block196. It relies on 
fluorescence imaging, and captures the autofluorescence of the tissue typically provided by 
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chemical groups such as flavins, found in a wide range of tissues198. The Histo-cutter 
automatically images the surface of a block containing a tissue sample as it is progressively 
sectioned. It is composed of an epifluorescent microscope (Nikon AZ100; Nikon AZ Plan 
Apo x4 lens, Numerical Aperture 0.4), a mercury lamp, a microtome and a camera (Fig. 29). 
The sample embedded within the block is sectioned serially by the microtome. Each freshly 
cut surface is excited at a specific wavelength and imaged through the microscope by the 
camera. The microscope contains multiple filters such that the same section can be excited 
and imaged sequentially at different wavelengths.  
    Importantly, the paraffin block needed to be stained to limit the depth of penetration of the 
excitation light. This prevents the tissue underneath the surface of the block from being 
excited, which would otherwise also emit fluorescence. Therefore, a stain is mixed with the 
paraffin so as to absorb the incoming light and avoid this out-of-focus fluorescence (see 
following section). 
 
Figure 29: Picture of the Histo-Cutter and its different components, labelled in red. For every section, the 
sample is automatically lowered towards the blade by the microtome, and brought back up in front of the 
objective. The mercury lamp is used to excite the tissue at the freshly-cut surface at a specific 
wavelength, defined by the microscope filters. The image is taken by the camera and recorded on a 
computer. 
Blade  
Microtome 
Camera Microscope 
Sample  
Mercury lamp 
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    The user is required to place the paraffin-embedded tissue onto the sample holder and 
optimize the focus and brightness of a reference image. The device is thereafter responsible 
for automatically sectioning the block surface, imaging the freshly cut surface and recording 
the images. The subsequent images are automatically aligned by the software using a laser 
position sensor.  Images of the freshly cut surface were recorded by a camera resulting in a 
stack of high-resolution 2-D JPEG images (4096x4096 pixels). The stack of images was 
then processed with specialized software to yield 3D reconstructions of the tissue. 
    Sections were cut from the block surface at 1 μm steps. A zoom was chosen such that 
1.72 mm x 1.72 mm of the block surface could be imaged, with a digital resolution (i.e. a 
pixel size) of 420 nm. The theoretical resolution based on light diffraction was 760 nm. Lower 
zooms captured a larger field of view such that a larger fraction of the eye was imaged but 
with a decreased resolution, which might have failed to capture small structures of interest 
such as collector channels. At each zoom, the device was calibrated with a micrometer 
stage (NT30-592, Edmund Optics, Nether Poppleton, UK).  
2.2.3. Tissue autofluorescence 
    To determine the optimal excitation and emission wavelengths to be used by the Histo-
cutter, we first characterized the spectrum of excitation and emission from the tissues 
comprising the conventional outflow pathway.  
    A lambda-scan was used to measure the intensity of the fluorescence emitted by the irido-
corneal angle after being excited by different lasers (data not shown, studies performed with 
Tali Ziskind199). These studies showed excitation lasers of 561 or 633 nm yielded the 
autofluorescence with the highest intensities, which was found in the wavelengths ranging 
from 590 to 680 nm. Therefore, we determined the Texas Red filter had the most optimal 
wavelengths for excitation/emission, which are 540-580nm for excitation and 600-660 nm for 
emission. 
2.2.4. Tissue embedding 
    First, eyes had to be embedded in paraffin so as to be able to undergo sectioning. Two 
MSc students (Ms. Tali Ziskind and Miss Oana Elena) validated a protocol for infiltrating the 
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eye with paraffin199,200. Briefly, the eye was dehydrated in increasing concentrations of 
ethanol (50, 70, 90 and 100%), prior to several clearing steps with Xylene and infiltration with 
different solutions containing paraffin at 75 °C. The last step of the embedding protocol 
consisted of placing the sample in the desired orientation on a thin layer of melted paraffin in 
the mould. Once the paraffin had solidified, it held the sample in position prior to pouring the 
remainder of the paraffin to fill the mould entirely.  
    Importantly, the paraffin had to be stained with a dye to absorb light emitted by deeper 
layers of the tissue and minimize the depth of penetration of the excitation light into the 
paraffin block. The optimal stain should absorb both the light exciting the surface of the block 
and that emitted by the block, which were determined to be 540-580 nm and 600-660 nm, 
respectively (see previous section, 2.2.3). Thus we searched for a dye which could absorb 
light in both ranges of wave lengths. Preliminary studies using a spectrophotometer 
investigated the viability of different dyes such as Sudan II and Sudan IV (Fig. 30). Our 
results show both Sudan IV and II absorb light within the excitatory light range (540-580 nm), 
although Sudan IV seems to have higher absorbance rates. However, Sudan IV does not 
seem to absorb light within the wavelengths where fluorescent light is emitted, between 600-
660 nm, whereas Sudan II does.  
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Figure 30: Absorbance spectra of Sudan II (green line) and IV (red line) dyes, measured by a 
spectrophotometer. Dashed lines represent the wavelengths range of the Texas Red filter excitation (TR 
Exc) and emission (TR Em) which were found to coincide with the tissue autofluroescence. Sudan IV and 
II absorb light within the wavelength range of the excitatory light but Sudan IV does not absorb the 
emitted fluorescence, while Sudan II does. Experiments were done with Barbara Murienne. 
 
    Thus we proposed Sudan II might be more efficient at blocking the out-of-focus 
fluorescent light emitted from the deeper layers of the block. This was further confirmed by 
Ms. Tali Ziskind and Miss Oana Elena, who showed 4% Sudan II provided the optimal 
contrast between the SC lumen and the surrounding tissue (Fig. 31).  
 
Figure 31: Section of a mouse eye embedded in paraffin stained with Sudan IV 0.5% (A) or Sudan II 0.5% 
(B). Asterisk shows SC location. Red arrows points to SC outer wall. Other concentrations of dyes were 
used, but these two are shown to illustrate the difference in contrast between the SC lumen and its 
surroundings caused by the use of different dyes. SC lumen is hardly detectable with Sudan IV 0.5% (A). 
In contrast, the cornea contrasts with the dark lumen of SC when using Sudan II 0.5% (B).  
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    The use of the dye introduced an important issue for the tissue embedding: it rendered the 
tissues opaque, such that they were not visible at the moment of embedding the eye in the 
wax. This was problematic because the eye needed to be placed in a specific orientation in 
the paraffin block, so that it was sectioned in the sagittal plane to reveal the cross-section of 
SC. In order to know the orientation of the eye, the eye was placed in a transparent solution 
of agarose (Fisher BioReagents, 1.8% agarose in filtered H20) prior to the start of the 
embedding protocol. More specifically, the gel was given a particular shape, which was used 
as an indication of the eye orientation during the embedding protocol, even when the gel 
became opaque. Typically, the gel was cut such that its largest flat surface was parallel to 
the sagittal plane of the eye (Fig. 32). The flat surface was easily recognizable at the last 
stage of embedding, in spite of the gel being opaque. This allowed simply laying the gel on 
its flat surface in the mould at the last stage of embedding, such that its sagittal plane was 
parallel to the surface of the block. Thus, when the block was trimmed by the microtome, it 
would reveal the sagittal plane or the eye, and thus the cross section of SC (Fig. 31B) 
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Figure 32: : Schematic diagram of the positioning of the mouse eye in the gel prior to embedding 
protocol (A), which will be cut such that the cross section drawn in (B) is revealed. 
2.2.4. Histo-cutter validation 
    At first, we aimed to ensure the images acquired with the Histo-cutter compared well with 
results from conventional histology. Images from the Histo-cutter were compared to images 
from eyes perfused with DBG that had been prepared by conventional histology in a 
previous study (Cohort 6, Chapter 3). For conventional histology, eyes were embedded in 
paraffin, sectioned and stained with hematoxylin and eosin. The sections were imaged under 
a light microscope. The anterior-posterior length (A-P length) of the SC (see following 
section, 2.2.5) was measured manually with ImageJ by Tali Ziskind199 on random sections 
from one eye provided by conventional histology (N =10) and the Histo-cutter (N =10).  
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    Images acquired with the Histo-cutter revealed a general limbal architecture similar to that 
seen by classical histology (Fig. 33). Yet, the images provided different information because 
the Histo-cutter uses fluorescence, while conventional histology relies on light transmission, 
and uses stains. Therefore, cell nuclei are visible on the images from conventional histology 
but not from the Histo-cutter.  In any case, the A-P length of SC imaged with the Histo-cutter 
was similar to that measured from conventional histology sections (129.52 ± 28.66 μm vs. 
107.14 ± 34.60 μm, respectively; mean±stdev). The difference was not statistically significant 
(p = 0.14; unpaired t-test). 
 
Figure 33: Mouse anterior segment cross section from A) Conventional histology, B) the Histo-cutter. The 
image acquired with the histo-cutter reveals a limbal organization similar to that shown by classical 
histology. Legend: CB: Ciliary Body. Red arrows point to SC.  
2.2.5. SC or collector channels segmentation  
    The SC was identified based on the contrast difference between its lumen and the 
surrounding tissue (i.e. sclera and TM). It was typically composed of one large oval-shaped 
lumen found at the irido-corneal angle (Fig. 34B).  We defined the anterior-posterior length of 
the SC as the distance from the extremity closest to the cornea to that found most posteriorly 
in the sclera (Fig. 34B). The SC width was defined as the largest distance between the edge 
of the SC in contact with the sclera and that in contact with the TM (Fig. 34C). Collector 
channels were defined as smaller vessels found in the deeper aspects of the sclera. In 
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addition, they had to depart from SC at some point along their length. This ensured that they 
were not confused with other intrascleral vessels such as arteries. 
 
 
Figure 34: SC segmentation and measurements. A) SC segmented in purple. B) Red line shows A-P 
length. C) Red line shows SC width. Note measurements were done on the reconstructed 3D 
representation of SC, rather than the 2D images. Legend: C=Cornea, AC=Anterior Chamber, S= Sclera, 
CB= Ciliary body. 
2.2.8. SC reconstruction 
    Following the acquisition of stacks of 2D images by the Histo-cutter for each sample, 
software was used to segment and reconstruct SC in 3D (AMIRA, VSG, Burlington, MA, 
USA). SC was segmented in a semi-automatic fashion by Ms. Tali Ziskind199. First, this 
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consisted of manually drawing an SC contour with an electronic pen every 5-10 slices. For 
the remaining sections, the software interpolated SC contours. The sections where SC was 
interpolated by the software were verified at least twice by the user and modified manually 
when necessary. A surface was generated by the software along the whole length of SC 
based on the contours drawn at each section (Fig. 35).  
    Raw images were imported as stacks and downsized to 1024x1024 pixels from their 
original size which was 4096x4096 pixels. This caused a 4 fold reduction in the pixel size 
and thus in resolution. Voxel size was therefore 1.6 μm x 1.6 μm x 1 μm in the x,y,z 
directions, respectively. 
 
Figure 35: Illustration of SC reconstruction process. SC is manually segmented every 5-10 sections, and 
automatically segmented in the remaining sections. Amira generates a 3D surface based on the SC 
segmentations performed in each section, shown in pink. Image taken from MSc dissertation of Miss Tali 
Ziskind. 
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2.3. Visualizing outflow patterns across the entire mouse eye: OPT 
2.3.1. OPT  
    Optical Projection Tomography (OPT) is a technique recently developed by Dr. Sharpe et 
al. to image biological samples in 3D for specimens of size 0.5-10 mm197.  I was given the 
opportunity to use the machine in Dr. Sharpe‟s laboratory in Spain via the Euro-Bioimaging 
Proof of Concept studies, and later thanks to funding from the Santander Bank. The OPT 
gives anatomical information about biological samples by mapping the sample‟s absorption 
of light. Importantly, the sample had to be optically clarified to maximize light transmission. 
This allowed taking images through the whole specimen. More specifically, the sample was 
rotated through 360 degrees in angular steps, such that 400 pictures are taken over one 
revolution. Projection images taken from each angle are then processed with specialized 
software to reconstruct the original 3D structure201.  
2.3.2. Tissue preparation 
    In this study, we used BALB/cJ eyes which lack pigmentation, which facilitates light 
transmission during the scan.  As a preliminary study, eyes were perfused at 8 mmHg with a 
bolus of 3 µL of 20 nM of quantum dots (Qdots, Q25001MP, Invitrogen, Life Technologies, 
Carlsbad, CA, USA).  Qdots are fluorescent nanocrystals, and the ones that we used were 
chemically tagged such that they are internalized by cells. Thus, we assumed they  
represented outflow patterns by entering cells which line the pathways of aqueous humour 
outflow channels, as in previous studies202.  
    Following perfusion, eyes were immersed in fixative. However, they were only placed in 4% 
paraformaldehyde (PFA) for 20 min as we observed 4% PFA can quench quantum dot 
fluorescence. Eyes were further immersed in 0.1% PFA for long term storage. Eyes were 
embedded in an agarose gel to provide mechanical support during scanning. More 
specifically, the gel containing the eye was glued onto a post which allowed rotating the eye.  
The gel was filtered to get rid of particles which could refract light during the OPT scan. The 
gels were then dehydrated with methanol, which was changed three times within 24 hrs. The 
gels were placed in BABB (2:1 mix of Benzyl Alcohol and Benzyl Benzoate). Because it was 
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observed BABB quenched the fluorescence of Qdots, we left the samples in BABB as little 
as possible, typically 1-2 hrs prior to scanning. N =2 eyes were successfully imaged for this 
preliminary study. 
2.3.3. OPT scan 
    Eyes were bathed in BABB during the scan. The filter used for detecting the quantum dots 
signal (Exc/Em: 405-565/605 nm) was Cy3, with Exc/Em: 530-560/573-637 nm.  
Autofluorescence was captured with the GFP1, (Exc/Em: 425/475; band pass filter), to 
provide morphological information about the tissue. 400 images were taken through 360 
degrees (0.9° angular steps). Two consecutive scans were performed, each with a separate 
filter. At each position, the gel was exposed for 0.5-1 sec to the excitation light. Data was 
reconstructed by Jim Swoger and Laura Quintana Rio in Dr. Sharpe‟s laboratory with a 
customized MatLab program. 
3- Results 
3.1. Cohort 12, AH Outflow changes with pressure 
    Our flow rate vs. pressure data did not reveal a linear relationship across the pressures 
ranging from 8 to 40 mmHg (Fig. 36).  This was because there was a “break” or transition in 
the flow vs. pressure data. This transition seemed to occur at 22-25 mmHg, as suggested by 
the two trend lines drawn below and above 22 mmHg which show very different slopes 
(0.013±0.005 vs. 0.026±0.014 μL/min.mmHg; N =4 eyes). Note however, the difference in 
conventional facility below and above 22 mmHg was not statistically significant (p =0.21; 
paired t-test). We therefore chose 8, 25 and 40 mmHg as pressure levels corresponding to 
different outflow facility regimens. 8 and 40 mmHg correspond to the low and high 
conventional facilities, while 25 mmHg is found at the transition.  
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Figure 36: Flow rates measured at pressure steps from 8 to 40 mmHg. The trend line and equation in red 
correspond to outflow facility across the low range of pressures from 8 to 22 mmHg, whereas the 
equation and trend line in blue represent outflow facility within the higher pressure range, from 22 to 40 
mmHg. 
3.2. Cohort 13, SC dimensions change at increasing pressures 
3.2.1. SC reconstruction and measurements 
    SCs from 3 samples, one per pressure level (8, 25 and 40 mmHg), were successfully 
imaged with the Histo-Cutter, reconstructed and quantified with AMIRA (see Methods and 
Fig 35). On average, SC was reconstructed for a length of 1062±195 µm (N= 3), which 
represents approximately 11% of the entire circumference (assuming the eye diameter is 3 
mm and SC is located at its equator). Fig. 37 shows that SC dimensions vary along its 
circumference; interestingly, it shows regions where SC is not reconstructed because it was 
not detected on the 2D images. This could be either because its lumen was collapsed or not 
detectable in the section. In the eye pressurized at 8 mmHg, SC was not detected in 17.5% 
of its reconstructed length, as opposed to 5.5% at 25 mmHg and no collapsed regions at 40 
mmHg.   
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Figure 37: SC reconstructed at:  A) 8 mmHg, B) 25 mmHg, C) 40 mmHg. Gaps correspond to regions 
where the SC lumen was not seen, i.e. it was either collapsed or nonexistent. 
3.2.2. AC deepening in the mouse 
    In order to investigate whether AC deepening occurs in mouse eye perfusions, we 
analyzed several 2D images from each sample. In particular, we looked at the posterior 
displacement of the iris at different pressures. Fig. 38 shows a typical example of the general 
morphology of eyes perfused at 8, 25 and 40 mmHg. The dashed white line represents the 
iris, which is difficult to distinguish from the opaque background. The images show the iris is 
dramatically displaced backwards from 8 to 25 or 40 mmHg. This results in the increase of 
the irido-corneal angle (depicted in blue), which can force the TM and SC to open at higher 
pressures. 
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Figure 38: Iris retrograde movement with increasing pressures. 2D images taken with the Histo-cutter of 
eyes pressurized at A) 8, B) 25, C) 40 mmHg. The white dashed line outlines the iris contour, which forms 
a larger angle (represented by blue lines) with the cornea at higher pressures (25, 40 mmHg) than at 8 
mmHg. Asterisks show the location of SC. Note SC is not visible in Panel A. 
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3.2.3. Collector channels 
    Collector channels were also detected, although not often (Fig. 39A-B). Only one CC was 
reconstructed from a preliminary study (green structure, Fig. 39C).However, CCs seemed to 
quickly disappear into the sclera, either because they collapsed or became too small to 
resolve.  
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Figure 39: A) Image of the irido-corneal angle of a mouse eye acquired with the Histo-cutter, showing a 
CC departing from SC. Asterisk shows the SC lumen. B) Close-up of SC from Panel A, which is 
segmented in yellow. Red arrow points to the CC which in subsequent sections splits from SC. C) 3D 
reconstruction of a collector channel (in green) departing from SC (in purple).  
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3.2.4. Link between choroid and SC 
    We also detected an interesting morphological feature, shown in Fig 40. Images from 
samples perfused at different pressures showed a possible link between the choroid and SC 
(red arrow, Fig. 40). The images suggest there might a direct connection, although it is not 
clear whether it is fibrous or consists of a channel per se. Although further research is 
needed, this could mean that the conventional pathway could merge directly with choroidal 
circulation. Yet, this could just be a consequence of pigmentation. 
 
Figure 40: Two examples of fusion of choroid with SC, from two different samples.  2D image taken with 
the Histo-cutter showing a link (red arrow) between the choroid (Ch) and the SC (star). 
3.3. OPT results 
    Only N =2 samples were successfully imaged by OPT. Both were fixed at physiological 
pressure (i.e. 8 mmHg in enucleated mouse eyes), even though the original aim was to 
observe changes in outflow patterns in eyes at different pressures. Unfortunately, we have 
not yet examined eyes at different pressures because we are still in the process of 
optimizing the protocol. Here, we present preliminary data for validating this novel protocol, 
which could be later used to examine outflow patterns in eyes fixed at different pressures. 
Fig. 41 shows projection images, taken at the same position of the eye. It can be seen that 
the GFP1 channel captured some autofluorescence from the cornea, but mostly detected 
signal from the sclera and extra-ocular tissues.  The Cy3 channel captured more specifically 
the fluorescence from the tracers, which were found at the limbus. Interestingly, they were 
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not found homogeneously around the circumference of the eye, and were highly 
concentrated only in some regions (Fig. 41C). Due to poor quality of the autofluorescence 
images, it is not possible to ascertain where the tracers are located in the TM and SC, but it 
is clear from the major landmarks of the eye (i.e. cornea, lens, sclera) they are in the limbal 
region. 
      
Figure 41: Images obtained with OPT of a BALB/cJ eye perfused with Qdots. Imaged A) in bright field 
mode, B) with the GFP1 filter, C) with the Cy3 filter. The eye was in the same position for the three 
images. Fluorescent tracers in B and C are detected as white signal.  
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    A second eye was imaged and reconstructed, as shown in Fig 42.  Blue structures 
represent autofluorescence captured with the GFP1 filter, while Qdots are shown in red. A 
similar distribution to that observed previously is found, wherein the Qdots are found around 
the limbus in focal locations only. Note Qdots are also found at the needle insertion site in 
the cornea. Fig 42B shows the fluorescence from the tracers only (Cy3 filter) from the same 
eye orientated in a different way, such that the entire circumference of the limbus is in a 
single plane. Our preliminary images support the findings that AH outflow is segmental in 
mouse eyes.   
 
 
Figure 42: 3D reconstruction of BALB/cJ mouse eye perfused with Qdots. Tissue autofluorescence is 
shown in blue, whereas the Qdot fluorescence is represented in red. Note images A and B were acquired 
on the same eye but in different orientations. The autofluorescence in image B is not reported for clarity, 
but was used to determine the location of the limbus. 
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4- Discussion 
    Our results suggest conventional facility in mice is pressure-dependent. This is particularly 
interesting as it is the opposite of the effect observed in other species, such as humans76. 
Using a 3D automated histological device, we show SC is most open at 40 mmHg, which is 
consistent with the high conventional facility measured at similar pressures.  Importantly, our 
histological images suggest this effect is likely caused by AC deepening, as previously 
observed in human studies. This suggests conventional facility in mice might be artificially 
increased at high pressures. In other words, mouse and human conventional facility may 
show similar pressure dependence, once AC deepening has been accounted for. 
    The effects of AC deepening in human eyes were reported in several early studies, 
amongst others by Grant who reported a two-fold increase in outflow facility in eyes when 
AC deepening was not prevented at physiological pressure levels89. More specifically, he 
described AC deepening as characterized by the enlargement of the anterior chamber which 
pushed the lens and the iris backwards, resulting in the iris forming a seal against the lens 
and closing the posterior chamber. Furthermore, he showed the effect was reversed 
following the re-establishment of a connection between the anterior and posterior chambers. 
This suggested that AC deepening was a result of the lack of pressurization of the posterior 
chamber caused by the direct delivery of perfusate to the anterior chamber. Finally, he 
showed AC deepening did not affect outflow facility after either the ciliary muscle or the TM 
was removed. Thus, his data further suggested outflow facility was increased because SC 
was artificially opened by a tension exerted on the ciliary muscle and TM, caused by the 
retro-displacement of the iris and the depression of the lens and zonules. This was further 
supported by studies from Van Buskirk195, who showed artificially depressing the lens 
opened SC. Father, he showed SC cross sectional area decreased with pressure in eyes 
where iridotomy was performed, leading to its collapse at 40 mmHg. 
    In our study, SC showed no collapsed regions at 40 mmHg, as opposed to the situation in 
eyes fixed at lower pressures. Our histological images suggest SC opening is likely caused 
by the deepening of the AC, indicated by the increase in the irido-corneal angle. This agrees 
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with our morphometric data showing SC was most open at 40 mmHg, as it is pulled open by 
the retro-displacement of the iris. Unfortunately, due to the small size of the mouse eye, 
preventing AC deepening in mice will be much more challenging than in humans, resulting in 
a previously unrealized limitation for mouse eye perfusions. Human or other large eye 
perfusions have overcome the problem, either by establishing a connection between the 
posterior and anterior chamber via an iridotomy, or by placing the needle directly in the 
posterior chamber. Such techniques are much more challenging in mice eyes, and this AC 
deepening effect might therefore be a fundamental problem for mouse eye perfusions in 
general. This warrants further research so as to determine whether mouse eye perfusions 
should only be carried out within a low pressure range that is relatively immune to this effect. 
    Here we have introduced a novel protocol to image SC morphology in mouse eyes. More 
specifically, the SC was reconstructed in 3D from a stack of high resolution 2D images of the 
murine limbal region, acquired with the Histo-Cutter196. Our results show SC in mice is 
mostly continuous, although its lumen was not visible in some regions. It is hard to know how 
to interpret the zones where SC was not visualized: although the images suggest SC was 
simply nonexistent, it might have been collapsed and hard to resolve. Apart from classical 
histology, few techniques to examine SC in mice exist; most recently murine SC was 
revealed by two-photon microscopy in intact enucleated mouse eyes203 or by confocal 
microscopy on    PECAM-1 immunostained wholemounts of murine anterior segments138. In 
addition, a goniolens has been developed to monitor the irido-corneal angle in living mice204, 
which allows locating SC; yet it provides only a macroscopic view of SC, and worked in 
albino mice when SC was filled with blood, thus limiting its applications. Currently, a 
collaborator is imaging the irido-corneal angle in anaesthetized mice, using Optical 
Coherence Tomography, to confirm our ex vivo data. Using the 3D histological technique, we 
also detected collector channels, although they were harder to resolve and seemed to 
disappear quickly in the sclera.  In addition to structural information provided by the 3D 
reconstruction of SC and CC, the high resolution images provided morphological information 
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about the surrounding structures of the limbus. In particular, an interesting feature was 
observed at several locations: SC seemed to be linked with the choroid, as shown in Fig. 40.    
Note however this could be due to pigmentation, and would need to be further investigated. 
    In addition, a second imaging mode (Optical Projection Tomography197,201, OPT) was 
tested to visualize outflow patterns in the whole mouse eye. Eventually, we hope that 
success with this approach would remove the need for embedding protocols or invasive 
procedures, such as sectioning, which can potentially damage the tissue and affect results. 
Note we attempted to combine the morphometric data from the Histo-Cutter with fluorescent 
outflow patterns, but were unsuccessful due to quenching of the Qdots by the relatively 
harsh embedding protocol. In contrast, images acquired with OPT successfully captured the 
fluorescence of the Qdots around the entire eye (Fig. 41, 42). Our results, albeit preliminary, 
were very encouraging and clearly demonstrated that tracer patterns were segmental around 
the circumference of the eye, as previously shown205. Note Qdots were still shown to be 
gradually quenched by BABB, a chemical required to clear the samples and maintain a 
proper refractive index during the OPT scan. Thus, we are currently investigating other 
potential tracers such as Rhodamine-Dextran which are not sensitive to quenching, and 
would be therefore more reliable. 
    Unfortunately, the morphological information provided by OPT was rather poor, thereby 
limiting our analysis. Indeed, although it is clear from the main landmarks of the eye the 
tracers are found within the limbal region as expected, no smaller structures such as the SC 
or CC were resolvable. Thus, it is not possible to infer whether the tracers are solely going 
through the conventional pathway or whether they are using a different route. The poor 
morphological rendering might have been caused by short exposure to the fixative (which 
enhances tissue autofluorescence) or because the structures we aim to observe are close to 
the resolution limit of the microscope (~ 5 µm).  Ongoing studies will refine our protocol in 
order to obtain more detailed morphology so as to be able to draw more definitive 
conclusions on the trajectory of the outflow patterns. One possibility is to label the tissue with 
anti-CD31 antibody so as to stain endothelial cells, which would allow visualization of the 
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limbal vasculature. Note we assume the tracer distribution represents AH flow patterns, 
which will also need to be further investigated. 
    In summary, we have shown encouraging preliminary data on novel protocols to image 
the detailed morphology and outflow patterns in whole mouse eyes. Importantly, our 
preliminary morphometric data has already brought insight into the previously unappreciated 
phenomenon of anterior chamber deepening in the mouse eye. Both techniques (OPT, 
Histo-Cutter) present major technical challenges, not least because of the small size of 
mouse eyes. Ongoing studies are aimed at optimizing the relevant protocols, so as to 
eventually be able to visually assess outflow patterns, their relationship to outflow resistance 
and their behaviour under pharmacological treatment.  
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Chapter 7: Generalisation of Goldman’s 
Equation to Account for IOP-Dependent Effects 
and Wash-Out 
 
 
1- Introduction 
    Goldmann‟s equation (Eq. 5) describes the relationship between parameters that 
determine IOP, including aqueous humour production (Fp), unconventional outflow (Fu), 
conventional outflow facility (C) and episcleral venous pressure (EVP): 
     
     
 
       
Equation 5 
This equation is commonly used to calculate conventional facility as the slope of a line 
regressed to the flow rate (Fp) vs. pressure (IOP) data (see Chapter 2, section 2.1). However 
it assumes conventional facility is constant, which is not necessarily true. In particular, 
conventional facility has been shown to depend on pressure and on the volume of perfusate 
in some studies on human and other types of eyes 76,206. More specifically, conventional 
facility decreases in human eyes at a rate of 1% per mmHg increase in IOP76, an effect 
attributed to the collapse of SC at high pressures195. Further, outflow facility has been shown 
to increase with increasing perfused volumes in bovine206,207 and monkey208,209 eyes. This 
phenomenon, termed washout, is possibly caused by a separation of the inner wall of SC 
from the JCT151. In bovine eyes, washout resulted into an increase in outflow facility of up to 
81% after 3 hrs of perfusion184. Interestingly, washout has been observed in all species 
studied to date, except for humans160 and mice12.  Despite experimental evidence showing 
that both pressure and washout can affect outflow facility, Goldmann‟s equation has never 
been modified to explicitly take these factors into account. Therefore, in this study, we 
propose a modified Goldmann‟s equation to include them. 
    This modification was further motivated by the non-linearity that we sometimes observed 
in our flow rate vs. pressure data, which is not predicted by Goldmann‟s equation. Usually, 
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we obtained a linear flow rate vs. pressure relationship, from which a constant slope could 
be interpolated to calculate C according to Goldmann‟s equation, see e.g. data from cohorts 
2 and 8 in Fig. 43, corresponding to C57BL/6 mouse eyes perfused at 35 °C from studies 
described in Chapter 2 and 4. However, cohorts of eyes from other studies belonging to the 
same strain of mouse and perfused under similar conditions behaved differently. For 
example, flow rates measured in eyes from Cohort 12 increased linearly with pressure until 
22 mmHg, after which they increased at a higher rate. This introduced a non-linearity in the 
flow vs. pressure data curve (dashed curve Fig. 43), not observed in cohorts 2 or 8. In the 
previous chapter, we showed that this effect might be attributable to AC deepening occurring 
at high pressures. Interestingly, Cohort 11 also shows a transition in flow rates, but at lower 
pressures (~ 15 mmHg), resulting in much higher flow rates than any other cohort at 25 
mmHg (red data point, Fig. 43).  
    Since flow rates measured at the same pressure seemed to behave so differently 
amongst apparently similar cohorts of mice, we investigated whether parameters other than 
pressure could be playing a role in this process. Interestingly, we found that the volumes of 
perfusion media delivered to eyes from Cohort 11 were higher than for any other cohort 
(Table 10). This suggested high volumes could have caused the large outflow facility 
observed in cohort 11, although the inverse could also be true, i.e. large volumes could have 
been caused by large outflow facility. This further prompted us to model volume and 
pressure effects in Goldmann‟s equation, to test whether they could explain the differences 
in our flow rate vs. pressure data between cohorts.  
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Figure 43:  Flow-Rate vs. pressure data for four different cohorts of C57BL/6 mice perfused under 
ostensibly identical conditions. The dashed curve is a nonlinear trend line fit to the data from Cohort 12, 
illustrating the nonlinearity observed in the data. The red data point correspond to a particularly high 
flow rate measured at 25 mmHg in Cohort 11 which differs strikingly from that of the other cohorts. 
Cohort 2 refers to data from Chapter 2, Cohort 8 to data from Chapter 4, Cohort 11 to data from Chapter 5 
and Cohort 12 to data from Chapter 6. All eyes were perfused at 35 °C with DBG while submerged in 
isotonic saline.  Bars are standard deviations. 
 C [μL/min.mmHg] V [μL] 
Cohort 2 (N= 6) 0.0172± 0.0028 25±16 
Cohort 8  (N = 9) 0.0147± 0.0029 14±3 
Cohort 11  (N =6) 0.0290 ± 0.0068 38±12 
Cohort 12 (N =5) 0.0155 ± 0.005 20±5 
 
Table 10: Conventional facility measured in cohorts of C57BL/6 mouse eyes perfused under apparently 
identical conditions (at 35 °C, submerged in isotonic saline).The highest volume perfused is highlighted 
in red and pertains to Cohort 11. Data are shown as mean ± standard deviations. C is conventional 
outflow facility, calculated according to the simplified Goldmann’s equation, and V is the volume 
perfused into the eye at the end of outflow facility measurement. 
 
    Thus, this chapter describes the development and evaluation of a modified Goldmann‟s 
equation. We hypothesise pressure and volume affects conventional facility, which could 
explain its variability between ostensibly similar cohorts of mice. The fit of the proposed 
modified equation is tested on our data to investigate whether it can better explain our 
measurements, specifically that of cohort 11. This meta-analysis pools all data reported in 
this thesis from C57BL/6 mouse eyes submerged in PBS and perfused at 35 °C with DBG. 
In addition, we analysed possible covariates such as gender, age and supplier that might 
have explained the variability in flow rate vs. pressure data between cohorts. 
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2- Methods 
2.1. Derivation of modified Goldmann’s equation 
    First, we model the dependence of conventional outflow facility (C) on intraocular pressure 
(IOP). Conventional outflow resistance has previously been shown to scale nearly linearly 
with IOP76.  Therefore we first express conventional outflow resistance as a linear function of 
IOP in Eq. 15, wherein β is a constant describing the proportional increase of Rc with 
increasing IOP, in units of mmHg-1:  
                               
Equation 15 
 
Rp0 represents the conventional outflow resistance extrapolated to zero pressure. Reported 
values for β in human, rabbit or bovine eyes range from 0.012 to 0.1 mmHg-1 76.  Note a 
positive value for β corresponds to an increase in Rc with IOP, while a negative value would 
represent a decrease in Rc with IOP. Since conventional outflow resistance corresponds to 
the inverse of conventional facility (i.e.    
 
 
), Eq. 15 can be rewritten as : 
   
   
       
 
Equation 16 
 
Note Cp0 is the inverse of Rp0 and represents conventional facility at extrapolated to zero 
pressure. Thus we obtain the following expression for the relative change of conventional 
outflow facility: 
 
 
   
 
 
       
 
Equation 17 
    
    Secondly, we introduce the effects of volume perfused, i.e. washout, on outflow facility. A 
previous study has demonstrated that outflow facility measured during perfusions scales with 
volume of the perfusate passing through the conventional outflow pathway (termed V) 206, as 
modeled by Eq. 18.  Cvo represents outflow facility measured with minimal or zero volumes 
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of perfusate (V), and α is a scalar describing the dependence of C upon V in units of μL-1.  α 
has been reported in bovine eyes to be 0.34*10-3 μL-1  206. 
 
                          
Equation 18 
 
This corresponds to a relative change in conventional facility described by Eq. 19: 
 
   
        
Equation 19 
 
We now combine the effects of washout and of intraocular pressure on outflow facility, such 
that C is a function of the perfused volume V and intra-ocular pressure IOP (Eq. 20): 
C= C (V, IOP) 
Equation 20 
 
We assume the effects of pressure and volume on conventional facility are additive, such 
that 
                       
Equation 21 
 
where f(V) and f(IOP) are equal to zero when V or IOP are zero, and C0 is outflow facility at 
zero pressure and volume perfused.  Note we assume the effects of perfused volume and 
IOP on facility are independent of each other. This is supported by a study showing, the 
washout rate was similar in bovine eyes at 6 and 15 mmHg206. No experiment, to our 
knowledge, has looked at effects of varying perfused volumes on changes in conventional 
facility with pressure. We assume the assumption of volume and pressure effects being 
independent holds true for mouse eyes, although this will need to be confirmed.  
  Thus, if we assume Cp0 =Cv0 = C0, for Equation 21 to be consistent with Equation 16 and 18, 
we have:    
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Equation 22 
 
        
 
       
 - 1 
Equation 23 
 
Substituting Equation 21 with Equation 22 and 23 yields: 
              
 
       
    
            
 
       
  
Equation 24 
 
Finally, we introduce Eq. 24 into Goldmann‟s equation adapted for enucleated mouse eyes 
(i.e. Fp=0 and EVP=0, cf. Eq. 8) 
          
 
       
          
Equation 25 
     
    Thus our modified Goldmann‟s equation (Eq. 26) contains four parameters, namely Co, Fu, 
β and α as opposed to the two parameters found in the original equation, C and Fu. Note Co 
is the reference outflow facility at zero pressure and zero volume perfused and does not 
equal C at the physiological state. Co would equal C at the physiological state if α= β=0. 
2.2. Testing the model viability with our data 
    In order to test the viability of our new model (Eq. 26), we performed a nonlinear fit of Eq. 
26 on our dataset. We also performed a linear fit to obtain the values of C and Fu that would 
have been obtained with the original Goldmann‟s equation (Eq. 8). The non-linear fit was 
done using Matlab‟s function Nonlinearmodel.fit (described below), while the fitting of the 
classical Goldmann equation was done using the MatLab function polyfit. Further, the non-
linear fit was performed when α and β were either simultaneously, or separately, set to zero. 
Finally, we tested whether the data were consistent with the predicted relationship of Eq. 26, 
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with all parameters (Co, Fu, β and α). For each analysis, we analyzed the values of the 
optimal values resulting from the fit, and whether they were statistically different from 0.   
    The function used for fitting our nonlinear model to the data was NonLinearModel.fit in 
Matlab. The function is asked to fit our F, IOP and V data (described below) to an equation 
of the form of Eq. 26, using initial guesses for each parameter. This function searches for 
values of parameters (in our case Co, Fu, β and α) that minimize the least square differences 
between the measured data and the values predicted by the model of interest. 
NonLinearModel.fit provides p-values to assess whether the estimates of the parameters are 
statistically significantly different from 0. Nonlinearnodel.fit reports the R2 coefficient for the 
best fit, describing the amount of variability in the data which can be described by the fit. 
However, the R2 value is known to automatically increase with the addition of parameters in 
the fit since a better fit can invariably be obtained by using more parameters. Thus, the 
values we show are the adjusted R2, which adjusts the fit by accounting for the number of 
parameters in the fit. In other words, the adjusted R2 will only increase if the R2 obtained with 
the additional parameter is larger than that expected based on the addition of any 
explanatory variable. Finally, Nonlinearmodel.fit can also provide the confidence interval for 
each parameter estimated by the best fit. We report the 95% confidence interval, such that 
there is less than 5% chance that the estimated parameter does not fall within that interval. 
The greater the variability of the parameter, the larger the confidence interval. 
    The initial guesses used for the parameters Co, Fu, β and α are listed in Table 11, which 
were chosen according to values found in the literature 15,76,206.  Note the initial value for β 
was set as negative because we have observed an increase in outflow facility with pressure 
in Cohort 12 (cf. Chapter 6). We also tested positive initial values for β (i.e. either -0.01 or 
0.01, table 11). In order to test the robustness of our model, we performed the fit with 
different initial values, increasing or decreasing each one by a factor of ten (see table 18, 
results section). No constraints were imposed on the predicted optimal values of the 
parameters Co, Fu, β and α.  
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 Initial values 
Co [μL/min.mmHg] 0.01 
Fu[μL/min] 0.01 
β [mmHg -1] -0.01 or 0.01 
α [μL -1] 0.01 
Table 11: Initial values used to search the optimal fit to our data with NonLinearModel.fit 
 
    All data used for fitting were taken from the custom Labview perfusion software151. The 
IOP data corresponds to the pressure level imposed during perfusions (4-40 mmHg). The 
software calculates the volume perfused, V, by numerically integrating the flow rate data 
over time. We use the average of the flow rate data (F) acquired at each steady pressure 
level (see Fig. 8, Chapter 2), and the total volume (V) perfused at the end of each pressure 
level.  For Cohort 11, we needed to account for the volume perfused during their pre-
pressurization step at 8 mmHg for 60 min with a PBS-filled reservoir before the perfusion. 
We estimated this volume using the conventional facility measurement performed at 8 
mmHg, assuming conventional facility did not change between the start of the pressurization 
and the flow rate measurement at 8 mmHg. This assumption seems reasonable since the 
volume perfused between the pre-pressurization step and the measurement of conventional 
facility at 8 mmHg was small, on average 1.27±0.64 µL. 
    This analysis considers each pressure measurement of each eye from cohorts 2, 8, 11 
and 12 individually. Note data from only one eye per animal was used in this study. This was 
because they correspond to untreated eyes from different studies, whose contralateral eyes 
typically received a different solution. Thus, data from their paired eyes were not considered 
in this meta-analysis, since they were treated differently. A total of 118 data points were 
used in this analysis, each of which was associated with a pressure level, a flow rate and a 
volume of perfused solution. In three cohorts of eyes (cohorts 2, 8 and 11), 3-4 data points 
belonged to the same eye; in cohort 12, 12 data points were measured in the same eye 
because perfusions were done up to 40 mmHg.  
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2.3. Analysis of the effects of age, gender and supplier 
    In order to investigate whether potential difference in age, gender or animal supplier could 
influence the variability observed in outflow facility between cohorts, we pooled our outflow 
facility data according to these variables and compared them between groups. The supplier 
was either Jackson laboratory (UK) or Charles River (UK). Mice were aged from 5 to 29 
weeks. Unfortunately, all mice from Jackson‟s laboratories were female and all mice from 
Charles River were male, which made it impossible to distinguish between supplier or 
gender effects. The comparison of outflow facility data between mice of different gender, 
supplier or age was made with 2-sided unpaired t-tests. In addition, we tested whether the 
slope of the best-fit linear trend line for the conventional facility vs. age data was significantly 
different from 0 with a two-sided t-test. For this analysis, data from both males and females 
was used together.  
3- Results 
3.1. Non linear vs. linear model 
    Using the function polyfit, we found the optimal values for the parameters in the classical 
Goldmann‟s equation listed in Table 12.  
 
 
 
 
 
 
 
 
 
 
 
Table 12: Values for the estimated parameters and R
2
 from the linear fit (i.e. Goldmann’s equation, Eq. 8) 
with polyfit. 
 
    Using the function Nonlinearmodel.fit, we fit an equation of the form of Eq. 26 with the 
constraints that α=β=0, thereby reducing it to the classical Goldmann‟s equation (Eq. 8). In 
this case, we obtained identical values for Co, Fu as were obtained for the previous linear fit 
(Table 13). Note in this case, we report the adjusted R2, for comparison with the following 
models with additional parameters (see Methods). In the previous analysis we reported the 
 Optimal values  
Fu [μL/min] -0.0454 
C 
[μL/min.mmHg] 
0.0178 
R2 0.753 
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R2, explaining why they are not exactly the same (0.753 vs. 0.751 for the R2 from the 
previous analysis and the adjusted R2 for the current analysis). Both parameters Co and Fu 
were statistically different from 0. As previously indicated (Fig. 43), flow rate values from 
cohort 11 seem to be considerably larger than that of other cohorts, and not particularly well 
explained by the linear fit (as shown by the arrows in Fig. 44). The linear fit predicts that Fu is 
negative, suggesting somewhat unrealistically an inward-directed unconventional outflow.  
Table 13: Values for the estimated parameters and the adjusted R
2
 from the nonlinear fit with α=β=0. P-
values lower than 0.05 indicate parameters that are statistically different from 0. CIs are confidence 
intervals reported for each optimal value. 
 
Figure 44: Nonlinear fit to the modified Goldmann’s equation, where α=β=0. The fit was performed on 
flow rate vs. pressure data comprising data points from cohort 2,8,11 and 12. The red line corresponds to 
the best fit using the nonlinear model with when α=β=0 (Eq. 26), and blue points represent the raw data.  
Note that the non-linear model produces the identical fit as the linear model when α=β=0. Arrow heads 
point to data points from cohort 11 at 25 mmHg, which seem to diverge from the prediction shown in red.  
 
    We next fit an equation of the form of Eq. 26 with the parameters Fu, Co and β but with α 
set to zero (Table 14). This case is motivated by the putative observation that washout does 
not occur in enucleated mouse eyes, which is consistent with α = 012. In this case, we obtain 
a statistically significant Co value, which at 8 mmHg corresponds to a facility of 0.0120 
Nonlinear model 
α=β=0 
Optimal values P-values CI 
Fu [μL/min] -0.0454 0.01456 -0.0816   -0.0091 
Co [μL/min.mmHg] 0.0178 4.58*10
-37 0.0160    0.0197 
Adjusted R2 0.751   
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μL/min.mmHg (using Eq. 16), which is similar to that obtained with the original Goldmann‟s 
equation (0.0178 μL/min.mmHg; tables 12&14) and in the physiological range.  The optimal 
value for β was also significantly different from 0. It was negative, indicating facility increased 
with pressure, consistent with our previous data indicating AC deepening at high pressures 
(Chapter 6). In contrast, Fu was not statistically different from 0. The adjusted R
2 value for 
this model was 0.763, only moderately higher than that of the previous model. Note this 
increase cannot be attributed to the addition of a parameter in our fit, because that is taken 
into account by the adjusted R2 value. Thus, our findings suggest that a model taking into 
account only pressure effects could explain relatively well our data but caused the intercept 
(or Fu) to disappear. Yet, it still does not explain the very high flow rates from cohort 11, 
shown in Fig. 45 by the arrow heads. 
Table 14: Values for the estimated parameters and the adjusted R
2
 from the nonlinear fit with α=0. P-
values lower than 0.05 indicate the parameters are statistically different from 0. CIs are confidence 
intervals reported for each optimal value. 
 
Figure 45: Non linear fit to the modified Goldmann’s equation, where α=0. The fit was performed on flow 
rate vs. pressure data comprising data points from cohorts 2,8,11 and 12. The red curve corresponds to 
the best fit using the nonlinear model with α=0 (Eq. 26), and blue points represent the raw data.  Arrow 
heads point to data points from cohort 11 at 25 mmHg, which seem to diverge from the fit shown in red.  
Nonlinear model 
α =0 
Optimal values P-value CI 
Fu [μL/min] 0.0068 0.76 -0.0385    0.0522 
Co [μL/min.mmHg] 0.0110 5.03*10
-8 0.0073    0.0147 
β [mmHg -1] -0.0104 0.0002 -0.0158   -0.0050 
Adjusted R2 0.763   
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    We further analyzed the fit of Eq. 26 with the parameters Fu, Co and α, but with β set to 
zero (Table 15). Similarly to our previous analysis, Fu was not statistically different from 0, 
but Co and α were significantly different from zero. Co is very similar to that found when α 
was set to zero (0.0104 vs. 0.0110 μL/min.mmHg; tables 14&15). The value of α is larger 
than values previously reported in the literature (α =0.0003 μL -1 206), possibly suggesting an 
unanticipated washout effect in mice12. The adjusted R2 value for this model was 0.82, 
relatively higher than that obtained by either previous analyses (Table 13&14). Note this 
increase in R2 compared to that obtained with only two parameters (Table 12) cannot be 
attributed to the addition of a parameter in our fit, because that is taken into account by the 
adjusted R2 value. Thus, our findings suggest that a model taking into account only volume 
pressure effects could also explain well our data. However, it still does not explain the very 
high flow rates from cohort 11, shown in Fig. 46 by the arrow heads.  
Table 15: Values for the estimated parameters and the adjusted R
2
 from the nonlinear fit with β=0. P 
values lower than 0.05 indicate the parameters are statistically different from 0. CIs are confidence 
intervals reported for each optimal value. 
Nonlinear model 
β =0 
Optimal values P-value CI 
Fu [μL/min] 0.0214 0.26 -0.0157    0.0586 
Co [μL/min.mmHg] 0.0104 2.83*10
-11 0.0076    0.0131 
α[μL -1] 0.0136 0.0004 0.0062    0.0210 
Adjusted R2 0.817   
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Figure 46: Non linear fit to the modified Goldmann’s equation, where β=0. The fit was performed on flow 
rate vs. pressure data comprising data points from cohorts 2,8,11 and 12. The filled red circles 
corresponds to the best fit using the non linear model with β=0 (Eq. 26), and blue empty circles represent 
the raw data.  Arrow heads point to data points from cohort 11 at 25 mmHg, which seem to diverge from 
the fit shown in red 
 
    Since both models considering either volume or pressure effect caused the intercept (or 
Fu) to become not statistically different from 0, we now consider the non linear model with α, 
β  and Co  but where Fu is set to zero.  Further, our analysis showed that the optimal value 
for Fu differed three fold between the analyses considering either volume or pressure alone, 
while Co varied only by 10%. This suggests the nonlinear effects of pressure or volume may 
artificially give rise to the appearance of a non-zero intercept in the F vs. IOP relationship, 
which could be wrongly interpreted as Fu. For these reasons, Fu was eliminated from the 
next analysis by setting it to zero. 
    When a non linear fit was performed with Fu set to zero, we obtained optimal values for Co 
and α which were statistically different from 0, while that of β was not (table 16). The value 
found for Co corresponded to a C at physiological pressure of 0.0141 µL/min.mmHg.  This is 
consistent with in vivo values reported in the literature5,6,9,10,14,15,102 and was close to the 
original value found with Goldmann‟s equation (0.0178 µL/min.mmHg table 12). The optimal 
value for α is still somewhat larger than that found in bovine eyes. In this case, the non linear 
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fit explains 83% of the variation seen in the data, but still fails to predict the high flow rates 
from cohort 11 (Fig. 47). This adjusted R2 value was relatively higher than the two first 
analyses (Table 13&14), but very similar to the model wherein β was set to zero (Table 15).  
These results suggest our data is consistent with a model where washout causes high flow 
rates and high C at large perfusion volumes.    
Table 16: Values for the estimated parameters and the adjusted R
2
 from the nonlinear fit with Fu=0. P 
values lower than 0.05 indicate the parameters are statistically different from 0. CIs are confidence 
intervals reported for each optimal value. 
 
Figure 47: Non linear fit to the modified Goldmann’s equation, where Fu=0. The fit was performed on flow 
rate vs. pressure data comprising data points from cohorts 2,8,11 and 12. The filled red data points 
corresponds to the best fit using the non linear model with Fu=0, and blue points represent the raw data.  
Arrow heads point to data points from cohort 11 at 25 mmHg, which seem to diverge from the fit shown 
in red 
 
    Finally, we performed the non linear model with all four parameters (Table 17), i.e. 
including Fu. In this case, none of the parameters are statistically different from 0. The 
adjusted R2 value was relatively higher than the two first analyses (Table 13&14), but very 
similar to the model wherein β or Fu were set to zero (Table 15&16).  More importantly, the 
Nonlinear model 
Fu  =0 
Optimal values P-value CI 
Co [μL/min.mmHg] 0.0170 1.75*10
-6 0.0103    0.0236 
β [mmHg -1] 0.0257 0.13 -0.0075      0.0589 
α[μL -1] 0.0104 6.03*10-9 0.0071   0.0136 
Adjusted R2 0.828   
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values for Co and Fu changed significantly from those found in the previous analyses where 
either α, β or Fu were constrained to equal zero (Tables 14-16). Further, in this case β was 
positive, indicating a decrease of facility with pressure, which disagrees with what we 
observed in cohort 12 (Chapter 6). These discrepancies further motivated the use of a model 
where Fu is not considered. 
Table 17: Values for the estimated parameters and the adjusted R
2
 from the full non-linear fit. P-values 
lower than 0.05 indicate the parameters are statistically different from 0. CIs are confidence intervals 
reported for each optimal value. 
 
 
Figure 48: Non linear fit to the modified Goldmann’s equation. The fit was performed on flow rate vs. 
pressure data comprising data points from cohorts 2,8,11 and 12. Red points correspond to the best fit 
model calculated by NonLinearModel.Fit and blue points represent the raw data.  Arrow heads point to 
three data points from cohort 11 at 25 mmHg, which seem to diverge from the nonlinear fit shown in red.  
 
Nonlinear model 
 
Optimal values P-value CI 
Fu [μL/min] -0.0847 0.30 -0.2448    0.0753 
Co [μL/min.mmHg] 0.0381 0.19 -0.0196    0.0958 
β [mmHg -1] 0.0718 0.27 -0.0558    0.1995 
α[μL -1] 0.0048 0.15 -0.0018    0.0115 
Adjusted R2 0.831   
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    Taken together, our analyses suggest our data cannot be explained by a combination of 
both volume and pressure effects, either when Fu is considered or not. We further 
investigated whether there was any combination of α and β which could explain our data 
within a domain of varying values of α and β. Thus, we computed the sum of squared 
differences between the measured and predicted data by plotting the sum of squared 
differences over a range of values for α and β to directly visualize for which parameters of α 
and β the sum of squared difference was the smallest in the domain of interest. The aim was 
to investigate whether there were other minima in the vicinity of the optimal values found by 
our previous analyses, which could have corresponded to values of α, β, Co and Fu  wherein 
both volume and pressure effects where statistically different from 0. This analysis was 
performed for values of α and β neighbouring the optimal values determined from the two 
previous analyses, where either α or β was set to zero (see tables 14&15). This was done 
both with and without considering Fu in the non linear model. The values of Co and Fu were 
fixed and chosen according to the optimal values found in the analysis wherein α and β were 
separately set to 0 (Table 14&15). Interestingly, in both cases, we observed the landscape in 
the domain was flat (Fig. 49, white region). The flat landscape suggests that there are a wide 
range of α and β parameters that produce equivalent fits. In other words, with our current 
data set, it is not possible to distinguish the non-linear effects arising from volume or 
pressure effects.  
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Figure 49: Sum of squared difference between the flow rate data measured and that predicted by our 
nonlinear model either with (A) or without (B) considering Fu, using a range of α (x-axis) and β (y-axis) 
parameters. The clear white regions correspond to the lowest sum of squared differences. In panels A 
and B, the value used for Co was 0.0104 µL/min.mmHg taken from the analysis where β was set to zero. In 
A, the value for Fu was 0.0214 µL/min taken from that same analysis (table 15). 
 
A 
B 
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    In summary, using a linear model (Goldmann‟s equation), both C and Fu are statistically 
different from 0. In contrast, Fu was not statistically different from 0 when either only α or β 
were considered in the nonlinear model (Eq. 26). Thus we performed the analysis setting Fu 
is equal to zero, in which case only the volume effects were significant. Thus, our current 
dataset seems to be explained by volume effects rather than pressure effects. Yet, even in 
that case, there seems to be numerous combinations of α or β which give the same 
predictions, suggesting our model might not be able to distinguish between the two effects. 
    Finally, we repeated the nonlinear fit with the model without Fu (i.e. with α, β or Co) using a 
range of initial guesses, to investigate how consistent our results were. Table 18 lists the 
values of the estimated parameters for each analysis where only one initial value has been 
changed (i.e. either α, β or Co). Interestingly, the estimated parameters are similar for most 
of the proposed changes to the initial values. Only the tenfold decrease of the initial guess 
for β parameter caused a significant change in the estimated parameters as well as a 
decrease in the adjusted R2 value (red highlights in Table 18). This repeatability of the 
results over a range of initial guesses suggests they correspond to the global solution, as 
suggested by our previous analysis showing only one minimum in the landscape of the sum 
squared differences in predicted and measured flow rates (Fig. 49).  
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 Original 
initial 
values 
Increasing one initial value at a time by tenfold 
Optimal 
values 
Co=α =0.01  
β =-0.01 
Fu=0 
Co 
=0.1 
β=-0.1 α=0.1 Co 
=0.001 
β=-
0.001 
α=0.001 
Co 
[μL/min.mmH
g] 
0.0170 0.0170 -0.004 0.0170 0.0170  0.0170  0.0170 
β [mmHg -1] 0.0257 0.0258 -0.0471 0.0257   0.0257   0.0257    0.0258 
α[μL -1] 0.0104 0.0104 -0.9727 0.0104   0.0104    0.0104    0.0104 
Adjusted R2 0.828 0.828 0.44 0.828 0.828 0.828 0.828 
 
 Original 
initial 
values 
Increasing one initial value at a time by tenfold 
Optimal 
values 
Co=α 
=0.01  
β =0.01 
Fu=0 
Co =0.1 β=0.1 α=0.1 Co 
=0.001 
β=-
0.001 
α=0.001 
Co 
[μL/min.mm
Hg] 
0.0170 0.0170 0.0170 0.0170 0.0170  0.0170 0.0170 
β [mmHg -1]     0.0258     0.0258  0.0258  0.0258   0.0257    0.0258    0.0258 
α[μL -1]     0.0104     0.0104  0.0104  0.0104   0.0104    0.0104    0.0104 
Adjusted R2 0.828 0.828 0.828 0.828 0.828 0.828 0.828 
 
Table 18: Values of the optimal values for the parameters from the nonlinear fit (with Fu=0) and adjusted 
R
2
, when the initial value of either Co, α, or β are increased or decreased10-fold. The first table uses 
negative values for β while the second table uses positive values. Only the increase in β seems to affect 
the estimated parameters as well as the adjusted R
2
 value (shown in red).  Note that in each case, α and 
Co were statistically different from 0 but β was not. 
3.2. Effects of gender/supplier and age on C 
    We also analysed the possible effects of gender and supplier on outflow facility, which 
could not be separated because all mice supplied by Jackson Laboratories were female 
whereas all mice provided by Charles River were male. Fig. 50 shows conventional facility 
seemed to be lower in female mice provided by Jackson Laboratories compared to males 
supplied by Charles River. The differences was statistically significant (p= 0.0086; unpaired 
t-test). Note that this is a meta-analysis pooling data acquired in ostensibly similar animals 
and experiments, which were however not performed at the same time. This should 
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therefore be confirmed by perfusing, at the same time, mouse eyes from either female or 
male C57BL/6 from the same supplier. 
 
Figure 50: Conventional facility shown by gender or supplier. Bars are SEM. All male mice were supplied 
by Charles River (Crl) while all female animals were supplied by Jackson’s laboratories. 
 
    Older animals seemed to show a decreased conventional facility, as shown by Fig. 51. 
Yet only 11% of the variability of our data could be explained by this correlation, which was 
not statistically significant (p = 0.14; two-sided t-test). No animals older than 30 weeks were 
used in any of our studies. Our results suggest facility could decrease by 1.2% per week 
(assuming the reference facility at birth is the intercept, i.e. 0.0249 μL/min.mmHg). We also 
show that most data points from young animals also correspond to male animals. Thus, in 
this study, they would have a higher conventional facility than females as observed 
previously (Fig. 50) Thus, the difference observed in conventional facility between genders 
could be attributed mostly to changes in age rather than gender. Inversely, the difference 
observed in conventional facility with age could be attributed to changes in gender. 
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Figure 51: Conventional facility as a function of the age of the animal at the time of enucleation. Each 
data point represents conventional facility measured ex vivo in one eye of the animal. Data from only one 
eye per animal was used. Filled data points correspond to males, while empty diamonds belong to 
females. 
4- Discussion 
    In this chapter, we modify Goldmann‟s equation to account for both pressure-dependent 
resistance and perfused volume effects. We show our data in enucleated mouse eyes is 
most specifically explained by volume rather than pressure effects. This however should be 
further investigated, as discussed below, especially in light of previous studies showing a 
lack of washout in mice12 and the anterior chamber deepening we observed histologically 
(Chapter 6, Fig. 38). Alternatively, it is possible that our model is unable to distinguish 
between the two nonlinear effects because of the presence of points with both high IOP and 
high volumes perfused. Interestingly, our analysis shows the nonlinear effects of pressure or 
volume might artificially give rise to a non-zero intercept, or Fu. Thus, our findings suggest 
nonlinear volume effects should be taken into account in future perfusion studies to 
understand the actual contribution of Fu in mouse eyes. In any case, our work paves the way 
for a more generalized Goldmann‟s equation which could be used for perfusion studies in 
other species too. 
    In our analysis, we show that when Fu is set to zero, our data is best predicted by volume 
effects (i.e. only α, and not β, was statistically different from 0). Yet we also show that a 
range of values for α and β yield similar predictions, suggesting our data set might not be 
C = -0.0003 x number of weeks + 0.0249 
R² = 0.1148 
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able to distinguish between the two effects. This is likely caused by our dataset containing 
few points with either high pressure and low volume perfused, or low pressure and large 
volume perfused, while containing points having both high IOP and large perfused volumes. 
Data points with both a high IOP and large perfused volumes could have a high leverage on 
both estimated parameters α and β, and thus provide leverage on whichever effect is 
modeled. This is further supported by our separate analyses wherein either α or β were 
considered. In each case, the best nonlinear fit found that either volume or pressure effects 
explained our data (i.e. α or β were statistically different from 0).  This should be therefore 
tested by fitting the model to data wherein each effect is represented independently, i.e. in 
eyes perfused at high pressures with low volumes or eyes at low pressure with large 
volumes.  
    Alternatively, perhaps pressure and volume effects on conventional facility interact, i.e. 
they affect each other. This was not modeled in our equations, and could therefore justify 
why our model fails to find specific parameters for both α and β that explain our data. Note 
however, that it was shown the washout rate did not change in bovine eyes at 6 vs. 15 
mmHg206. This further suggests investigating whether such an interaction occurs in mice, by 
perfusing eyes at pressures subject to AC deepening or not, with a large volume of perfusate. 
Further, eyes perfused with small or large volumes at a high pressure prone to AC 
deepening would be analyzed morphologically as previously shown (Chapter 6) to 
investigate whether volume affects AC deepening. 
    The values found for C, β and α from the analyses which considered pressure and volume 
effect separately, or together when Fu was set to zero (Table 16) agreed well with previous 
reports from other species (Table 14&15). At 8 mmHg, conventional facility was 0.0141 
µL/min.mmHg (calculated using Eq. 16, table 16), which is consistent with published values 
(0.005-0.018 µL/min.mmHg5–11,14–16). The parameter describing the change of conventional 
facility with pressure, β, was found to be 0.0257 mmHg-1, which has the same order of 
magnitude of previously reported values for bovine or human eyes (0.012-0.1 mmHg-1 76). 
Note however it is positive, suggesting a decrease in facility with pressure, unlike what was 
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observed in Cohort 12 (Chapter 6). Finally the parameter describing the washout rate, α, 
was found to be 0.0104 μL-1 which is larger than that found in bovine eyes (0.0003 μL-1 206). 
Assuming a typical perfusion rate of 8 µL/min in bovine eyes150 at 10.7 mmHg (inferred from 
data in Gual‟s paper as the facility measurement, 0.73 uL/min.mmHg, multiplied by the 
perfusion pressure, 10.7 mmHg), this would correspond to a 14% increase in flow rates after 
1 hr of perfusion at 11 mmHg, compared to an 8% increase in mouse eyes after 1 hr of 
perfusion at a rate physiological inflow rate of 0.13 μL/min at 8 mmHg (see Cohort 2). More 
specifically, this would represent a 1% increase in conventional facility per μL perfused in 
mice, or an estimated 26% over a typical perfusion where 25 μL of perfusate is injected.  At 
8 mmHg, this would result in the increase of flow rate from 0.123 μL/min (measured at 35 °C 
in eyes immersed in isotonic saline Fig. 11) to 0.155 µL/min after perfusing 25 µL. This 
increase of 0.032 µL/min could be too low to appreciate since it is in the range of the 
standard deviation of the flow rates at 8 mmHg which were 0.043 µL/min (Fig. 11). This 
could explain why no washout has been detected so far in mouse eyes. 
    It was interesting to observe that the parameters of our model became statistically 
different from 0 when α or β was set to zero, except for Fu. This suggests enucleated mouse 
eyes do not demonstrate unconventional outflow, as indicated by our previous findings in 
Chapter 2, wherein Fu was shown to disappear in eyes immersed in isotonic saline (Fig. 10). 
This could be consistent with the concept of unconventional outflow relying on uveal 
reabsorption34. More specifically, following enucleation and the stoppage of blood perfusion, 
there could be an equilibration of osmotic pressure across the uveal capillaries, thus 
stopping absorption of unconventional outflow into the uveal circulation. Note however Fu 
has been previously measured in enucleated human, monkey or porcine eyes 65,145,155.  
Perhaps Fu still exists immediately after death but disappears as the osmotic pressure 
gradient across the uveal capillaries equilibrates in the lack of blood perfusion. Further, 
perhaps this equilibration occurs more quickly in the smaller mouse eye, thus leading to the 
extinction of Fu. This could possibly be tested by measuring aqueous humour outflow at 
different pressure levels in enucleated porcine eyes at different time points post mortem for 
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an extended period of time, in the hope of seeing a decrease in unconventional outflow with 
time associated with an equilibration of osmotic pressure across the uveal capillaries. 
    We also considered other effects such as age, supplier and gender in our meta-analysis. 
We observed a significant effect of gender or supplier on facility, although it is not clear 
whether they are both affecting outflow facility because all male animals in this study were 
provided by the same supplier, while all females were obtained from the other supplier. 
Although no study has examined gender-related differences in outflow facility, it has been 
shown IOP is higher in female patients210,211, which could potentially correspond to a lower 
conventional facility, as observed in this study. Finally, the effects of age on outflow facility 
have never been measured in mice but it is known that facility decreases with age in 
humans73,212,213. Therefore, our data would agree with such results and further consolidate 
the mouse as a good model for human AH outflow.  
    In summary, we propose a novel equation to account for two important phenomena, 
namely washout and pressure effects on outflow facility. This represents an improvement 
which could be applied to eye perfusions in general. Yet, it did not seem to be particularly 
powerful for our data in enucleated mouse eyes. Rather, we found that only volume effects 
specifically explained our data. This however contradicts a previous study showing there is 
no washout in mice12, and our findings about AC deepening occurring in mice at high 
pressures (Chapter 6). Thus we suggest our model is perhaps not able to differentiate 
between these effects with the current dataset for reasons described above. In addition, our 
model did not seem to explain the particularly high flow rates found in cohort 11. This 
suggests other effects might be at play, or perhaps this cohort of mice presented particular 
characteristics. Taken together, this suggests important variability in conventional facility can 
arise between mice either because of intrinsic (e.g. age, gender) or extrinsic (e.g. perfusion 
system or solution, success of cannulation) factors which are difficult to account for. This 
highlights the importance of studying conventional facility within cohorts of mice used under 
the most similar conditions possible, and makes post hoc comparisons between cohorts of 
mice from different studies more complex and unreliable. 
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Chapter 8: Conclusions 
8.1. Summary  
 
    Throughout this project, we have developed the mouse as a valid and useful model for 
investigating IOP generation and regulation as occurs in the human conventional outflow 
pathway. Numerous studies were performed to improve our understanding of outflow 
resistance in the mouse eye, resulting in various interesting contributions described below. 
    We first presented an improved perfusion system for measuring conventional 
outflow facility in enucleated mouse eyes in a physiologically-relevant manner. More 
specifically, we included control of hydration and temperature of the tissue during perfusion. 
Conventional facility was shown to compare well to that previously measured in vivo5–11,14–16, 
while unconventional outflow was shown to be highly influenced by hydration. This marked 
sensitivity of unconventional outflow to hydration prompted us to focus on conventional 
facility for the rest of the studies. Importantly, we showed that long post mortem times affect 
conventional facility as shown by a previous study150, emphasizing the benefits of using 
mouse eyes which can be obtained immediately after death, as opposed to human eyes 
which are typically obtained up to 48 hrs post mortem77. In addition, we show paired mouse 
eyes have very similar conventional facility when measured within 3 hrs, so that one eye can 
be used as a control for its contralateral eye. 
    We then showed that two receptor-mediated drugs (S1P, EP4 agonist 3,7-dithisPGE1) 
either increased or decreased conventional facility in the mouse to a similar extent as 
the response reported in human eyes79,80,86. This demonstrated the mouse acts as a 
suitable model for studying the pharmacology of human conventional facility, thereby 
encouraging its use for testing other drugs for preventing glaucoma. In addition, we show 
pharmacological effects are reduced by long post mortem times, confirming the importance 
of using fresh tissues for perfusion studies. 
    In a third study, we demonstrated that different strains of mice (BALB/cJ, C57BL/6J, 
CBA/J) show distinct IOPs because of corresponding differences in conventional 
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facility. This suggests conventional facility is an important determinant of IOP in mice, as 
observed in humans. Importantly, our results warrant further research into the genetic 
differences between the studied strains which could underlie their different conventional 
facilities. 
    In a fourth study, we provided the first evidence of metabolic activity associated with 
outflow facility. More specifically, our results suggested that 30% of conventional facility is 
dependent on metabolic energy. This represents a novel insight into the process of outflow 
facility generation, which has commonly been assumed to be passive77,78.  
    In a fifth study, we provide data showing conventional facility increases with pressure 
in mice, as opposed to what happens in humans. Although initially worrisome for the validity 
of the mouse model, our histological analysis suggests this effect is probably explained by 
an artefact previously reported in humans, known as anterior chamber deepening89,195. 
Although this needs to be further investigated, it suggests the fact that conventional facility 
increases with pressure in mice is an artefact. This further suggests mice do not differ from 
humans and can continue to be used in perfusion studies. Note however preventing AC 
deepening in mouse eye perfusions might require non trivial protocol optimization. Lastly, we 
describe two novel protocols (Histo-Cutter196 and Optical Projection Tomography197) which 
could pave the way for visualizing morphology and outflow patterns in 3D across the entire 
intact mouse eye.     
    Finally, we report a high variability in conventional facility between cohorts of mice, which 
we hypothesized might be caused by effects of perfusate volume or perfusion pressure. 
Thus, we proposed modifications to Goldmann’s equation such that both pressure and 
volume effects on conventional facility are taken into account. Although the modified 
equation failed to account for the differences in flow rate between cohorts, it potentially 
explained better our data in the high pressure range. We show our data in enucleated 
mouse eyes is most specifically explained by volume rather than pressure effects, although 
this will require experimental evidence. This prompted us to investigate other effects which 
might explain the different conventional facility across cohorts, and we concluded that age 
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and gender may be important factors. Altogether, our data highlights the advantage of 
performing paired eye studies, wherein each eye is compared to its contralateral eye to 
minimize variability.  
    Overall, our findings emphasize the suitability of mice as models for studying the 
physiology and pharmacology of human conventional facility. We shed light on important 
phenomenon related to all mouse eye perfusions (both in vivo and ex vivo) which have been 
so far ignored (e.g. hydration or AC deepening) as well as factors which can influence 
conventional and unconventional outflow (Table 19). An open question remains about the 
nature of unconventional outflow in mice, which should be answered to ultimately determine 
whether it also mimics that of humans. Still, we also present novel tools which could be used 
to visualize unconventional outflow, so as to answer more fundamental questions related to 
AH outflow in mice.  
 Conventional facility, C Unconventional outflow, 
Fu 
Hydration (Ch. 2)  More physiologic hydration 
decreases Fu 
Temperature (Ch. 2) Increasing temperature increases C  
Sphingosine-1-
phosphate (Ch. 3) 
Decreases C  
Dithia-PGE4 (Ch. 3) Increases C  
Metabolic inhibitors 
(Ch. 5) 
Decrease C  
Anterior chamber 
deepening (Ch. 6) 
Increases C  
Age (Ch. 7) Older mice have decreasing C  
Gender (Ch. 7) Females have lower C  
Table 19: Factors affecting conventional facility and unconventional outflow in mice. Age and gender 
effects are in italic because they were only indirectly suggested by our meta-analysis, and would need 
further testing. Next to each effect is written the chapter where it was reported. In addition, conventional 
facility was shown to depend on the strain of the mouse (Ch. 4). 
8.2. Recommendations for future work 
    The data acquired during this project raises many interesting questions which could be 
answered with the technology validated in the present study. In this section, we propose a 
number of ideas for future work, each motivated by a different chapter. 
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8.2.1. Unconventional outflow 
    In Chapter 2, we showed unconventional outflow (Fu) was eliminated in enucleated mouse 
eyes immersed in isotonic saline. This warrants studies to elucidate the role of 
unconventional outflow in mouse eyes. Importantly, this raises questions both in vivo and ex 
vivo: first, what is the fraction of unconventional outflow in living mice, and second whether 
enucleation alters unconventional outflow.  
    A first interesting study would consist of testing whether hydration affects Fu in living mice, 
similarly to what we show in enucleated mouse eyes. Our data suggested Fu might have 
been an artefact from evaporation in enucleated mouse eyes. This could also occur in in vivo 
perfusion, wherein eyelids are typically maintained open for facilitating cannulation. This 
exposes a large portion of the cornea, which can potentially suffer from evaporation. 
Therefore, we suggest in vivo perfusions could be performed with and without PBS dropped 
onto the cornea to examine resulting changes in Fu.  
    On the other hand, outflow patterns through the unconventional pathway could be directly 
visualized by analyzing the trajectory of fluorescent tracers injected into the eye. Tracers 
could be perfused in eyes from anaesthetized animals, which could be imaged in 3D with 
OPT following death and enucleation as described in Chapter 6. More specifically, this would 
allow examining the hypothetical pathway for unconventional outflow through the ciliary 
muscle into the suprachoroidal space. However, this will require protocol optimization to 
better visualize the morphology of the limbus, but could eventually shed light into the 
existence of Fu in mouse eyes. Similarly, eyes perfused with tracers in vivo with and without 
hydration could confirm whether hydration affects outflow patterns in the unconventional 
pathway. 
    In order to understand the effects on Fu of enucleation and halting blood supply to the eye, 
we propose AH outflow is measured in vivo and compared to that of their contralateral 
enucleated eyes. Note AH outflow measurement in vivo would require the measurement of 
EVP or Fp, as done in previous studies
5,6.This should reveal whether Fu changes following 
death and enucleation. A previous study has shown Fu does not change immediately after 
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death in eyes which were left in the cadaveric mouse6. Yet, this does not per se provide 
information about what happens to of Fu following enucleation. This is important to ultimately 
validate our ex vivo model for unconventional outflow. Once more, perfusion studies using 
fluorescent tracers could be performed to reveal different outflow patterns in vivo vs. ex vivo 
to directly assess changes in unconventional outflow.  
8.2.3. Studies on inter-strain differences in conventional facility 
    The finding that different strains of mice possess different conventional facility raises the 
possibility of corresponding morphological differences in the outflow pathways. For example, 
SC in BALB/cJ, C57BL/6J and CBA/J strains could be imaged and analysed so as to reveal 
whether there exist structural differences that could explain changes in conventional facility. 
This could be done with the Histo-cutter, as shown in Chapter 6, allowing the analysis of SC 
in 3D. 
    Finally, we also report an IOP in CBA/CaJ significantly lower than that reported by 
Savinova141, which could stem from our mice being much younger than those used in that 
study (Chapter 4). Thus, our data motivates research into effects of age on IOP in mice. 
Similarly, our meta-analysis warrants research into the effects of age on conventional facility 
(Chapter 7). Our findings suggest conventional facility decreases with age, as observed in 
humans73,212,213. Furthermore, our post hoc analysis suggests conventional facility might be 
dependent on gender, or on the supplier, which could also be investigated.  
8.2.4. Metabolic study 
    In Chapter 5, we show anti-metabolic agents (2-deoxy-D-glucose and sodium azide) 
decrease conventional facility. Strikingly, this contradicts a previous study which showed 
total outflow resistance was unaffected in bovine eyes by several anti-metabolic agents78, 
even though one of the anti-metabolic agents was sodium azide, similar to the anti-metabolic 
agent we used. We propose the reason sodium azide did not affect outflow was because it 
targets only cellular respiration, which has been shown to provide a minimal amount of the 
energy requirements in the TM192. Similarly, we suggest the rest of the anti-metabolic agents 
used in that study78 failed to inhibit ATP production as thoroughly as our anti-metabolic 
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agents. This could be further confirmed by measuring facility in mouse eyes perfused either 
with sodium azide alone, or sodium azide and 2-deoxy-D-glucose. We hypothesize sodium 
alone will not affect conventional facility, because it does not completely inhibit ATP 
production in the TM, unlike the combination of sodium azide and 2-deoxy-D-glucose. This 
would further consolidate our findings that conventional facility is indeed dependent on 
cellular metabolism, and explain the discrepancies with previous pioneering work. 
8.2.5. AC deepening in mouse eyes 
    Perhaps most importantly, future studies will need to address the potential problem 
associated with AC deepening during perfusions in mice. In Chapter 6 we suggested AC 
deepening might be occurring in mouse eye perfusions, by showing the iris was pushed 
backwards at high pressures. This is known to happen when the posterior chamber is not 
pressurized during perfusions in eyes from other species89,195. Therefore, procedures 
performed in humans to prevent AC deepening could be replicated in mice, such as inserting 
the needle in the posterior chamber or performing iridotomy. The aim would be to show 
these procedures have prevented AC deepening by measuring AH outflow and imaging the 
irido-corneal angle. For example, AH outflow could be measured in an eye cannulated in the 
posterior chamber and compared to its fellow eye cannulated in the AC. The aim would be to 
show lower flow rates occur at high pressures in the eye cannulated in the posterior 
chamber because of a lack of AC deepening.  In addition to measuring AH outflow, we could 
analyse the morphology of the AC of eyes pressurized in the posterior or anterior chamber, 
as done in Chapter 6. This would confirm whether we have indeed prevented the opening of 
the irido-corneal angle. 
    Unfortunately the very small size of mouse eyes will make such procedures extremely 
challenging. If so, that could mean mouse eyes should only be perfused within the pressure 
range immune to such artificial AC deepening effects. In other words, this unconsidered 
phenomenon could pose a major problem for the utility of mouse eye perfusions. 
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Appendix 1: List of cohorts for each chapter  
 
    This table summarizes the effect tested and solutions perfused in either control or 
experimental enucleated mouse eyes per cohort. DBG stands for PBS with 5.5 mM glucose, 
BSA for bovine serum albumin and PFA for Paraformaldehyde. The details of each study 
and compound can be found in the corresponding chapter. 
Chapter Cohort Effect tested on C Control eye Experimental eye 
2 1 Hydration DBG DBG 
2  Temperature DBG DBG 
3 A 
 
3 B 
 
3C 
3 hrs post mortem time in 
PBS 
24 hrs post mortem time 
in PBS  
24 hrs post mortem time 
in DMEM 
DBG 
 
DBG 
 
DBG 
DBG 
 
DBG 
 
DBG 
3 4 S1P BSA+DBG+S1P BSA+S1P 
5A 
 
5B 
 
5C 
W146 on S1P 
 
JTE-013 on S1P 
 
JTE-013 alone 
BSA +DBG + 
S1P 
BSA +DBG + 
S1P 
DBG  
BSA +DBG + S1P+ 
W146 
BSA +DBG + S1P+ 
JTE-013 
DBG+JTE-013 
6A 
6B 
dithia-PGE1 
dithia-PGE1 24 hrs post 
mortem time 
DBG 
DBG 
DBG+ dithia-PGE1 
DBG+ dithia-PGE1 
4 7 Difference between 
strains of mice (CBA/J, 
BALB/cJ, C57BL/6J) 
DBG - 
8 DBG - 
9 DBG - 
5 10 Anti-metabolic agents at 
20 vs. 35°C 
2-deoxy-D-
glucose + 
sodium azide 
2-deoxy-D-glucose 
+ sodium azide 
11 Anti-metabolic agents at 
35°C 
DBG 2-deoxy-D-glucose 
+ sodium azide 
6 12 High pressures  DBG - 
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